US20230015259A1 - Inserter for guiding a device through a hemostasis valve and method thereof - Google Patents
Inserter for guiding a device through a hemostasis valve and method thereof Download PDFInfo
- Publication number
- US20230015259A1 US20230015259A1 US17/810,743 US202217810743A US2023015259A1 US 20230015259 A1 US20230015259 A1 US 20230015259A1 US 202217810743 A US202217810743 A US 202217810743A US 2023015259 A1 US2023015259 A1 US 2023015259A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- tubular body
- distal
- valve
- segment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M39/0693—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof including means for seal penetration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22031—Gripping instruments, e.g. forceps, for removing or smashing calculi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320758—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a rotating cutting instrument, e.g. motor driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3462—Trocars; Puncturing needles with means for changing the diameter or the orientation of the entrance port of the cannula, e.g. for use with different-sized instruments, reduction ports, adapter seals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3498—Valves therefor, e.g. flapper valves, slide valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4444—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
- A61B8/445—Details of catheter construction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/005—Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/005—Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
- A61M25/0053—Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids having a variable stiffness along the longitudinal axis, e.g. by varying the pitch of the coil or braid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0054—Catheters; Hollow probes characterised by structural features with regions for increasing flexibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M25/0138—Tip steering devices having flexible regions as a result of weakened outer material, e.g. slots, slits, cuts, joints or coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00681—Aspects not otherwise provided for
- A61B2017/00685—Archimedes screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/0084—Material properties low friction
- A61B2017/00849—Material properties low friction with respect to tissue, e.g. hollow organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00902—Material properties transparent or translucent
- A61B2017/00907—Material properties transparent or translucent for light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22031—Gripping instruments, e.g. forceps, for removing or smashing calculi
- A61B2017/22034—Gripping instruments, e.g. forceps, for removing or smashing calculi for gripping the obstruction or the tissue part from inside
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22079—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with suction of debris
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A61B2017/2217—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions single wire changing shape to a gripping configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B2017/3454—Details of tips
- A61B2017/3458—Details of tips threaded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
- A61B2090/065—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring contact or contact pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/08—Accessories or related features not otherwise provided for
- A61B2090/0807—Indication means
- A61B2090/0811—Indication means for the position of a particular part of an instrument with respect to the rest of the instrument, e.g. position of the anvil of a stapling instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/306—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/309—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using white LEDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/361—Image-producing devices, e.g. surgical cameras
- A61B2090/3614—Image-producing devices, e.g. surgical cameras using optical fibre
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/373—Surgical systems with images on a monitor during operation using light, e.g. by using optical scanners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
- A61B2090/3782—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
- A61B2090/3784—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument both receiver and transmitter being in the instrument or receiver being also transmitter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/005—Auxiliary appliance with suction drainage system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/007—Auxiliary appliance with irrigation system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
- A61M1/85—Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0004—Catheters; Hollow probes having two or more concentrically arranged tubes for forming a concentric catheter system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0004—Catheters; Hollow probes having two or more concentrically arranged tubes for forming a concentric catheter system
- A61M2025/0006—Catheters; Hollow probes having two or more concentrically arranged tubes for forming a concentric catheter system which can be secured against axial movement, e.g. by using a locking cuff
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
- A61M2025/0046—Coatings for improving slidability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M2025/0183—Rapid exchange or monorail catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
- A61M2025/0687—Guide tubes having means for atraumatic insertion in the body or protection of the tip of the sheath during insertion, e.g. special designs of dilators, needles or sheaths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/125—Heart
Definitions
- Removal of blood clots from the vascular system (thrombectomy) using a trans vascular approach may be accomplished at any of a variety of treatment sites, such as arteries in the extremities, veins for deep vein thrombosis (DVT), large veins and arteries (central vessels) such as iliac veins and arteries, the aorta, the inferior vena cava and pulmonary arteries to treat pulmonary emboli (PE).
- VVT deep vein thrombosis
- PE pulmonary emboli
- VTE venous thromboembolic disease
- DVT and PE are part of the same continuum of disease, with over 95% of emboli originating in the lower extremities.
- PE pulmonary artery
- RV right ventricular
- PE thrombolytic therapy delivered systemically or more locally through Catheter Directed Thrombolytics. These approaches result in multiple catheterization lab visits, lengthy hospital stays and often lead to bleeding complications.
- Newer approaches to PE treatment include single session thrombectomy treatments without the use of thrombolytics. These thrombectomy treatments include delivering a catheter into the PA to remove the thrombus through aspiration, and secondary tools may also macerate or disrupt the thrombus prior to aspiration.
- thrombectomy results in fewer bleeding complications and reduced hospital stays compared to thrombolytics, there is much to be improved upon given the challenges of the procedure itself, including the ability to capture a broad spectrum of thrombus types and reduce the total volume of blood loss during the procedure.
- the thrombectomy catheter is introduced through an introducer puncture in a large diameter vein.
- a flexible guide wire is passed through the introducer into the vein and the introducer is removed.
- the flexible guidewire provides a rail for a flexible guide catheter to be advanced through the right atrium into the right ventricle and into the pulmonary artery.
- the flexible guidewire is removed and replaced with a stiff guidewire.
- the large diameter thrombectomy catheter with support dilator is then advanced over the stiff guidewire to the pulmonary artery and the dilator is removed. If the large diameter thrombectomy catheter is not successful in accessing or aspirating thrombus in a more distal portion of the vessel, a smaller diameter catheter may be inserted through the large diameter catheter.
- peripheral arterial occlusive (PAO) disease occurs in more than 4% of individuals over age 40 and markedly increases in incidence after the age of 70.
- Acute PAO is usually due to thrombosis of the peripheral vasculature and is associated with a significant risk of limb loss.
- therapy for acute PAO centers on the rapid restoration of arterial patency and blood flow such as through mechanical thrombectomy in procedures similar to those described above.
- Clot aspiration using certain commercial vacuum-assisted thrombectomy systems may sometimes need to be terminated due to the risk of excessive blood loss by the patient, especially when using large aspiration catheters.
- aspiration thrombectomy when the catheter tip falls out of contact with the thrombus or other occlusive material, the tip is exposed to healthy blood and full flow of blood through the catheter ensues. Under such conditions, the total volume of blood loss may be excessive, and in some cases, may result in premature termination of the procedure.
- the blood loss rate can be on the order of 30-40 cc per second with an 24 French size catheter. With a maximum tolerable blood loss on the order of about 500 mL, the catheter cannot run in unrestricted mode for more than approximately 10 to 15 seconds. The aggregate blood loss may reach an unacceptable level before sufficient clot is removed.
- a clot capture module for use in a thrombectomy system, such as within the sterile field.
- the clot capture module comprises a housing; a clot capture chamber in the housing; a window in the housing to permit visual inspection of the clot chamber; and a filter in the clot chamber, visible through the window, the filter having an upstream surface and a downstream surface.
- An incoming flow path is configured to direct incoming blood from an aspiration catheter against the upstream surface of the filter.
- An aspiration control valve is provided in the incoming flow path, configured to block or permit the flow of incoming blood.
- An outgoing flow path is configured to direct blood from the second side of the filter to a remote vacuum canister.
- the clot capture module may further comprise a vent valve, openable to permit an optically transparent media such as air or saline to be drawn into the clot chamber, enabling blood to be evacuated from the clot chamber to a remote canister.
- the upstream surface of the filter may be visible through the window, so that clot accumulated on the upstream surface can be visually observed through the window, once the vent has been opened to evacuate blood from the clot capture chamber.
- the window may comprise a transparent cylindrical portion of the housing.
- the upstream surface of the filter may be substantially planar. Alternatively, the upstream surface of the filter may be convex.
- the filter may comprise a tubular porous membrane such as a cylinder, and the upstream surface of the filter may be on a radially outwardly facing surface of the membrane.
- the tubular filter membrane may enclose a filtered blood chamber which is in communication with the outgoing flow path.
- the module may further comprise an aspiration control, for controlling the aspiration control valve.
- the aspiration control may comprise a rocker switch, configured to selectively collapse or allow reopening of a collapsible tubing.
- the aspiration control valve may be normally closed, and may be spring biased into the closed configuration.
- the clot capture module may be provided in combination with a vacuum line leading to an aspiration pump and canister, wherein the clot capture module is configured to reside within a sterile field and the aspiration pump and canister are outside of the sterile field.
- the vacuum line may be at least about 30 inches or 50 inches or more in length.
- a manually actuated aspiration device e.g., a syringe
- an aspiration pump to permit a user to manually apply aspiration through the vacuum line.
- a thrombus engagement tool configured to advance through an aspiration catheter and engage thrombus.
- the thrombus engagement tool comprises a rotatable core wire having a proximal end and a distal end; and a thrombus engagement tip on the distal end of the core wire.
- the tip may comprise a helical thread; an advance segment on a distal side of the thread and a trailing segment on a proximal side of the thread.
- the advance segment, helical thread and trailing segment may all be molded onto the core wire.
- the thrombus engagement tool may further comprise a projection on the core wire, underneath at least one of the advance segment and the trailing segment, to form an interference fit with the thrombus engagement tip.
- the projection may comprise an annular ring, which may be a radiopaque marker.
- the thrombus engagement tool may comprise a first radiopaque marker under the advance segment and a second radiopaque marker under the trailing segment.
- An outer periphery of the helical thread may substantially conform to an inside surface of a cylinder.
- the thread may comprise a proximal surface which inclines radially outwardly in a proximal direction to define a proximally opening undercut.
- the thrombus engagement tool may further comprise a handle on the proximal end of the core wire configured for hand turning the core wire.
- a limit bearing surface may be provided on the handle, for limiting distal projection of the thrombus engagement tip relative to a distal end of the aspiration catheter.
- the method comprises the steps of providing an aspiration catheter having a central lumen and a distal end; advancing the distal end to obstructive material in a vessel; applying vacuum to the lumen to draw clot at least partially into the lumen; and introducing a thrombus engagement tool into the lumen.
- the thrombus engagement tool may have a tip with an axial length of no more than about 1 cm or about 5 mm and a helical thread having a major diameter that is at least about 0.015 inches smaller than an inside diameter of the lumen, to provide an aspiration flow path through the lumen around the outside of the tip.
- the method further comprises manually rotating the tip to engage clot between the tip and an inside wall of the lumen.
- a method of aspirating a vascular occlusion from a remote site comprises the steps of advancing an elongate tubular body through a vascular access site and up to a vascular occlusion, the tubular body comprising a proximal end, a distal end, a central lumen, and a stop surface.
- a rotatable core is advanced distally through the lumen until a limit surface carried by the core rotatably slidably engages the stop surface to provide a rotatable bearing which limits further distal advance of the core within the lumen. Vacuum is applied to the lumen and the core is manually rotated to engage thrombus.
- the advancing the rotatable core may be accomplished after the step of advancing the elongate tubular body through the vascular access site and up to the vascular occlusion.
- the core may be a solid core wire or a cannulated structure such as a hypotube or microcatheter having a central lumen extending axially between a proximal opening and a distal opening.
- the core may carry a proximal handle, and the limit surface may be carried by the handle.
- the tubular body may include a proximal hub, and the stop surface may be carried by the hub.
- the core may carry an engagement tip having a helical thread, and the engaging thrombus step may comprise pinning thrombus between a first side of the tip and an inside surface of the tubular body.
- an inserter for guiding a device through a hemostasis valve comprising an elongate tubular body, having a proximal end, a distal end and a central lumen; a laterally facing concave landing zone on the proximal end, having a radius of curvature that increases in the proximal direction; and an axially extending slit in the sidewall, extending from the distal end to the landing zone.
- the tubular body may further comprise a tapered distal tip, and a proximal pull tab to facilitate removal of the inserter from the device.
- a surface of the landing zone may comprises a different color than an outside surface of the tubular body, to facilitate visualization of the landing zone and advancing the distal end of the device into the tubular body.
- a method of passing a device through a hemostasis valve may comprise the steps of providing an inserter, having a tubular body with a split sidewall; advancing the tubular body through a hemostasis valve; advancing a device through the tubular body and beyond the hemostasis valve; and proximally retracting the tubular body so that the device escapes laterally from the tubular body through the split sidewall, leaving the device in place across the hemostasis valve.
- the advancing the tubular body step may comprise advancing a tapered distal tip on the tubular body through the hemostasis valve.
- the advancing the tubular body through the hemostasis valve step may be accomplished with the device pre loaded inside the tubular body.
- a distal nose segment of the tubular body may expand in diameter in response to advancing the device therethrough.
- the device may be a thrombus engagement tool or a secondary catheter.
- the secondary catheter may be an aspiration catheter.
- FIG. 1 is a schematic view of a thrombus removal system in accordance with the present invention.
- FIG. 2 is a perspective view of a flow control module.
- FIG. 3 is an elevational of cross-sectional view through the flow control module of FIG. 2 .
- FIG. 4 is a schematic view of the dual vacuum chamber configuration that produces an accelerated aspiration response.
- FIG. 5 is a qualitative fluid flow rate diagram at the catheter tip following opening of the vacuum control valve.
- FIG. 6 A is a side elevational view of a thrombus engagement tool.
- FIG. 6 B is an enlarged detail view of the distal end of the thrombus engagement tool of FIG. 6 A .
- FIG. 6 C is a longitudinal elevational cross-section through the thrombus engagement tool of FIG. 6 B .
- FIGS. 7 A- 7 E are side elevational views of various embodiments of thrombectomy catheters.
- FIG. 8 is a cross-sectional view through a distal portion of the embolectomy catheter showing a side wall construction.
- FIG. 9 is a cross-sectional view through a distal portion of the embolectomy catheter showing the radiopaque marker and inclined distal face.
- FIGS. 10 A- 10 B are perspective views of an inserter tool to facilitate passing a catheter through a hemostasis valve.
- FIG. 10 C is an end view of the inserter of FIGS. 10 A and 10 B .
- the system 10 includes a thrombectomy catheter 12 , having an elongate tubular body 14 extending between the proximal end 16 and a distal end 18 .
- a central lumen 20 (not illustrated in FIG. 1 ) extends between a proximal catheter connector 22 and a distal port 24 on the distal end 18 .
- catheters of the present invention can readily be modified to incorporate additional structures, such as permanent or removable column strength enhancing mandrels, two or more lumen such as to permit drug, contrast or irrigant infusion or to supply inflation media to an inflatable balloon carried by the catheter, or any combinations of these features, as will be readily apparent to one of skill in the art in view of the disclosure herein.
- additional structures such as permanent or removable column strength enhancing mandrels, two or more lumen such as to permit drug, contrast or irrigant infusion or to supply inflation media to an inflatable balloon carried by the catheter, or any combinations of these features, as will be readily apparent to one of skill in the art in view of the disclosure herein.
- the disclosure will be described primarily in the context of removing obstructive material from the vasculature, but it will be understood to have applicability as an access catheter for delivery and removal of any of a variety of diagnostics or therapeutic devices with or without aspiration.
- catheters disclosed herein may readily be adapted for use throughout the body wherever it may be desirable to distally advance a low profile high flexibility catheter into a variety of type of vasculature, such as small or large vasculature and/or tortuous or relatively straight vasculature.
- catheter shafts in accordance with any embodiment described herein may be dimensioned for use throughout the neurovascular, coronary and peripheral vasculature, the gastrointestinal tract, the urethra, ureters, Fallopian tubes and other lumens and potential lumens, as well.
- the catheter shaft construction of any embodiment herein may also be used to provide minimally invasive percutaneous tissue access, such as for diagnostic or therapeutic access to a solid tissue target (e.g., breast or liver or brain biopsy or tissue excision), delivery of laparoscopic tools or access to bones such as the spine for delivery of screws, bone cement or other tools or implants.
- a solid tissue target e.g., breast or liver or brain biopsy or tissue excision
- laparoscopic tools or access to bones such as the spine for delivery of screws, bone cement or other tools or implants.
- Catheter 12 will have a length and diameter suitable for the intended access point and target location.
- the catheter 12 may have an effective length from the distal end of manifold or hub 22 to distal tip 18 generally no more than about 230 cm, no more than about 210 cm, no more than about 180 cm, or no more than about 160 cm. and typically from about 50 cm to about 150 cm, from about 90 cm to about 130 cm, or from about 105 cm to about 115 cm.
- the outer diameter of the catheter 10 may be from about 0.035 inches to about 0.15 inches, from about 0.09 inches to about 0.13 inches, and may be lower in a distal segment than in a proximal segment.
- the inner diameter of the catheter 12 in a single central lumen embodiment may be greater than or equal to about 0.1 inches, greater than or equal to about 0.088 inches, or greater than or equal to about 0.08 inches, or greater than or equal to about 0.06.
- the inner diameter of the catheter 12 in a single central lumen embodiment may be less than about 0.20 inches or 0.15 inches, or less than or equal to about 0.11 inches, less than or equal to about 0.1 inches, less than or equal to about 0.088 inches, or less than or equal to about 0.07 inches, and often no more than about 0.095 inches.
- the catheter 12 is releasably connectable to a flow control module 28 by way of a complementary connector module 30 .
- Connector module 30 provides a releasable connection to complementary catheter connector 22 and may include a side port 32 for releasable connection to tubing 34 which may lead to a valve 36 .
- Connector module 30 may additionally comprise a hemostasis valve configured to receive another device such as a guidewire or thrombus engagement tool, discussed below.
- Valve 36 may selectively place tubing 34 into communication with side port 37 or the flow control module 28 discussed in greater detail below.
- Side port 37 may be placed into communication with a source of media such as saline, contrast solution or medication, or a manifold 38 which can provide selective communication with each.
- the use of valve 36 allows infusion of a desired media without detaching the tubing 34 from the connector module 30 .
- the flow control module 28 is in communication with the valve 36 by way of a distal tube 44 .
- Flow control module 28 is in communication with the selector valve 49 by way of a proximal tube 46 . This establishes a flow path between the distal port 24 through the catheter 12 through the various tubing and flow control module 28 to the pump assembly 42 .
- the flow control module 28 may be integrally formed within the hub of thrombectomy catheter 12 to which the catheter 12 may be removably or non-removably attached or within the connector module 30 .
- a manually actuated aspiration device e.g., a syringe
- an aspiration pump assembly 42 may be used in addition to, or as an alternative to, an aspiration pump assembly 42 to permit a user to manually apply aspiration through the vacuum line.
- a manually actuated aspiration device may be in in addition to, or as an alternative to, the pump assembly described in any embodiment herein.
- Flow control module 28 may include a flow regulator such as an on-off control for regulating flow through the flow path between the catheter 12 and pump 42 .
- the flow regulator is configured to provide a reversible restriction in the flow path, such as by an expandable or contractible iris, a ball valve or other rotary core valve, leaf valve, a pinch tubing, or others known in the art.
- the flow regulator comprises a collapsible portion 29 of the tubular wall defining the flow path, such as a section of polymeric tubing.
- An actuator 31 positioned adjacent the tubing is movable in response to a control such as a push button or toggle switch 48 between a first position where it compresses the tubing, thereby completely restricting flow, and a second position where it has moved away from the tubing, allowing the tubing to resume its full inside diameter and allow fluid flow.
- the actuator 31 may be spring biased or have another default driver in the direction of the first (restricted) position, and only movable into the second (open) position in the presence of an affirmative mechanical force or release of a constraint allowing the flow path to open. Upon removal of the momentary “on” command, the actuator 31 automatically resumes the first position, obstructing flow.
- the actuator 31 may be driven by a mechanical control such as a lever or rotatable knob, or an electrically driven system such as a solenoid, operated by any of a variety of buttons, levers, triggers, foot pedals or other switches known in the art, depending upon the desired functionality.
- a mechanical control such as a lever or rotatable knob
- an electrically driven system such as a solenoid, operated by any of a variety of buttons, levers, triggers, foot pedals or other switches known in the art, depending upon the desired functionality.
- the flow control module 28 may contain a filter chamber 33 for example, which is in communication with the vacuum canister 58 on the pump assembly 42 by way of elongate aspiration tubing 40 .
- the toggle switch 48 is in between the filter chamber 33 and the catheter 12 . In a default off position of some embodiments, this allows the entire length of the aspiration tubing 40 and the filter chamber 33 to reach the same low pressure as the aspiration canister 58 on the pump 42 .
- a filter assembly 35 includes an outer tubular sidewall 37 having a transparent window 39 . In some implementations the entire tubular sidewall 37 can be a transparent window.
- the side wall 37 encloses a filter 41 .
- the filter 41 includes a filter sidewall 43 defining an interior (downstream) chamber (not illustrated) for filtered blood.
- blood and thrombus are drawn in the direction from catheter 12 via vacuum line 44 through a first filter aperture 45 and into the clot collection chamber 33 . Any thrombus will be captured on the outside (upstream side) of filter 43 . Blood is drawn through the filter 43 and proximal tubing 46 en route to the canister 58 .
- the filter 43 is tubular however it may alternatively be planar or other shape depending upon the desired configuration.
- the switch 48 may thereafter be closed to compress tubing 29 and isolate the catheter 12 from the vacuum source.
- a normally closed vent 47 may be momentarily opened, to permit intake of an optically transparent media such as saline or ambient air. This allows residual blood in the chamber 33 to be drawn through the filter 43 and aspirated out via proximal tubing 46 , enabling visualization of any clot on the surface of the filter 43 through the window 39 .
- the vent 47 may be manually actuated by a user and/or automatically actuated by the system. In some instances, a user may manually actuate the vent 47 through actuation of a button 62 located on the flow control module 28 .
- the vent 67 may be normally closed, and then transitioned to an open configuration when the button 62 is being actuated (or vice versa). When in the open configuration, the vent 67 may expose the clot collection chamber 33 to an ambient environment. In some instances, exposure of the chamber 33 to the ambient environment allowing intake of air and acceleration of blood flow through the clot collection chamber 33 and towards the proximal tubing. Increased acceleration of blood flow due to vent 47 actuation may facilitate visualization of the clot by displacing the amount of blood or other fluids from the optical path between the window and the filter and/or decrease the amount of time required for the physician to accurately identify the clot in the chamber 33 .
- the valved vent also allows the physician to deliver pulsatile negative pressure waves at the distal opening 24 .
- the flow control module 28 comprises a proximal housing 31 and a distal housing 29 separated by the transparent tubular sidewall 35 .
- the tubular sidewall 35 and the filter 43 are carried by the proximal housing 31 .
- Housing 29 and tubular sidewall 35 may be joined at a releasable connection 33 that, in some instances, includes a gasket 59 to form a sealed connection.
- Complementary surface structures e.g., inclined corresponding grooves and pins or flanges
- the proximal housing 31 and the distal housing 29 may be rotated relative to each other (e.g., by relative rotation across the gasket) to disconnect the housings from each other.
- the filter 43 may be attached to any one of the distal housing 29 or the proximal housing 31 upon disconnection of the housings.
- the tubular sidewall 35 may be attached to either one of the distal housing 29 and/or the proximal housing 31 such that, upon disconnection, the tubular sidewall 35 may remain attached to one of the housings 29 , 31 .
- the tubular sidewall 35 may be configured to remain around the filter 43 or may be configured to be removed from over the filter 43 . In either instance, disconnection of the housings 29 , 31 from each other can expose the filter 43 and allow a clot to be easily accessed and removed.
- the interior surface of the clot collection container 33 may comprise a coating to provide one or more of a variety of properties to the clot collection containers 33 .
- the coating may be configured to enhance visualization through at least a portion of the clot collection container 33 (such as the transparent window 39 ).
- the coating may be configured to inhibit blood accumulation or increase blood repellant properties.
- the clot collection container 33 may comprise a coating to inhibit foam formation during an aspiration procedure.
- the coatings may be located at least partially along an interior surface of the tubular sidewall 35 and/or the clot collection container 33 or along an entire interior surface of the tubular sidewall 35 and/or the clot collection container 33 .
- the coating is located along an interior surface of the transparent window 39 .
- the coating can be both hydrophobic and oleophobic.
- the coating may have some hydrophilic features on a portion of the polymer to increase oleophobic properties.
- Aspiration pump assembly 42 may be releasably placed into communication with flow control module 28 such as by a luer connection between selector valve 45 and tubing 40 .
- Aspiration pump assembly 42 may include a vacuum pump 50 , and may also include a vacuum gauge 51 , and an optional pressure adjustment control 54 .
- the vacuum gauge 51 is in fluid communication with the vacuum pump and indicates the vacuum pressure generated by the pump.
- the pressure adjustment control 54 allows the user to set to a specific vacuum pressure.
- Power button 56 activates the pump 50 .
- the vacuum canister 58 may be provided with a vent 53 to atmosphere, opened or closed by a valve.
- the valve is normally closed to permit vacuum in the canister to reach a desired low pressure.
- the valve may be momentarily opened as desired to permit introduction of air and reduction of the vacuum, such as to reduce foaming within the vacuum canister 58 .
- the vent may function to reduce foaming and increase visibility within the canister.
- the vent 53 comprises a permanently opened vent such as in a lid or side wall of the vacuum canister.
- the vent may comprise an aperture formed through the lid or side wall having a diameter of no more than about 0.5 mm or 0.25 mm and may be a laser cut hole through a metal sheet which may be in the form of a disc carried by the lid.
- the inside surface of the canister 58 may be provided with a coating of one or more materials to inhibit foaming of blood under vacuum.
- the coatings may be located at least partially along or entirely along an interior surface of the vacuum canister 58 .
- the coating can be both hydrophobic and oleophobic. In some instances, the coating may have some hydrophilic features on a portion of the polymer to increase oleophobic properties.
- Aspiration pump 50 may alternatively be a manually activated pump such as a syringe.
- a flow restrictor may be coupled such as by luer connectors in series with the vacuum line 40 .
- the flow restrictors enables toggling between a low flow and a high flow configuration.
- the flow restrictors may comprise a variable restrictor that may be adjusted by a user. This may be accomplished by selectively diverting flow between a relatively smaller diameter and larger diameter aperture, a variable diameter aperture, or other flow regulators such as any of those disclosed in the United States patent publication No. 2021/0315597 to Buck, et al, entitled Aspiration System with Accelerated Response, the disclosure of which is hereby incorporated in its entirety herein.
- a rotatable drum is provided with a first transverse flow path having a first diameter.
- the drum is rotatable within a housing having an inlet port and an outlet port.
- the drum may be rotated to place the inlet port into fluid communication with the outlet port through the first flow path.
- a second flow path having a second, different diameter also extends transversely through the drum, rotationally offset from the first flow path.
- the drum may be rotated to place the inlet port into communication with the outlet port through the second flow path, thereby providing a flow rate through the drum different from the flow rate provided by the first flow path.
- the filter chamber 33 on the flow control module 28 or on the connector module 30 is spaced apart from the remote vacuum pump 42 and vacuum canister 58 to provide enhanced aspiration performance.
- Conventional aspiration pumps and filters are intended to be placed outside of the sterile field and may be far enough away from the patient to require a length of aspiration tubing 40 between the pump assembly 42 and the catheter 12 to be at least about 50 inches or about 100 inches or more.
- the tubing 40 may be about 102 inches.
- the pump typically includes an aspiration canister 58 for blood collection.
- an aspiration canister 58 for blood collection.
- a valve is opened to place the low pressure canister 58 in communication with the catheter 12 by way of the aspiration tubing 40 , to aspirate material from the patient.
- the length of the aspiration tubing extending from inside to outside of the sterile field operates as a flow restrictor, causing a delay between the time of activating the vacuum button on the pump assembly 42 and actual application of suction to the clot at the distal end of the catheter.
- the only flow restriction between a source of vacuum (filter chamber 33 ) and the patient is the relatively short aspiration pathway between the on/off valve in the handpiece actuated by toggle switch 48 and the distal end 18 of the catheter.
- the aspiration control 48 is activated to open the flow path, the flow restriction and enclosed volume on the patient side of the filter chamber 33 is low relative to the flow restriction and enclosed volume through aspiration tubing 40 on the pump side of the filter chamber 33 .
- This dual chamber configuration produces a rapid spike in negative pressure experienced at the distal end 18 of the catheter 12 upon activation of the aspiration control 48 , and rapid filling of the chamber 33 .
- the response time between activating the aspiration control 48 and realizing suction actually experienced at the clot is significantly faster and allows significantly higher initial flow than the response time realized in a conventional system having only a vacuum chamber 58 located at the pump assembly 42 outside of the sterile field.
- the spike of negative pressure experienced at the distal end of the catheter will fade as pressure equilibrium is reached between the filter chamber 33 and canister 58 .
- the vacuum pump 50 will gradually bring the pressure in the filter chamber 33 back down to the level in the vacuum canister 58 at the pump.
- FIG. 4 A simplified fluid flow diagram is illustrated in FIG. 4 , and a qualitative flow rate diagram is illustrated in FIG. 5 .
- the flow restriction between chamber 33 and the distal end 18 of catheter 12 is small relative to the flow restriction between the vacuum canister 58 and the vacuum chamber 33 . This allows a negative pressure peak experienced at distal end 18 almost instantaneously upon activation of vacuum switch 48 .
- the flow rate of material into the catheter 12 rapidly reaches a peak and subsides as vacuum chamber 33 fills with aspirated material.
- the vacuum in chamber 33 declines to a minimum, and slowly recharges by the large vacuum chamber 58 and associated pump through tubing 40 when the toggle switch 48 is moved into the closed position.
- a clinician may choose to close the vacuum switch 48 at or shortly following the maximum flow rate, just giving a short burst or series of bursts of pulsatile vacuum to facilitate spiration of thrombus into the catheter 12 .
- a similar effect may be established by utilizing the vent 47 .
- the vacuum in chamber 33 may decline to a minimum as the button 62 is actuated such that the vent is opened. Thereafter, the vacuum chamber 33 may slowly recharge by the large vacuum chamber 58 and associated pump through tubing 40 when the button 62 and vent 47 are moved into the closed position.
- a clinician may choose to open the vent 47 at or shortly following the maximum flow rate, just giving a short burst or series of bursts of pulsatile vacuum to facilitate spiration of thrombus into the catheter 12 .
- an elongate flexible thrombus engagement tool may be advanced through the aspiration catheter, to facilitate retrieval of the clot.
- the thrombus engagement tool may comprise an elongate flexible shaft having a proximal hand piece such as a knob configured to be rotated by hand.
- the distal end carries a clot engagement tip which may include one or more radially outwardly extending engagement structures such as a helical thread.
- a thrombus engagement tool 80 may comprise an elongate flexible shaft 82 having a proximal end 84 and a distal end 86 .
- a proximal hand piece such as a torquing handle 88 may be configured to be rotated by hand.
- Distal end 86 carries a clot engagement tip 90 which may include one or more radially outwardly extending structures such as a helical thread 92 .
- the handle 88 may have an indicium of rotational direction such as a printed or molded arrow 94 which indicates the direction to rotate the handle 88 in order for the helical thread 92 to engage clot.
- the distal tip 90 includes a helical thread 92 extending between a distal thread end 96 and a proximal thread end 94 and supported by flexible shaft 98 .
- the axial length of the distal tip 90 is at least about 5 mm or 10 mm or 15 mm or 20 mm and in some embodiments no more than about 30 mm or 20 mm measured along the flexible shaft 98 .
- the axial length will be within the range of from about 20 mm to about 25 mm.
- the helical thread 92 wraps around the axis at least about 1 or 2 or 4 or more full revolutions, but in some embodiments no more than about 10 or no more than about 6 revolutions. Preferably, the thread 92 wraps around the axis within the range of from about 2.5 to about 4.5 revolutions. In some embodiments the axial length along the threaded portion of the tip is within the range of from about 5 to about 15 mm, and preferably within the range of from about 8 mm to about 12 mm.
- the helical thread 92 on this implementation may have a constant pitch throughout its length.
- the pitch may be within the range of from about 5 to about 10 threads per inch depending upon desired performance.
- the thread to thread spacing in the axial direction may be within the range of from about 2 mm to about 6 mm, preferably from about 3 mm to about 4 mm.
- the thread may have multiple pitches (e.g. stepped or graduated) designed to engage, transport or grasp thrombus within the catheter lumen.
- a distal pitch may be less than a proximal pitch.
- the pitch may vary continuously along the length of the thread, or may step from a first, constant pitch in a proximal zone to a second, different pitch in a distal zone of the thread.
- the thread 92 may comprise a continuous single helical flange or may have a plurality of discontinuities to produce a plurality of teeth or serrations, arranged helically around the core wire.
- the maximum OD of the thread 92 is preferably smaller than the diameter of a sliding fit within the intended catheter lumen, and may generally be at least about 0.015 inches or at least about 0.010 inches smaller than the catheter lumen ID. In some implementations, the max OD of the tip may be significantly less than the inside diameter of the catheter lumen to allow more space for the thrombus along the side of the tip but still create significant grasping force via lateral engagement of the helical threads with the thrombus.
- the maximum helical thread diameter is about 0.110 inches
- the catheter lumen ID is about 0.275 inches (24 F) (a 0.165 inch gap between the helical threads and catheter wall).
- the maximum OD of the tip is within the range of from about 0.03 to about 0.06 inches within a catheter having a distal end ID within the range from about 0.068 inches to about 0.073 inches. This leaves a substantial tip bypass flow path.
- the max OD of the tip is no more than about 35% or no more than about 40% or no more than about 60% of the ID of the corresponding catheter and may be within the range of from about 35% to about 55% of the catheter ID. In some instances, the max OD of the tip may slightly less than the ID of the corresponding catheter to provide a sliding fit within the intended catheter lumen. For example, the max OD of the tip may be no less than about 90% or no less than about 95% or no less than about 97% of the ID of the corresponding catheter.
- the tip 90 will normally be pushed to one side of the aspiration lumen.
- manual manipulation such as rotation of the tip 90 can engage the clot like a worm gear and either grasp the clot (e.g., by pinning it against the opposing catheter sidewall) for retraction or facilitate freeing the blockage and aid in ingestion of the clot into the catheter.
- Manual manipulation may also include axial proximal and distal reciprocation along with rotation, during aspiration, which can facilitate ingestion of the clot into the catheter.
- annular flow path is created in the annular (if the tip were centered) space between the maximum OD of the tip, and the ID of the catheter lumen.
- This annular flow path cooperates with the vacuum and helical tip to grab and pull obstructive material into the catheter under rotation and vacuum.
- the annular flow path is significantly greater than any flow path created by manufacturing tolerances in a tip configured to shear embolic material between the tip and the catheter wall.
- a cross sectional area of the helical flow path of a tip having a maximum OD in the range of from about 0.0400 to about 0.0406 inches will generally be at least about 0.0003 square inches, and in some embodiments at least about 0.00035 or at least about 0.000375 inches.
- the total aspiration flow path across the helical tip is therefore the sum of the helical flow path through the tip and the annular flow path defined between the OD of the tip and the ID of the catheter lumen.
- Aspiration occurs both through the helical channel formed between adjacent helical threads as well as around the outside of the tip such that the assembly is configured for engaging and capturing embolic material but not shearing it between a sharp edge of the thread and the inside wall of the catheter.
- the distal advance segment 100 advantageously permits the thrombus engagement device 80 to at least partially move past the thrombus without “pushing” the thrombus in a distal direction as the tip 90 is advanced. This may inhibit the thrombus (or any particulate thereof) from passing downstream within the vessel during engagement of the device 80 with the thrombus.
- the distal advance segment 100 can comprise a continuation of the helical thread 92 .
- the distal advance segment 100 may comprise a threaded segment continuing from the helical thread 92 .
- the threaded distal advance segment 100 may maintain an outer diameter consistent with the remainder of the helical thread 92 .
- the threaded distal advance segment 100 may comprise a thread that tapers in a distal direction towards a smaller outer diameter relative to the remainder of the helical thread 92 .
- the helical thread 92 may comprise a proximal cylindrical segment and a distal tapered segment that extends along the distal advance segment 100 .
- the profile of the tip 90 in an end view along the axis of rotation may be circular and/or, in some instances, may vary to create a non circular pattern around the axis of rotation.
- profile may comprise a helical pattern, such as an oval cross-section that rotates along the axis of rotation to create the helical profile.
- the tip as seen in an end elevational view thus may exhibit a major diameter and a minor diameter.
- the minor diameter may be no more than about 95% or 90% or 80% or 70% of the major diameter, depending upon desired performance.
- the outer edge 93 of the thread 92 lies along the surface of a cylinder.
- an outer edge 93 of the thread 92 thus has a linear surface in the axial direction, substantially conforming to the surface of a cylinder.
- a distal side 95 of the thread 92 is inclined radially outwardly in a proximal direction.
- a proximal side 97 of the thread 92 also inclines radially outwardly in a proximal direction thereby defining a proximally facing undercut along the length of the thread.
- the illustrated tip 90 includes an atraumatic, tapered distal advance segment 100 extending between an atraumatic distal tip at 102 and a transition to the distal end 96 of the thread 92 .
- Helical thread 92 extends proximally from the transition to a proximal end 94 of the helical thread 92 .
- a trailing segment 104 may extend between the proximal end 94 of the thread and the proximal end 106 of the tip.
- the axial length of the distal advance segment 100 may be at least about 5 mm or at least about 8 mm or 9 mm and generally less than about 15 mm, and in some implementations is within the range of from about 8 mm to about 12 mm.
- the outside diameter of the flexible shaft 82 is generally less than about 0.02 inches, or less than about 0.015 inches and, in one implementation, is about 0.008 inches.
- the flexible shaft 82 may comprise a distal tapered section.
- the distal tapered section may advantageously increase tip flexibility and/or maximize aspiration.
- the outside diameter at the distal end of the distal tapered section of the flexible shaft 82 is generally less than about 0.01 inches, or less than about 0.008 inches and, in one implementation, is no more than about 0.006 inches.
- the outside diameter of the advance segment 100 at distal tip 102 is generally less than about 0.024 inches, or less than about 0.020 inches and, in one implementation, is about 0.018 inches.
- the maximum outside diameter of the advance segment 100 and helical thread 92 may be within the range from about 0.020 to about 0.045 inches, and, in one implementation, is less than about 0.040 inches, such as about 0.035 inches.
- the advance segment, helical thread and trailing segment of the tip 90 may be molded as a single piece over the flexible shaft 82 using any of a variety of polymers known in the catheter arts.
- a first radiopaque marker 110 may be carried on the flexible shaft 82 beneath the advance segment 100 .
- a second radiopaque marker 112 may be carried on the flexible shaft 82 within the trailing segment 104 .
- Each radiopaque marker may comprise a radiopaque tube or a coil of radiopaque wire such as a platinum iridium alloy wire having a diameter about 0.002 inches and positioned or wrapped around the flexible shaft 82 and soldered to the flexible shaft 82 to produce an RO sleeve or coil having an outside diameter of less than about 0.020 inches, such as about 0.012 inches.
- the radiopaque markers may also provide an axial interference fit between the flexible shaft 82 and the advance segment 100 and trailing segment 104 to resist core wire axial pull out from the tip 90 (tip detachment).
- the maximum OD of the thread 92 exceeds the maximum OD of the advance segment 100 by at least about 15% or 25% or 30% or more of the OD of the advance segment 100 , to facilitate crossing the clot with the advance segment 100 and engaging the clot with the thread 92 .
- the distal tip 102 may be permitted to extend at least about 2 cm or 3 cm and preferably as much as 4 to 8 cm beyond the catheter (such as to permit manual removal of engaged thrombus), but generally will be limited to extend no more than a preset distance such as 12 cm or 8 cm or 5 cm beyond the catheter (e.g., within the range of from about 5 cm to about 10 cm) depending upon desired performance.
- Distal advance of the tip 102 may be limited by providing mechanical interference at the desired distal limit of travel.
- a distal stop surface 114 which may be on the handle 88 (see FIG. 6 A ) provides an interference engagement with a complementary proximal surface (e.g. proximal surface 33 on connector module 30 or on the catheter hub) carried by the aspiration catheter through which the thrombus engagement tool 80 is advanced.
- a distal engagement surface can be carried anywhere along the length of the thrombus engagement tool 80 , for sliding rotational engagement with a complementary proximally facing stop surface carried by the catheter. Additional details of distal limit configurations may be found in U.S.
- the limit on distal advance of the helical tip may enable a first configuration in which the distal tip may be advanced through the catheter and placed at a first position approximately aligned with the distal end of the catheter 12 . The physician may then advance the tip to a second position extending beyond the distal end of the catheter such as for inspection and cleaning purposes.
- a position indicator 85 may be carried by the flexible shaft 82 spaced apart from the distal surface 114 by a distance corresponding to the maximum length of the thrombus engagement tool intended to extend beyond the distal end of the catheter.
- the distal tip 102 may be positioned approximately at the distal end of the catheter. This way the physician will know that any further distal advance of the thrombus engagement tool will be extending beyond the distal end of the catheter. The maximum extension will be reached when the distal surface 114 contacts the catheter hub.
- the position indicator 85 may comprise any of a variety of visual or tactile features, such as a color change or a colored band surrounding the flexible shaft 82 .
- a visual indicium implementation color change or circumferential line
- the distal tip 102 may be positioned approximately at the distal end of the catheter when the indicator is visible just outside of the hub.
- the position indicator 85 comprises the transition between the distal end of the hypo tube 87 and the underlying flexible shaft 82 . This provides haptic feedback as the indicator (step in outside diameter) encounters and passes through the valve of the RHV.
- the hypo tube 87 additionally functions as a strain relief or anti buckling feature and may have an axial length within the range of from about 3 cm to about 15 cm and in some implementations within the range of from about 5 cm to about 9 cm.
- a distal segment 120 may have a length within the range of about 1-3 cm and a durometer of less than about 35 D or 30 D.
- An adjacent proximal segment 122 may have a length within the range of about 4-6 cm, and a durometer of less than about 35 D or 30 D.
- An adjacent proximal segment 124 may have a length within the range of about 4-6 cm, and a durometer of about 35 D or less.
- An adjacent proximal segment 126 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35 D to about 45 D (e.g., 40 D).
- An adjacent proximal segment 128 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 50 D to about 60 D (e.g., about 55 D).
- An adjacent proximal segment 130 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35 D to about 50 D to about 60 D (e.g., about 55 D).
- An adjacent proximal segment 132 may have a length within the range of about 1-3 cm, and a durometer of at least about 60 D and typically less than about 75 D. More proximal segments may have a durometer of at least about 65 D or 70 D.
- the distal most two or three segments may comprise a material such as Tecothane and/or PEBAX, and more proximal segments may comprise PEBAX or other catheter jacket materials known in the art. At least three or five or seven or nine or more discrete segments may be utilized, having a change in durometer between highest and lowest along the length of the catheter shaft of at least about 10 D, preferably at least about 20 D and in some implementations at least about 30 D or 40 D or more.
- FIGS. 7 A- 7 E illustrate various embodiments of catheters, at least some of which incorporate a plurality of catheter outer jacket segments with varying lengths and/or hardness for varying flexibility along the length of the catheter body. It will be understood that any of the features shown or described in connection with any of the catheters of FIGS. 7 A- 7 E can be used with any of the embodiments described and/or contemplated herein. It will also be understood that any of the features described and/or contemplated in connection with any of the embodiments disclosed herein can be utilized with any of the catheters described in connection with FIGS. 7 A- 7 E . As with all embodiments in this specification, any feature, structure, material, method, or step that is described and/or illustrated in the embodiments of FIGS. 7 A- 7 E can be used with or instead of any feature, structure, material, method, or step that is described and/or illustrated in any other embodiment of this specification.
- FIGS. 7 B- 7 E illustrates embodiments of various catheters 400 , 500 , 600 .
- the catheters 400 , 500 , 600 may include differing properties (e.g., such as length, diameter, etc.) such that one or more of the catheters 400 , 500 , 600 may interact with any of the other catheters 400 , 500 , 600 in any various manner.
- each of catheters 400 , 500 , 600 may comprise a different size to permit the catheters 400 , 500 , 600 to at least partially extend through one or more of the other catheters 400 , 500 , 600 .
- the lengths of each of the catheters 400 , 500 , 600 may vary so as to permit a smaller catheter to pass through and extend distally beyond a larger catheter in a telescoping manner.
- catheter 500 may be configured to pass through and extend beyond catheter 400 .
- catheter 600 may be configured to pass through and extend beyond at least one of catheter 500 or catheter 400 in a telescoping manner.
- FIG. 7 E illustrates an example telescoping catheter stack including each of catheters 400 , 500 , 600 , it will be understood by one having skill in the art that any combination of catheters 400 , 500 , 600 may be utilized.
- a system may incorporate the use of catheter 400 and catheter 500 , the use of catheter 400 and catheter 600 , or the use of catheter 500 and catheter 600 .
- Catheter 400 may comprise an 8 F catheter. In some instances, catheter 400 comprises a diameter larger than the diameter of any of the remaining catheters in a system. Additionally, or alternatively, catheter 400 may comprise an overall length shorter than the length of any of the remaining catheters in a system. In this manner, catheter 400 may comprise the outermost catheter in a telescoping system and may permit any of the remaining catheters 500 , 600 to extend distally beyond a distal end of catheter 400 .
- the catheter 400 may comprise a length between about 35 cm and about 105 cm or, a length between about 45 cm and about 95 cm.
- the catheter 400 may comprise a length of from about 50 cm to about 90 cm.
- the catheter 400 may comprise a length at least shorter than any catheter with a diameter smaller than catheter 400 (e.g., such as catheter 500 , 600 ).
- Catheter 500 may comprise a 6 F catheter.
- catheter 500 comprises a diameter in between the diameters of the remaining catheters in a system.
- catheter 500 may comprise a length in between the lengths of the remaining catheters in the system.
- catheter 500 may comprise a middle catheter in a telescoping system and may be configured to pass through and extend beyond one or more catheters while also permitting another catheter to extend distally beyond a distal end of catheter 500 .
- the catheter 500 may comprise a length between about 120 cm and about 155 cm or between about 130 cm and about 145 cm.
- the catheter 500 may comprise a length of about from 135 cm to about 137 cm.
- the catheter 500 may comprise a length at least longer than any catheter with a diameter larger than catheter 500 (e.g., such as catheter 400 ).
- the catheter 500 may comprise a length at least shorter than any catheter with a diameter smaller than catheter 500 (e.g., such as catheter 600 ).
- Catheter 600 may comprise a 5 F catheter. In some instances, catheter 600 comprises a diameter smaller than the diameters of the remaining catheters in a system. Additionally, or alternatively, catheter 600 may comprise a length longer than the lengths of any of the remaining catheters in the system. In this manner, catheter 600 may comprise an innermost catheter in a telescoping system and may be configured to pass through and extend beyond one or more of the other catheters.
- the catheter 600 may comprise a length between about 145 cm and about 175 cm or between about 155 cm and about 165 cm.
- the catheter 600 may comprise a length of about 160 cm.
- the catheter 600 may comprise a length at least longer than any catheter with a diameter larger than catheter 600 (e.g., such as catheter 400 , 500 ).
- One or more of the catheters 400 , 500 , 600 may include a coil and/or a braid in the sidewall extending through at least a portion of the sidewall of the catheter 400 , 500 , 600 , as discussed herein.
- the braid may have properties that vary along the length of each catheter 400 , 500 , 600 to generate a variety of desired characteristics of the catheter 400 , 500 , 600 .
- a wire density of the braid may vary gradually or in steps along the length of the catheter 400 , 500 , 600 and/or vary between discrete sections of the catheter 400 , 500 , 600 .
- Catheter 600 may comprise one or more discrete sections with braid properties varying between one or more of the sections.
- catheter 600 may comprise a first section, a second (e.g., intermediate) section, and a third distal section.
- a sidewall property such as a length and/or a wire density the braid along a respective section, may vary between the sections.
- a pics per inch (ppi) count of the braid in connection with the wire density of the braid may gradually transition between one or more of the catheter sections.
- the ppi count of the braid in some instances, may remain generally consistent through a length of the first section and a length of the third section but gradually transition along the length of the second, intermediate section.
- the first section of catheter 600 may have a length of at least about 20 cm.
- the length of the first section may be from about 25 cm to about 35 cm or, in one example, about 30 cm.
- the braid through the first section may have a wire density of at least about 100 ppi.
- the braid through the first section may have wire density of at least about 120 ppi or, more specifically, about 130 ppi.
- the third section of catheter 600 may have a length of at least about 100 cm.
- the length of the third section may be from about 120 cm to about 140 cm or, more specifically, about 130 cm.
- the braid through the third section may have a wire density of no greater than about 85 ppi.
- the braid through the third section may have wire density from about 70 ppi to about 80 ppi.
- the second section of catheter 600 may be an intermediate section between the first section and the third section.
- the second section may have a length of at least about 3 cm. In some instances, the second section may have a length no greater than about 20 cm or, more specifically, no greater than about 10 cm. For example, the length of the second section may be about 5 cm.
- the braid through the second section may have a wire density of no greater than the wire density of the first section and no less than the wire density of the third section.
- Catheter 500 may comprise one or more discrete sections with braid properties varying between one or more of the sections.
- catheter 500 may comprise a first section, a second (e.g., intermediate) section, and a third section.
- a sidewall property such as a length and/or a wire density the braid along a respective section, may vary between the sections.
- a ppi count of the braid in connection with the wire density of the braid may gradually transition between one or more of the catheter sections.
- the ppi count of the braid in some instances, may remain generally consistent through a length of the first section and a length of the third section but gradually transition along the length of the second, intermediate section.
- the first section of catheter 500 may have a length of at least about 20 cm.
- the length of the first section may be from about 25 cm to about 35 cm or, in one example, about 30 cm.
- the braid through the first section may have a wire density of at least about 100 ppi.
- the braid through the first section may have wire density of at least about 120 ppi or, in one example, about 130 ppi.
- the third section of catheter 500 may have a length of at least about 80 cm.
- the length of the third section may be from about 100 cm to about 120 cm or, in one example, about 105 cm.
- the braid through the third section may have a wire density of no greater than about 100 ppi.
- the braid through the third section may have wire density from about 80 ppi to about 90 ppi.
- the second section of catheter 600 may be an intermediate section between the first section and the third section.
- the second section may have a length of at least about 3 cm. In some instances, the second section may have a length no greater than about 20 cm or, more specifically, no greater than about 10 cm. For example, the length of the second section may be about 5 cm.
- the braid through the second section may have a wire density of no greater than the wire density of the first section and no less than the wire density of the third section.
- Catheter 400 may comprise one or more discrete sections with braid properties varying between one or more of the sections.
- catheter 400 may comprise one section.
- the catheter 400 may comprise a greater number of sections (e.g., two sections, three sections, four sections, or greater).
- catheter 400 may comprise three sections as described in connection with either one or catheter 500 or catheter 600 .
- a sidewall property, such as a length and/or a wire density the braid, may vary along catheter 400 .
- a ppi count of the braid in connection with the wire density of the braid may gradually transition to increasing flexibility in a distal direction along catheter 400 .
- the section of catheter 400 may have a length of at least about 40 cm.
- the length of the section may be from about 50 cm to about 60 cm or, in one example, about 55 cm.
- the braid through the section may have a wire density of at least about 80 ppi.
- the braid through the section may have wire density of at least about 90 ppi.
- the braid in some instances, may extend along an entire length of the catheter sidewall. In some instance, a junction between the braid and a coil is not present in the catheter and/or the catheter sidewall does not incorporate a coil. It will be understood that this braid configuration may be applied to any catheter disclosed herein, including, but not limited to, catheters 400 , 500 , 600 .
- One or more of the catheters 400 , 500 , 600 may an outer jacket segment stacking pattern for a progressive flexibility catheter.
- the outer jacket segment may each have properties that vary along the length of each catheter 400 , 500 , 600 to generate a variety of desired characteristics of the catheter 400 , 500 , 600 .
- each segment of the outer jacket may have a corresponding Shore D hardness to vary the flexibility along the length of the catheter 400 , 500 , 600 .
- the outer jacket segments may be made of a thermoplastic elastomer made of flexible polyether and rigid polyamide (e.g., Pebax®).
- each segment of the outer jacket may comprise a different variation of the thermoplastic elastomer to alter flexiblity.
- Catheter 600 may comprise a plurality of discrete segments of the outer jacket with varying flexibility between one or more of the segments.
- catheter 600 may comprise a plurality of segments.
- a sidewall property, such as Shore D hardness and/or flexibility, may vary between the segments.
- a Shore D hardness of the outer jacket segments may gradually transition from higher at proximal end segment of the outer jacket to lower at a distal end segment of the outer jacket.
- the proximal end segment of the outer jacket of the catheter 600 may have a Shore D hardness of at least about 60.
- the Shore D hardness of the proximal end segment may be from about 70 to about 80 or, more specifically, at least about 75.
- the distal end segment of the outer jacket of the catheter 600 may have a Shore D hardness of at most about 40.
- Shore D hardness of the distal end segment may be from about 30 to about 20 or, more specifically, no more than about 27.
- a plurality of the intermediate segments between the distal end segment and the proximal end segment may each comprise a variety of Shore D hardness.
- each segment decreases in a Shore D hardness in a distal direction and may have a smaller Shore D hardness than a proximally adjacent segment.
- the Shore D hardness of a first segment may be from about 30 to about 50 or, more specifically, about 40.
- the first segment in some instances, may be between positioned about 120 cm to about 160 cm or, more specifically, about 140 cm away from a distal end face of the catheter 600 .
- the Shore D hardness of the second segment may be from about 50 to about 70 or, more specifically, about 65.
- the second segment in some instances, may be between positioned about 220 cm to about 260 cm or, more specifically, about 240 cm away from a distal end face of the catheter 600 .
- Catheter 500 may comprise a plurality of discrete segments of the outer jacket with varying flexibility between one or more of the segments.
- catheter may comprise a plurality of segments.
- a sidewall property, such as Shore D hardness and/or flexibility, may vary between the segments.
- a Shore D hardness of the outer jacket segments may gradually transition from higher at a proximal end segment of the outer jacket to lower at a distal end segment of the outer jacket.
- the proximal end segment of the outer jacket of the catheter 500 may have a Shore D hardness of at least about 60.
- the Shore D hardness of the proximal end segment may be from about 70 to about 80 or, more specifically, at least about 75.
- the distal end segment of the outer jacket of the catheter 500 may have a Shore D hardness of at most about 40.
- Shore D hardness of the distal end segment may be from about 30 to about 20 or, more specifically, no more than about 27.
- a plurality of the intermediate segments between the distal end segment and the proximal end segment may each comprise a variety of Shore D hardness.
- each segment decreases in a Shore D hardness in a distal direction and may have a smaller Shore D hardness than a proximally adjacent segment.
- the Shore D hardness of a first segment may be from about 30 to about 50 or, more specifically, about 40.
- the first segment in some instances, may be between positioned about 70 cm to about 110 cm or, more specifically, about 90 cm away from a distal end face of the catheter 500 .
- the Shore D hardness of a second segment may be from about 50 to about 70 or, more specifically, about 65.
- the second segment in some instances, may be between positioned about 160 cm to about 200 cm or, more specifically, about 180 cm away from a distal end face of the catheter 500 .
- Catheter 400 may comprise a plurality of discrete segments of the outer jacket with varying flexibility between one or more of the segments.
- catheter 400 may comprise a plurality of segments.
- a sidewall property, such as Shore D hardness and/or flexibility, may vary between the segments.
- a Shore D hardness of the outer jacket segments may gradually transition from a proximal end segment of the outer jacket to a distal end segment of the outer jacket.
- the proximal end segment of the outer jacket of the catheter 400 may have a Shore D hardness of at least about 60.
- the Shore D hardness of the proximal end segment may be from about 70 to about 80 or, more specifically, about 75.
- the distal end segment of the outer jacket of the catheter 400 may have a Shore D hardness of at most about 40.
- Shore D hardness of the distal end segment may be from about 30 to about 20 or, more specifically, no more than about 27.
- a plurality of the intermediate segments between the distal end segment and the proximal end segment may each comprise a variety of Shore D hardness.
- each segment decreases in a Shore D hardness in a distal direction and may have a smaller Shore D hardness than a proximally adjacent segment.
- the Shore D hardness of a first segment may be from about 30 to about 50 or, more specifically, about 40.
- a first segment in some instances, may be between positioned about 65 cm to about 105 cm or, more specifically, about 85 cm away from a distal end face of the catheter 400 .
- the Shore D hardness of a second segment may be from about 40 to about 65 or, more specifically, about 55.
- the second segment in some instances, may be between positioned about 105 cm to about 145 cm or, more specifically, about 125 cm away from a distal end face of the catheter 400 .
- the Shore D hardness of a third segment may be from about 60 to about 80 or, more specifically, about 70.
- the third segment in some instances, may be between positioned about 140 cm to about 180 cm or, more specifically, about 160 cm away from a distal end face of the catheter 400 .
- Catheter 400 may comprise a tubular body length of about 90+/ ⁇ 5 cm. In some instances, catheter 400 may comprise a tubular body length of about 50+/ ⁇ 5 cm. A number of the plurality of discrete segments of the outer jacket of catheter 400 may vary with respect to the tubular body length of catheter 400 . A length of the respective segments of the plurality of discrete segments of the outer jacket of catheter 400 may vary with respect to the tubular body length of catheter 400 .
- a coating in some instances, may be located along an outer diameter of a distal portion of the catheter sidewall.
- the coating can be configured to decrease frictional resistance of the distal portion of the catheter sidewall with any adjacent structure (e.g., a vessel wall). In some instances, the coating increases the lubriciousness of the catheter distal portion outer sidewall.
- the coating may advantageously reduce friction on the distal end of the catheter going through tortuous vasculature. This may facilitate advancement and rotation of the catheter distal end, particularly in situations where the catheter contains an increased flexibility along a distal end portion of the catheter.
- the coating may extend in a proximal direction from, or proximate to, a catheter distal end face. The coating may extend at least about 20 cm in a proximal direction.
- the coating extends no farther than about 50 cm from the catheter distal end face.
- the coating may extend for a length of about 25 cm to about 35 cm or, more specifically, about 30 cm from a catheter distal end face. It will be understood that the coating may be applied to any catheter disclosed herein, including, but not limited to, catheters 400 , 500 , 600 .
- FIG. 8 illustrates a cross section through the sidewall of a distal portion of a single lumen catheter.
- An internal support layer may comprise either a coil or braid.
- adjacent loops or filars of the coil 140 may have a constant pitch throughout the length of the coil or may be closely tightly wound in a proximal zone with a distal section having looser spacing between adjacent loops.
- At least the distal about 1 cm or about 2 cm or about 3 cm or about 4 cm of the coil will have a spacing that is at least about 130%, and in some implementations at least about 150% or more than the spacing in the proximal coil section.
- the spacing in the proximal coil may be about 0.004 inches and in the distal section may be at least about 0.006 inches or about 0.007 inches or more.
- the distal end of the coil or braid 140 can be spaced proximally from the distal end of the inner liner 142 , for example, to provide room for an annular radiopaque marker 144 .
- the coil or braid 140 may be set back proximally from the distal end, in some embodiments, by approximately no more than about 1 cm, about 2 cm, or about 3 cm.
- the distal end of the catheter 12 is provided with a beveled (inclined) distal surface 146 residing on a plane having an angle of at least about 10 degrees or about 20 degrees and in one embodiment about 30 degrees with respect to a longitudinal axis of the catheter 10 .
- At least a distally facing edge of the annular radiopaque marker 144 may be an ellipse, residing on a plane which is inclined with respect to the longitudinal axis to complement the bevel angle of the distal surface 146 . Additional details are described in connection with FIG. 9 below.
- the distal braid or coil and the RO marker 144 are provided with an outer jacket 156 such as a polymer tube formed from a plurality of axially adjacent cylindrical segments to enclose the catheter body 16 .
- the outer sleeve 156 may comprise any of a variety of materials, such as polyethylene, polyurethane, polyether block amide (e.g., PEBAXTM), nylon or others known in the art. Sufficient heat is applied to cause the polymer to flow into and embed the proximal braid and distal coil.
- the outer jacket 156 is formed by sequentially advancing a plurality of short tubular segments 133 , 132 , 130 , 128 , 126 , 124 , 122 , 120 concentrically over the catheter shaft subassembly, and applying heat to shrink the sections on to the catheter 12 and provide a smooth continuous outer tubular body.
- the foregoing segmented construction may extend along at least the most distal about 10 cm, and preferably at least about the most distal about 20 cm, about 25 cm, about 30 cm, about 35 cm, about 40 cm, or more than about 40 cm of the catheter body 10 .
- the entire length of the outer jacket 156 may be formed from tubular segments and the length of the distal tubular segments may be shorter than the one or more tubular segments forming the proximal portion of the outer jacket 156 proximal to the junction between the braid 150 and coil 140 in order to provide proximal backup support and steeper transitions in flexibility toward the distal end of the catheter 12 .
- the durometer of the outer wall segments may decrease in a distal direction.
- proximal segments such as 133 and 132
- proximal segments such as 133 and 132
- a 25 cm section may have at least about 3 or about 5 or about 7 or more segments and the catheter 12 overall may have at least about 6 or about 8 or about 10 or more distinct flexibility zones.
- the distal 1 or 2 or 4 or more segments 122 , 120 may have a smaller OD following shrinking than the more proximal segments 133 - 124 to produce a step down in OD for the finished catheter body 16 .
- the length of a lower OD section 160 may be within the range of from about 3 cm to about 15 cm and, in some embodiments, is within the range of from about 5 cm to about 10 cm such as about 7 cm or about 8 cm and may be accomplished by providing the distal segments 122 , 120 with a lower wall thickness.
- the most distal portion of the catheter 12 may comprise a durometer of less than approximately 35 D (e.g., 25 D) to form a highly flexible distal portion of the catheter and have a length between approximately 25 cm and approximately 35 cm.
- the distal portion may comprise one or more tubular segments of the same durometer (e.g., segment 120 ).
- a series of proximally adjacent tubular segments may form a transition region between a proximal stiffer portion of the catheter 12 and the distal highly flexible portion of the catheter.
- the series of tubular segments forming the transition region may have the same or substantially similar lengths, such as approximately 1 cm.
- each of the series of tubular segments may provide a steep drop in durometer over the transition region.
- the transition region may have a proximal tubular segment 122 (proximally adjacent the distal portion) having a durometer of approximately 35 D.
- An adjacent proximal segment 124 may have a durometer of approximately 55 D.
- An adjacent proximal segment 126 may have a durometer of approximately 63 D.
- An adjacent proximal segment 128 may have a durometer of approximately 72 D.
- More proximal segments may comprise a durometer or durometers greater than approximately 72 D and may extend to the proximal end of the catheter.
- a catheter segment may comprise a proximal portion greater than approximately 72 D between about 1 cm and about 3 cm. In some embodiments, the proximal portion may be about 2 cm long.
- the most distal segments e.g., 120 , 122
- more proximal segments may comprise a generally stiffer material, such as Vestamid®.
- the inner diameter of the catheter 10 may be between approximately 0.06 and 0.08 inches, between approximately 0.065 and 0.075 inches, or between approximately 0.068 and 0.073 inches. In some embodiments, the inner diameter is approximately 0.071 inches.
- the distal most portion may step or taper to a decreased inner diameter such as under segments 122 and 120 .
- the taper may occur approximately between the distal highly flexible portion and the transition region (e.g., over the most proximal portion of the distal highly flexible portion).
- the taper may be relatively gradual (e.g., occurring over approximately 10 or more cm) or may be relatively steep (e.g., occurring over less than approximately 5 cm).
- the inner diameter may taper to an inner diameter between about 0.03 and about 0.06 inches.
- the inner diameter may be about 0.035 inches, about 0.045 inches, or about 0.055 inches at the distal end of the catheter 12 .
- the inner diameter may remain constant, at least over the catheter extension segment.
- the coil 140 may extend proximally from a distal end of the catheter 12 along the highly flexible distal portion ending at or overlapping with the distal end of the braid 150 . In other embodiments, the coil 140 may extend the entire length of the catheter 12 .
- the braid 150 when present, may extend from about the transition 163 the proximal end of the coil 140 to the proximal end of the catheter 12 .
- distal catheter tip 18 comprises a tubular body 14 which includes an advance segment 200 , and a marker band 144 .
- An inner tubular liner 142 may extend throughout the length of the distal catheter tip and may comprise dip coated PTFE.
- a reinforcing element 140 such as a braid and/or spring coil is embedded in an outer jacket which may extend the entire length of the catheter proximally of the radiopaque marker.
- the advance segment 200 terminates distally in an angled face 146 , to provide a leading side wall portion 202 having a length measured between the distal end 204 of the marker band 144 and a distal tip 206 .
- a trailing side wall portion 208 of the advance segment 200 has an axial length in the illustrated embodiment of approximately equal to the axial length of the leading side wall portion 202 as measured at approximately 180 degrees around the catheter from the leading side wall portion 202 .
- the leading side wall portion 202 may have an axial length within the range of from about 0.1 mm to about 5 mm and generally within the range of from about 1 to 3 mm.
- the trailing side wall portion 208 may be at least about 0.1 or 0.5 or 1 mm or 2 mm or more shorter than the axial length of the leading side wall portion 202 , depending upon the desired performance.
- the angled face 146 inclines at an angle A within the range of from about 45 degrees to about 80 degrees from the longitudinal axis of the catheter.
- the angle is within the range of from about 50 degrees to about 70 degrees or within the range of from about 55 degrees to about 65 degrees from the longitudinal axis of the catheter.
- the angle A is about 60 degrees.
- One consequence of an angle A of less than 90 degrees is an elongation of a major axis of the area of the distal port which increases the surface area of the port and may enhance clot aspiration or clot retention.
- the area of the angled port is generally at least about 105%, and no more than about 130%, in some implementations within the range of from about 110% and about 125% and in one example is about 115%.
- the axial length of the advance segment is substantially constant around the circumference of the catheter, so that the angled face 146 is approximately parallel to the distal surface 210 of the marker band 144 .
- the marker band 144 has a proximal surface approximately transverse to the longitudinal axis of the catheter, producing a marker band 144 having a right trapezoid configuration in a side elevational view.
- a short sidewall 212 is rotationally aligned with the trailing side wall portion 208 , and has an axial length within the range of from about 0.2 mm to about 4 mm, and typically from about 0.5 mm to about 2 mm.
- An opposing long sidewall 214 is rotationally aligned with the leading side wall portion 202 .
- Long sidewall 214 of the marker band 144 is generally at least about 10% or 20% longer than short sidewall 212 and may be at least about 50% or 70% or 90% or more longer than short sidewall 212 , depending upon desired performance. Generally, the long sidewall 214 will have a length of at least about 0.5 mm or 1 mm and less than about 5 mm or about 4 mm.
- any of the marker bands described herein may be a continuous annular structure, or may optionally have at least one and optionally two or three or more axially extending slits throughout its length.
- the slit may be located on the short sidewall 212 or the long sidewall 214 or in between, depending upon desired bending characteristics.
- Any of the marker bands described herein may comprise any of a variety of radiopaque materials, such as a platinum/iridium alloy, with a wall thickness preferably no more than about 0.003 inches and in one implementation is about 0.001 inches.
- the advance segment 200 may comprise a distal extension of the outer polymer jacket and optionally the inner liner, without other internal supporting structures distally of the marker band 144 .
- the outer jacket may comprise extruded Tecothane and/or PEBAX.
- the advance segment 200 may have a bending stiffness and radial crush stiffness that is no more than about 50%, and in some implementations no more than about 25% or 15% or 5% or less than the corresponding value for the adjacent proximal catheter body.
- the proximal end of the catheter 12 is preferably provided with a hemostasis valve, to facilitate introduction of a thrombus engagement tool or a secondary catheter there through.
- the hemostasis valve may be carried by the connector module 30 , or directly by the proximal catheter connector 22 . Any of a variety of hemostasis valve configurations may be used.
- valve inserter in accordance with another embodiment.
- the inserter enables opening a valve (e.g., the hemostasis valve and/or an introducer sheath valve having an elastomeric membrane valve with a passive slit) and supporting it in an open configuration while providing an access lumen therethrough to enable a delicate secondary device such as a thrombus engagement tool or a catheter to advance therethrough without encountering any resistance or damage from the valve.
- a valve e.g., the hemostasis valve and/or an introducer sheath valve having an elastomeric membrane valve with a passive slit
- the inserter 300 comprises an elongate tubular body 302 having a proximal end 304 , a distal end 306 , and a central lumen 308 extending therethrough.
- the tubular body 302 has an inside diameter sufficient to accommodate the secondary device, and an OD capable of passing through a compatible hemostasis valve.
- tubular body will have an outside diameter within the range of from about 0.04′′ to about 0.1, and a length within the range of from about 1′′ to about 4′′.
- Tubular body 302 can be formed as an extrusion from any of a variety of common catheter polymers such as Nylon, PEEK, polyethylene, polyimide or others known in the art having sufficient crush resistance and column strength to enter and to maintain patency under the closing pressure of a hemostasis valve.
- common catheter polymers such as Nylon, PEEK, polyethylene, polyimide or others known in the art having sufficient crush resistance and column strength to enter and to maintain patency under the closing pressure of a hemostasis valve.
- the proximal end 304 of the tubular body 302 may be provided with a funnel shaped landing zone 322 leading to the central lumen, to facilitate introducing the distal tip of the secondary device into the inserter.
- the proximal end of the tubular body is provided with an inclined face 314 .
- a distal, leading edge 316 of the inclined face 314 is axially distally spaced apart from the trailing proximal edge 318 of the face 314 by a distance D.
- the distance D [between 316 and 318] may be at least about 0.1′′ and typically no more than about 0.5′′.
- the inclined face cooperates with the curved sidewall of the tube to create a side opening for funneling the distal tip of the secondary device into the proximal end of the lumen.
- the side wall at the trailing edge 318 may be provided with a curvature having a greater radius than the radius of curvature at the leading edge 316 with a progressively changing radius in between, creating a funnel shape for the landing zone 322 .
- the tubular body 302 is provided with an axially extending slit 310 extending between the distal end 306 and the leading edge 316 of the inclined face 314 , to enable the inserter to be peeled away laterally from the secondary device extending therethrough once the inserter has enabled passage of the secondary device through the hemostasis valve.
- a pull tab 312 may be provided on the proximal end of the tubular body 302 to enable the inserter 300 to be grasped and pulled away from the secondary device extending therethrough.
- the pull tab 312 may be integrally formed with the tubular body 302 (e.g., as a portion of the sidewall of the tube stock as illustrated) or attached thereto such as by adhesive bonding or mechanical compression or interference engagement.
- the pull tab 312 inclines laterally away from the longitudinal axis of the tubular body, to allow coaxial approach and introduction of the catheter into the inserter 300 .
- the tubular body has a substantially constant diameter throughout most (e.g., at least about 80% or 90%) of its length overall. However, at least the outside diameter in a distal nose segment 324 may be necked down to a smaller outside diameter at the distal end. This enables the inserter to better enter the hemostasis valve under distal compression.
- the tubular body has an 8 French ID along most of its length but necks down to 6 French in the distal nose segment 324 . This inserter will facilitate the introduction of either a 6 French or an 8 French catheter through the hemostasis valve, since the 8 French catheter can simply forcibly dilate the necked distal end due to the axial slit 310 .
- the concave entrance funnel surface of the landing zone 322 may be provided with a visual indicium such as a different color than the outside surface of the tubular body 302 , to facilitate visualization of the funnel opening and assist in loading the secondary catheter into the funnel. This may be accomplished by providing a colored coating on either the inside or outside surface of the tube stock, or by forming at least a portion of the tube stock as a coextrusion of dissimilar colored materials.
- a clot capture module for use in a thrombectomy system, the clot capture module comprising one or more of the following:
- a filter in the clot capture chamber the filter being visible through the window, the filter having an upstream surface and a downstream surface;
- an incoming flow path configured to direct incoming blood from an aspiration catheter against the upstream surface of the filter
- a normally closed aspiration control valve in the incoming flow path configured to block flow of incoming aspirated blood until actuated to permit inflow of aspirated blood
- an outgoing flow path configured to direct blood from a downstream side of the filter to a remote vacuum canister.
- a clot capture module as described in any embodiment herein, wherein the upstream surface of the filter is visible through the window.
- a clot capture module as described in any embodiment herein, wherein the filter comprises a blood permeable membrane, and wherein the upstream surface of the filter is on a radially outwardly facing surface of the blood permeable membrane.
- a clot capture module as described in any embodiment herein, wherein the blood permeable membrane at least partially encloses a filtered blood chamber which is in fluid communication with the outgoing flow path.
- a clot capture module as described in any embodiment herein, comprising a proximal housing, and a distal housing separated by a transparent tubular side wall.
- a clot capture module as described in any embodiment herein, wherein at least one of the proximal housing and distal housing is releasably connected to the transparent tubular side wall.
- a thrombus engagement tool configured to be advanced through a catheter and to engage thrombus, the thrombus engagement tool comprising one or more of the following:
- a rotatable core having a proximal end and a distal end
- thrombus engagement tip on the distal end of the rotatable core, the thrombus engagement tip comprising:
- a thrombus engagement tool as described in any embodiment herein, comprising a first radiopaque marker under the advance segment and a second radiopaque marker under the trailing segment.
- a thrombus engagement tool as described in any embodiment herein, comprising a limit bearing surface on the handle, the limit bearing surface being configured to limit projection of the thrombus engagement tip in a distal direction relative to a distal end of the aspiration catheter.
- a thrombus engagement tool as described in any embodiment herein, wherein the advance segment, the helical thread, and the trailing segment are all molded onto the rotatable core.
- a method of removing embolic material from a vessel with mechanical and aspiration assistance comprising one or more of the following:
- an aspiration catheter having a central lumen and a distal end
- the thrombus engagement tool having a tip comprising a helical thread having a major diameter that is at least about 0.015 inches smaller than an inside diameter of the central lumen, the helical thread being configured to provide an aspiration flow path around the tip;
- a method of removing embolic material as described in any embodiment herein, comprising the step of advancing the catheter to a pulmonary embolism.
- a method of removing embolic material as described in any embodiment herein, comprising the step of advancing the catheter to a deep venous thrombosis.
- a method of removing embolic material as described in any embodiment herein, comprising the step of introducing a thrombus engagement tool having a tip with a major diameter that is no more than about 60% of the inside diameter of the central lumen.
- a method of removing embolic material as described in any embodiment herein, comprising introducing a thrombus engagement tool having a tip with a major diameter that is no more than about 40% of the inside diameter of the central lumen.
- a method of removing embolic material as described in any embodiment herein further comprising axially reciprocating the thrombus engagement tool within the catheter.
- a method of removing embolic material as described in any embodiment herein, comprising extending the distal tip at least about 2 cm beyond the distal end of the catheter.
- a method of removing embolic material as described in any embodiment herein, comprising axially aligning the distal tip with the distal end of the catheter using a position indicator on the rotatable core.
- An inserter for guiding a device through a valve comprising one or more of the following:
- an elongate tubular body having a proximal end, a distal end, and a sidewall at least partially defining a central lumen
- the concave landing zone having a radius of curvature that increases in a proximal direction
- a surface of the concave landing zone comprises a different color than an outside surface of the elongate tubular body.
- a method of passing a device through a valve comprising one or more of the following:
- a method of passing a device through a valve as described in any embodiment herein, wherein advancing the tubular body through the valve comprises advancing a tapered distal tip on the tubular body through the valve.
Abstract
An inserter for guiding a device through a hemostasis valve. The inserter comprises an elongate tubular body, a concave landing zone, and an axially extending slit. The elongate body tubular body of the inserter partially defines a central lumen. A method a of passing a device through a valve comprises the steps of providing an inserter having a tubular body with a split sidewall, advancing the tubular body through a valve, advancing a device through the tubular body and beyond the valve and retracting the tubular body so that the device escapes laterally from the tubular body through the split sidewall, leaving the device in place across the valve.
Description
- This application claims the priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application No. 63/341,926, filed May 13, 2022.
- Removal of blood clots from the vascular system (thrombectomy) using a trans vascular approach may be accomplished at any of a variety of treatment sites, such as arteries in the extremities, veins for deep vein thrombosis (DVT), large veins and arteries (central vessels) such as iliac veins and arteries, the aorta, the inferior vena cava and pulmonary arteries to treat pulmonary emboli (PE).
- For example, venous thromboembolic disease (VTE) is a worldwide crisis. There are over 10 million cases of DVT and PE diagnosed globally per year, with 1 million cases occurring in the United States and over 700,000 in France, Italy, Germany, Spain, Sweden, and the United Kingdom combined each year. There are approximately 60,000 to 100,000 deaths from PE in the United States each year. DVT and PE are part of the same continuum of disease, with over 95% of emboli originating in the lower extremities. When PE occurs, the severity depends on the embolic burden and its effect on the right ventricle as well as underlying cardiopulmonary comorbidities. Death can result from the acute increase in pulmonary artery (PA) pressure with increased right ventricular (RV) afterload and dysfunction.
- Patients with high-risk PE have been treated primarily with thrombolytic therapy delivered systemically or more locally through Catheter Directed Thrombolytics. These approaches result in multiple catheterization lab visits, lengthy hospital stays and often lead to bleeding complications. Newer approaches to PE treatment include single session thrombectomy treatments without the use of thrombolytics. These thrombectomy treatments include delivering a catheter into the PA to remove the thrombus through aspiration, and secondary tools may also macerate or disrupt the thrombus prior to aspiration. While thrombectomy results in fewer bleeding complications and reduced hospital stays compared to thrombolytics, there is much to be improved upon given the challenges of the procedure itself, including the ability to capture a broad spectrum of thrombus types and reduce the total volume of blood loss during the procedure.
- The thrombectomy catheter is introduced through an introducer puncture in a large diameter vein. A flexible guide wire is passed through the introducer into the vein and the introducer is removed. The flexible guidewire provides a rail for a flexible guide catheter to be advanced through the right atrium into the right ventricle and into the pulmonary artery. The flexible guidewire is removed and replaced with a stiff guidewire. The large diameter thrombectomy catheter with support dilator is then advanced over the stiff guidewire to the pulmonary artery and the dilator is removed. If the large diameter thrombectomy catheter is not successful in accessing or aspirating thrombus in a more distal portion of the vessel, a smaller diameter catheter may be inserted through the large diameter catheter.
- In addition, peripheral arterial occlusive (PAO) disease occurs in more than 4% of individuals over
age 40 and markedly increases in incidence after the age of 70. Acute PAO is usually due to thrombosis of the peripheral vasculature and is associated with a significant risk of limb loss. In order to preserve the limb, therapy for acute PAO centers on the rapid restoration of arterial patency and blood flow such as through mechanical thrombectomy in procedures similar to those described above. - Clot aspiration using certain commercial vacuum-assisted thrombectomy systems may sometimes need to be terminated due to the risk of excessive blood loss by the patient, especially when using large aspiration catheters. During aspiration thrombectomy, when the catheter tip falls out of contact with the thrombus or other occlusive material, the tip is exposed to healthy blood and full flow of blood through the catheter ensues. Under such conditions, the total volume of blood loss may be excessive, and in some cases, may result in premature termination of the procedure. For example, during a procedure when the catheter enters healthy blood and full aspiration flow ensues, the blood loss rate can be on the order of 30-40 cc per second with an 24 French size catheter. With a maximum tolerable blood loss on the order of about 500 mL, the catheter cannot run in unrestricted mode for more than approximately 10 to 15 seconds. The aggregate blood loss may reach an unacceptable level before sufficient clot is removed.
- Thus, notwithstanding prior efforts, there remains a need for an improved technology for removing or reducing thrombotic restrictions and occlusions within either the patient's arterial or venous blood vessels.
- There is provided in accordance with one aspect of the present invention, a clot capture module for use in a thrombectomy system, such as within the sterile field. The clot capture module comprises a housing; a clot capture chamber in the housing; a window in the housing to permit visual inspection of the clot chamber; and a filter in the clot chamber, visible through the window, the filter having an upstream surface and a downstream surface.
- An incoming flow path is configured to direct incoming blood from an aspiration catheter against the upstream surface of the filter. An aspiration control valve is provided in the incoming flow path, configured to block or permit the flow of incoming blood. An outgoing flow path is configured to direct blood from the second side of the filter to a remote vacuum canister.
- The clot capture module may further comprise a vent valve, openable to permit an optically transparent media such as air or saline to be drawn into the clot chamber, enabling blood to be evacuated from the clot chamber to a remote canister. The upstream surface of the filter may be visible through the window, so that clot accumulated on the upstream surface can be visually observed through the window, once the vent has been opened to evacuate blood from the clot capture chamber. The window may comprise a transparent cylindrical portion of the housing.
- The upstream surface of the filter may be substantially planar. Alternatively, the upstream surface of the filter may be convex. The filter may comprise a tubular porous membrane such as a cylinder, and the upstream surface of the filter may be on a radially outwardly facing surface of the membrane. The tubular filter membrane may enclose a filtered blood chamber which is in communication with the outgoing flow path.
- The module may further comprise an aspiration control, for controlling the aspiration control valve. The aspiration control may comprise a rocker switch, configured to selectively collapse or allow reopening of a collapsible tubing. The aspiration control valve may be normally closed, and may be spring biased into the closed configuration.
- The clot capture module may be provided in combination with a vacuum line leading to an aspiration pump and canister, wherein the clot capture module is configured to reside within a sterile field and the aspiration pump and canister are outside of the sterile field. The vacuum line may be at least about 30 inches or 50 inches or more in length. In some instances, a manually actuated aspiration device (e.g., a syringe) may be used in addition to, or as an alternative to, an aspiration pump to permit a user to manually apply aspiration through the vacuum line.
- There is provided in accordance with another aspect of the present invention, a thrombus engagement tool, configured to advance through an aspiration catheter and engage thrombus. The thrombus engagement tool comprises a rotatable core wire having a proximal end and a distal end; and a thrombus engagement tip on the distal end of the core wire. The tip may comprise a helical thread; an advance segment on a distal side of the thread and a trailing segment on a proximal side of the thread. The advance segment, helical thread and trailing segment may all be molded onto the core wire.
- The thrombus engagement tool may further comprise a projection on the core wire, underneath at least one of the advance segment and the trailing segment, to form an interference fit with the thrombus engagement tip. The projection may comprise an annular ring, which may be a radiopaque marker. The thrombus engagement tool may comprise a first radiopaque marker under the advance segment and a second radiopaque marker under the trailing segment.
- An outer periphery of the helical thread may substantially conform to an inside surface of a cylinder. The thread may comprise a proximal surface which inclines radially outwardly in a proximal direction to define a proximally opening undercut.
- The thrombus engagement tool may further comprise a handle on the proximal end of the core wire configured for hand turning the core wire. A limit bearing surface may be provided on the handle, for limiting distal projection of the thrombus engagement tip relative to a distal end of the aspiration catheter.
- There is further provided a method of removing embolic material from a vessel with mechanical and aspiration assistance. The method comprises the steps of providing an aspiration catheter having a central lumen and a distal end; advancing the distal end to obstructive material in a vessel; applying vacuum to the lumen to draw clot at least partially into the lumen; and introducing a thrombus engagement tool into the lumen. The thrombus engagement tool may have a tip with an axial length of no more than about 1 cm or about 5 mm and a helical thread having a major diameter that is at least about 0.015 inches smaller than an inside diameter of the lumen, to provide an aspiration flow path through the lumen around the outside of the tip. The method further comprises manually rotating the tip to engage clot between the tip and an inside wall of the lumen.
- A method of aspirating a vascular occlusion from a remote site, comprises the steps of advancing an elongate tubular body through a vascular access site and up to a vascular occlusion, the tubular body comprising a proximal end, a distal end, a central lumen, and a stop surface. A rotatable core is advanced distally through the lumen until a limit surface carried by the core rotatably slidably engages the stop surface to provide a rotatable bearing which limits further distal advance of the core within the lumen. Vacuum is applied to the lumen and the core is manually rotated to engage thrombus. The advancing the rotatable core may be accomplished after the step of advancing the elongate tubular body through the vascular access site and up to the vascular occlusion. The core may be a solid core wire or a cannulated structure such as a hypotube or microcatheter having a central lumen extending axially between a proximal opening and a distal opening.
- The core may carry a proximal handle, and the limit surface may be carried by the handle. The tubular body may include a proximal hub, and the stop surface may be carried by the hub. The core may carry an engagement tip having a helical thread, and the engaging thrombus step may comprise pinning thrombus between a first side of the tip and an inside surface of the tubular body.
- There is also provided an inserter for guiding a device through a hemostasis valve, comprising an elongate tubular body, having a proximal end, a distal end and a central lumen; a laterally facing concave landing zone on the proximal end, having a radius of curvature that increases in the proximal direction; and an axially extending slit in the sidewall, extending from the distal end to the landing zone. The tubular body may further comprise a tapered distal tip, and a proximal pull tab to facilitate removal of the inserter from the device. A surface of the landing zone may comprises a different color than an outside surface of the tubular body, to facilitate visualization of the landing zone and advancing the distal end of the device into the tubular body.
- A method of passing a device through a hemostasis valve may comprise the steps of providing an inserter, having a tubular body with a split sidewall; advancing the tubular body through a hemostasis valve; advancing a device through the tubular body and beyond the hemostasis valve; and proximally retracting the tubular body so that the device escapes laterally from the tubular body through the split sidewall, leaving the device in place across the hemostasis valve.
- The advancing the tubular body step may comprise advancing a tapered distal tip on the tubular body through the hemostasis valve. The advancing the tubular body through the hemostasis valve step may be accomplished with the device pre loaded inside the tubular body.
- A distal nose segment of the tubular body may expand in diameter in response to advancing the device therethrough. The device may be a thrombus engagement tool or a secondary catheter. The secondary catheter may be an aspiration catheter.
-
FIG. 1 is a schematic view of a thrombus removal system in accordance with the present invention. -
FIG. 2 is a perspective view of a flow control module. -
FIG. 3 is an elevational of cross-sectional view through the flow control module ofFIG. 2 . -
FIG. 4 is a schematic view of the dual vacuum chamber configuration that produces an accelerated aspiration response. -
FIG. 5 is a qualitative fluid flow rate diagram at the catheter tip following opening of the vacuum control valve. -
FIG. 6A is a side elevational view of a thrombus engagement tool. -
FIG. 6B is an enlarged detail view of the distal end of the thrombus engagement tool ofFIG. 6A . -
FIG. 6C is a longitudinal elevational cross-section through the thrombus engagement tool ofFIG. 6B . -
FIGS. 7A-7E are side elevational views of various embodiments of thrombectomy catheters. -
FIG. 8 is a cross-sectional view through a distal portion of the embolectomy catheter showing a side wall construction. -
FIG. 9 is a cross-sectional view through a distal portion of the embolectomy catheter showing the radiopaque marker and inclined distal face. -
FIGS. 10A-10B are perspective views of an inserter tool to facilitate passing a catheter through a hemostasis valve. -
FIG. 10C is an end view of the inserter ofFIGS. 10A and 10B . - Referring to
FIG. 1 , there is illustrated a thrombectomy system such as for PE or DVT aspiration procedures. Thesystem 10 includes athrombectomy catheter 12, having an elongatetubular body 14 extending between theproximal end 16 and adistal end 18. A central lumen 20 (not illustrated inFIG. 1 ) extends between aproximal catheter connector 22 and adistal port 24 on thedistal end 18. - Although primarily described in the context of an aspiration catheter with a single central lumen, catheters of the present invention can readily be modified to incorporate additional structures, such as permanent or removable column strength enhancing mandrels, two or more lumen such as to permit drug, contrast or irrigant infusion or to supply inflation media to an inflatable balloon carried by the catheter, or any combinations of these features, as will be readily apparent to one of skill in the art in view of the disclosure herein. In addition, the disclosure will be described primarily in the context of removing obstructive material from the vasculature, but it will be understood to have applicability as an access catheter for delivery and removal of any of a variety of diagnostics or therapeutic devices with or without aspiration.
- The catheters disclosed herein may readily be adapted for use throughout the body wherever it may be desirable to distally advance a low profile high flexibility catheter into a variety of type of vasculature, such as small or large vasculature and/or tortuous or relatively straight vasculature. For example, catheter shafts in accordance with any embodiment described herein may be dimensioned for use throughout the neurovascular, coronary and peripheral vasculature, the gastrointestinal tract, the urethra, ureters, Fallopian tubes and other lumens and potential lumens, as well. The catheter shaft construction of any embodiment herein may also be used to provide minimally invasive percutaneous tissue access, such as for diagnostic or therapeutic access to a solid tissue target (e.g., breast or liver or brain biopsy or tissue excision), delivery of laparoscopic tools or access to bones such as the spine for delivery of screws, bone cement or other tools or implants.
-
Catheter 12 will have a length and diameter suitable for the intended access point and target location. In one example, referring toFIG. 1 , thecatheter 12 may have an effective length from the distal end of manifold orhub 22 todistal tip 18 generally no more than about 230 cm, no more than about 210 cm, no more than about 180 cm, or no more than about 160 cm. and typically from about 50 cm to about 150 cm, from about 90 cm to about 130 cm, or from about 105 cm to about 115 cm. The outer diameter of thecatheter 10 may be from about 0.035 inches to about 0.15 inches, from about 0.09 inches to about 0.13 inches, and may be lower in a distal segment than in a proximal segment. - The inner diameter of the
catheter 12 in a single central lumen embodiment may be greater than or equal to about 0.1 inches, greater than or equal to about 0.088 inches, or greater than or equal to about 0.08 inches, or greater than or equal to about 0.06. The inner diameter of thecatheter 12 in a single central lumen embodiment may be less than about 0.20 inches or 0.15 inches, or less than or equal to about 0.11 inches, less than or equal to about 0.1 inches, less than or equal to about 0.088 inches, or less than or equal to about 0.07 inches, and often no more than about 0.095 inches. - In the illustrated embodiment, the
catheter 12 is releasably connectable to aflow control module 28 by way of acomplementary connector module 30.Connector module 30 provides a releasable connection tocomplementary catheter connector 22 and may include aside port 32 for releasable connection totubing 34 which may lead to avalve 36.Connector module 30 may additionally comprise a hemostasis valve configured to receive another device such as a guidewire or thrombus engagement tool, discussed below. -
Valve 36 may selectively placetubing 34 into communication withside port 37 or theflow control module 28 discussed in greater detail below.Side port 37 may be placed into communication with a source of media such as saline, contrast solution or medication, or a manifold 38 which can provide selective communication with each. The use ofvalve 36 allows infusion of a desired media without detaching thetubing 34 from theconnector module 30. - Referring to
FIGS. 2 and 3 , theflow control module 28 is in communication with thevalve 36 by way of adistal tube 44.Flow control module 28 is in communication with theselector valve 49 by way of aproximal tube 46. This establishes a flow path between thedistal port 24 through thecatheter 12 through the various tubing andflow control module 28 to thepump assembly 42. In an alternate implementation of the invention, theflow control module 28 may be integrally formed within the hub ofthrombectomy catheter 12 to which thecatheter 12 may be removably or non-removably attached or within theconnector module 30. In some instances, a manually actuated aspiration device (e.g., a syringe) may be used in addition to, or as an alternative to, anaspiration pump assembly 42 to permit a user to manually apply aspiration through the vacuum line. It will be understood by one having skill in the art that a manually actuated aspiration device may be in in addition to, or as an alternative to, the pump assembly described in any embodiment herein. -
Flow control module 28 may include a flow regulator such as an on-off control for regulating flow through the flow path between thecatheter 12 andpump 42. The flow regulator is configured to provide a reversible restriction in the flow path, such as by an expandable or contractible iris, a ball valve or other rotary core valve, leaf valve, a pinch tubing, or others known in the art. - In one implementation, the flow regulator comprises a
collapsible portion 29 of the tubular wall defining the flow path, such as a section of polymeric tubing. An actuator 31 positioned adjacent the tubing is movable in response to a control such as a push button ortoggle switch 48 between a first position where it compresses the tubing, thereby completely restricting flow, and a second position where it has moved away from the tubing, allowing the tubing to resume its full inside diameter and allow fluid flow. Theactuator 31 may be spring biased or have another default driver in the direction of the first (restricted) position, and only movable into the second (open) position in the presence of an affirmative mechanical force or release of a constraint allowing the flow path to open. Upon removal of the momentary “on” command, theactuator 31 automatically resumes the first position, obstructing flow. - The
actuator 31 may be driven by a mechanical control such as a lever or rotatable knob, or an electrically driven system such as a solenoid, operated by any of a variety of buttons, levers, triggers, foot pedals or other switches known in the art, depending upon the desired functionality. - The
flow control module 28 may contain afilter chamber 33 for example, which is in communication with thevacuum canister 58 on thepump assembly 42 by way ofelongate aspiration tubing 40. Thetoggle switch 48 is in between thefilter chamber 33 and thecatheter 12. In a default off position of some embodiments, this allows the entire length of theaspiration tubing 40 and thefilter chamber 33 to reach the same low pressure as theaspiration canister 58 on thepump 42. - Additional details of the filter assembly and related structures are illustrated in
FIG. 3 . Afilter assembly 35 includes an outertubular sidewall 37 having atransparent window 39. In some implementations the entiretubular sidewall 37 can be a transparent window. Theside wall 37 encloses afilter 41. Thefilter 41 includes afilter sidewall 43 defining an interior (downstream) chamber (not illustrated) for filtered blood. - Upon opening the flow path by activating the
switch 48, blood and thrombus are drawn in the direction fromcatheter 12 viavacuum line 44 through afirst filter aperture 45 and into theclot collection chamber 33. Any thrombus will be captured on the outside (upstream side) offilter 43. Blood is drawn through thefilter 43 andproximal tubing 46 en route to thecanister 58. In the illustrated example, thefilter 43 is tubular however it may alternatively be planar or other shape depending upon the desired configuration. - The
switch 48 may thereafter be closed to compresstubing 29 and isolate thecatheter 12 from the vacuum source. A normally closedvent 47 may be momentarily opened, to permit intake of an optically transparent media such as saline or ambient air. This allows residual blood in thechamber 33 to be drawn through thefilter 43 and aspirated out viaproximal tubing 46, enabling visualization of any clot on the surface of thefilter 43 through thewindow 39. Thevent 47 may be manually actuated by a user and/or automatically actuated by the system. In some instances, a user may manually actuate thevent 47 through actuation of abutton 62 located on theflow control module 28. - For example, the vent 67 may be normally closed, and then transitioned to an open configuration when the
button 62 is being actuated (or vice versa). When in the open configuration, the vent 67 may expose theclot collection chamber 33 to an ambient environment. In some instances, exposure of thechamber 33 to the ambient environment allowing intake of air and acceleration of blood flow through theclot collection chamber 33 and towards the proximal tubing. Increased acceleration of blood flow due to vent 47 actuation may facilitate visualization of the clot by displacing the amount of blood or other fluids from the optical path between the window and the filter and/or decrease the amount of time required for the physician to accurately identify the clot in thechamber 33. The valved vent also allows the physician to deliver pulsatile negative pressure waves at thedistal opening 24. - In the illustrated embodiment, the
flow control module 28 comprises aproximal housing 31 and adistal housing 29 separated by the transparenttubular sidewall 35. Thetubular sidewall 35 and thefilter 43 are carried by theproximal housing 31.Housing 29 andtubular sidewall 35 may be joined at areleasable connection 33 that, in some instances, includes agasket 59 to form a sealed connection. Complementary surface structures (e.g., inclined corresponding grooves and pins or flanges) may permit rapid attachment and detachment. For example, theproximal housing 31 and thedistal housing 29 may be rotated relative to each other (e.g., by relative rotation across the gasket) to disconnect the housings from each other. - The
filter 43 may be attached to any one of thedistal housing 29 or theproximal housing 31 upon disconnection of the housings. Thetubular sidewall 35 may be attached to either one of thedistal housing 29 and/or theproximal housing 31 such that, upon disconnection, thetubular sidewall 35 may remain attached to one of thehousings proximal housing 31 from thedistal housing 29, thetubular sidewall 35 may be configured to remain around thefilter 43 or may be configured to be removed from over thefilter 43. In either instance, disconnection of thehousings filter 43 and allow a clot to be easily accessed and removed. - The interior surface of the
clot collection container 33 may comprise a coating to provide one or more of a variety of properties to theclot collection containers 33. In some instances, the coating may be configured to enhance visualization through at least a portion of the clot collection container 33 (such as the transparent window 39). The coating may be configured to inhibit blood accumulation or increase blood repellant properties. In some instances, theclot collection container 33 may comprise a coating to inhibit foam formation during an aspiration procedure. The coatings may be located at least partially along an interior surface of thetubular sidewall 35 and/or theclot collection container 33 or along an entire interior surface of thetubular sidewall 35 and/or theclot collection container 33. In some instance, the coating is located along an interior surface of thetransparent window 39. The coating can be both hydrophobic and oleophobic. In some instances, the coating may have some hydrophilic features on a portion of the polymer to increase oleophobic properties. -
Aspiration pump assembly 42 may be releasably placed into communication withflow control module 28 such as by a luer connection betweenselector valve 45 andtubing 40.Aspiration pump assembly 42 may include avacuum pump 50, and may also include avacuum gauge 51, and an optionalpressure adjustment control 54. Thevacuum gauge 51 is in fluid communication with the vacuum pump and indicates the vacuum pressure generated by the pump. Thepressure adjustment control 54 allows the user to set to a specific vacuum pressure.Power button 56 activates thepump 50. - The
vacuum canister 58 may be provided with a vent 53 to atmosphere, opened or closed by a valve. In one implementation the valve is normally closed to permit vacuum in the canister to reach a desired low pressure. The valve may be momentarily opened as desired to permit introduction of air and reduction of the vacuum, such as to reduce foaming within thevacuum canister 58. - The vent may function to reduce foaming and increase visibility within the canister. In some instances, the vent 53 comprises a permanently opened vent such as in a lid or side wall of the vacuum canister. The vent may comprise an aperture formed through the lid or side wall having a diameter of no more than about 0.5 mm or 0.25 mm and may be a laser cut hole through a metal sheet which may be in the form of a disc carried by the lid.
- In addition to or as an alternative to the vent, the inside surface of the
canister 58 may be provided with a coating of one or more materials to inhibit foaming of blood under vacuum. The coatings may be located at least partially along or entirely along an interior surface of thevacuum canister 58. The coating can be both hydrophobic and oleophobic. In some instances, the coating may have some hydrophilic features on a portion of the polymer to increase oleophobic properties. - Any of a variety of controls may be utilized to operate the various pump functions, including switches, buttons, levers, rotatable knobs, and others which will be apparent to those of skill in the art in view of the disclosure herein.
Aspiration pump 50 may alternatively be a manually activated pump such as a syringe. - In some applications, it may be desirable to provide a non occlusive restriction of flow between the
vacuum canister 58 and theflow control module 28. A flow restrictor may be coupled such as by luer connectors in series with thevacuum line 40. In one implementation the flow restrictors enables toggling between a low flow and a high flow configuration. The flow restrictors may comprise a variable restrictor that may be adjusted by a user. This may be accomplished by selectively diverting flow between a relatively smaller diameter and larger diameter aperture, a variable diameter aperture, or other flow regulators such as any of those disclosed in the United States patent publication No. 2021/0315597 to Buck, et al, entitled Aspiration System with Accelerated Response, the disclosure of which is hereby incorporated in its entirety herein. - In one particular implementation, a rotatable drum is provided with a first transverse flow path having a first diameter. The drum is rotatable within a housing having an inlet port and an outlet port. The drum may be rotated to place the inlet port into fluid communication with the outlet port through the first flow path. A second flow path having a second, different diameter also extends transversely through the drum, rotationally offset from the first flow path. The drum may be rotated to place the inlet port into communication with the outlet port through the second flow path, thereby providing a flow rate through the drum different from the flow rate provided by the first flow path.
- The
filter chamber 33 on theflow control module 28 or on theconnector module 30 is spaced apart from theremote vacuum pump 42 andvacuum canister 58 to provide enhanced aspiration performance. Conventional aspiration pumps and filters are intended to be placed outside of the sterile field and may be far enough away from the patient to require a length ofaspiration tubing 40 between thepump assembly 42 and thecatheter 12 to be at least about 50 inches or about 100 inches or more. For example, thetubing 40 may be about 102 inches. - The pump typically includes an
aspiration canister 58 for blood collection. When aspiration is desired in a prior art system, a valve is opened to place thelow pressure canister 58 in communication with thecatheter 12 by way of theaspiration tubing 40, to aspirate material from the patient. But the length of the aspiration tubing extending from inside to outside of the sterile field operates as a flow restrictor, causing a delay between the time of activating the vacuum button on thepump assembly 42 and actual application of suction to the clot at the distal end of the catheter. - In the illustrated implementation, the only flow restriction between a source of vacuum (filter chamber 33) and the patient is the relatively short aspiration pathway between the on/off valve in the handpiece actuated by
toggle switch 48 and thedistal end 18 of the catheter. When theaspiration control 48 is activated to open the flow path, the flow restriction and enclosed volume on the patient side of thefilter chamber 33 is low relative to the flow restriction and enclosed volume throughaspiration tubing 40 on the pump side of thefilter chamber 33. - This dual chamber configuration produces a rapid spike in negative pressure experienced at the
distal end 18 of thecatheter 12 upon activation of theaspiration control 48, and rapid filling of thechamber 33. The response time between activating theaspiration control 48 and realizing suction actually experienced at the clot is significantly faster and allows significantly higher initial flow than the response time realized in a conventional system having only avacuum chamber 58 located at thepump assembly 42 outside of the sterile field. - The spike of negative pressure experienced at the distal end of the catheter will fade as pressure equilibrium is reached between the
filter chamber 33 andcanister 58. When theaspiration control 48 is closed, thevacuum pump 50 will gradually bring the pressure in thefilter chamber 33 back down to the level in thevacuum canister 58 at the pump. - A simplified fluid flow diagram is illustrated in
FIG. 4 , and a qualitative flow rate diagram is illustrated inFIG. 5 . The flow restriction betweenchamber 33 and thedistal end 18 ofcatheter 12 is small relative to the flow restriction between thevacuum canister 58 and thevacuum chamber 33. This allows a negative pressure peak experienced atdistal end 18 almost instantaneously upon activation ofvacuum switch 48. The flow rate of material into thecatheter 12 rapidly reaches a peak and subsides asvacuum chamber 33 fills with aspirated material. The vacuum inchamber 33 declines to a minimum, and slowly recharges by thelarge vacuum chamber 58 and associated pump throughtubing 40 when thetoggle switch 48 is moved into the closed position. In some instances of use, a clinician may choose to close thevacuum switch 48 at or shortly following the maximum flow rate, just giving a short burst or series of bursts of pulsatile vacuum to facilitate spiration of thrombus into thecatheter 12. In use, a similar effect may be established by utilizing thevent 47. The vacuum inchamber 33 may decline to a minimum as thebutton 62 is actuated such that the vent is opened. Thereafter, thevacuum chamber 33 may slowly recharge by thelarge vacuum chamber 58 and associated pump throughtubing 40 when thebutton 62 and vent 47 are moved into the closed position. In some instances of use, a clinician may choose to open thevent 47 at or shortly following the maximum flow rate, just giving a short burst or series of bursts of pulsatile vacuum to facilitate spiration of thrombus into thecatheter 12. - If the application of vacuum is not able to aspirate the clot into the catheter, an elongate flexible thrombus engagement tool may be advanced through the aspiration catheter, to facilitate retrieval of the clot. The thrombus engagement tool may comprise an elongate flexible shaft having a proximal hand piece such as a knob configured to be rotated by hand. The distal end carries a clot engagement tip which may include one or more radially outwardly extending engagement structures such as a helical thread.
- Referring to
FIGS. 6A-6C , athrombus engagement tool 80 may comprise an elongateflexible shaft 82 having aproximal end 84 and adistal end 86. A proximal hand piece such as a torquinghandle 88 may be configured to be rotated by hand.Distal end 86 carries aclot engagement tip 90 which may include one or more radially outwardly extending structures such as ahelical thread 92. Thehandle 88 may have an indicium of rotational direction such as a printed or moldedarrow 94 which indicates the direction to rotate thehandle 88 in order for thehelical thread 92 to engage clot. - Referring to
FIG. 6B , thedistal tip 90 includes ahelical thread 92 extending between adistal thread end 96 and aproximal thread end 94 and supported by flexible shaft 98. The axial length of thedistal tip 90 is at least about 5 mm or 10 mm or 15 mm or 20 mm and in some embodiments no more than about 30 mm or 20 mm measured along the flexible shaft 98. Preferably, the axial length will be within the range of from about 20 mm to about 25 mm. - The
helical thread 92 wraps around the axis at least about 1 or 2 or 4 or more full revolutions, but in some embodiments no more than about 10 or no more than about 6 revolutions. Preferably, thethread 92 wraps around the axis within the range of from about 2.5 to about 4.5 revolutions. In some embodiments the axial length along the threaded portion of the tip is within the range of from about 5 to about 15 mm, and preferably within the range of from about 8 mm to about 12 mm. - The
helical thread 92 on this implementation may have a constant pitch throughout its length. The pitch may be within the range of from about 5 to about 10 threads per inch depending upon desired performance. For example, the thread to thread spacing in the axial direction may be within the range of from about 2 mm to about 6 mm, preferably from about 3 mm to about 4 mm. - Alternatively, the thread may have multiple pitches (e.g. stepped or graduated) designed to engage, transport or grasp thrombus within the catheter lumen. A distal pitch may be less than a proximal pitch. The pitch may vary continuously along the length of the thread, or may step from a first, constant pitch in a proximal zone to a second, different pitch in a distal zone of the thread. The
thread 92 may comprise a continuous single helical flange or may have a plurality of discontinuities to produce a plurality of teeth or serrations, arranged helically around the core wire. - The maximum OD of the
thread 92 is preferably smaller than the diameter of a sliding fit within the intended catheter lumen, and may generally be at least about 0.015 inches or at least about 0.010 inches smaller than the catheter lumen ID. In some implementations, the max OD of the tip may be significantly less than the inside diameter of the catheter lumen to allow more space for the thrombus along the side of the tip but still create significant grasping force via lateral engagement of the helical threads with the thrombus. - In one implementation, the maximum helical thread diameter is about 0.110 inches, and the catheter lumen ID is about 0.275 inches (24 F) (a 0.165 inch gap between the helical threads and catheter wall). In another implementation, the maximum OD of the tip is within the range of from about 0.03 to about 0.06 inches within a catheter having a distal end ID within the range from about 0.068 inches to about 0.073 inches. This leaves a substantial tip bypass flow path.
- In certain applications, the max OD of the tip is no more than about 35% or no more than about 40% or no more than about 60% of the ID of the corresponding catheter and may be within the range of from about 35% to about 55% of the catheter ID. In some instances, the max OD of the tip may slightly less than the ID of the corresponding catheter to provide a sliding fit within the intended catheter lumen. For example, the max OD of the tip may be no less than about 90% or no less than about 95% or no less than about 97% of the ID of the corresponding catheter.
- Since this implementation of the thrombus engagement tool does not have any centering structures for the
tip 90 orshaft 82, thetip 90 will normally be pushed to one side of the aspiration lumen. When a clot becomes lodged between thetip 90 and the opposing inside surface of the side wall of the catheter, manual manipulation such as rotation of thetip 90 can engage the clot like a worm gear and either grasp the clot (e.g., by pinning it against the opposing catheter sidewall) for retraction or facilitate freeing the blockage and aid in ingestion of the clot into the catheter. Manual manipulation may also include axial proximal and distal reciprocation along with rotation, during aspiration, which can facilitate ingestion of the clot into the catheter. - Thus, an unimpeded flow path is created in the annular (if the tip were centered) space between the maximum OD of the tip, and the ID of the catheter lumen. This annular flow path cooperates with the vacuum and helical tip to grab and pull obstructive material into the catheter under rotation and vacuum. The annular flow path is significantly greater than any flow path created by manufacturing tolerances in a tip configured to shear embolic material between the tip and the catheter wall.
- Additional aspiration volume is obtained as a result of the helical channel defined between each two adjacent threads of the tip. A cross sectional area of the helical flow path of a tip having a maximum OD in the range of from about 0.0400 to about 0.0406 inches will generally be at least about 0.0003 square inches, and in some embodiments at least about 0.00035 or at least about 0.000375 inches. The total aspiration flow path across the helical tip is therefore the sum of the helical flow path through the tip and the annular flow path defined between the OD of the tip and the ID of the catheter lumen.
- Aspiration occurs both through the helical channel formed between adjacent helical threads as well as around the outside of the tip such that the assembly is configured for engaging and capturing embolic material but not shearing it between a sharp edge of the thread and the inside wall of the catheter.
- The
distal advance segment 100 advantageously permits thethrombus engagement device 80 to at least partially move past the thrombus without “pushing” the thrombus in a distal direction as thetip 90 is advanced. This may inhibit the thrombus (or any particulate thereof) from passing downstream within the vessel during engagement of thedevice 80 with the thrombus. - In some instances, the
distal advance segment 100 can comprise a continuation of thehelical thread 92. For example, thedistal advance segment 100 may comprise a threaded segment continuing from thehelical thread 92. The threadeddistal advance segment 100, in some instances, may maintain an outer diameter consistent with the remainder of thehelical thread 92. The threadeddistal advance segment 100, in some instances, may comprise a thread that tapers in a distal direction towards a smaller outer diameter relative to the remainder of thehelical thread 92. For example, thehelical thread 92 may comprise a proximal cylindrical segment and a distal tapered segment that extends along thedistal advance segment 100. - The profile of the
tip 90 in an end view along the axis of rotation may be circular and/or, in some instances, may vary to create a non circular pattern around the axis of rotation. For example, profile may comprise a helical pattern, such as an oval cross-section that rotates along the axis of rotation to create the helical profile. The tip as seen in an end elevational view thus may exhibit a major diameter and a minor diameter. The minor diameter may be no more than about 95% or 90% or 80% or 70% of the major diameter, depending upon desired performance. In the illustrated example, theouter edge 93 of thethread 92 lies along the surface of a cylinder. - In the illustrated implementation, an
outer edge 93 of thethread 92 thus has a linear surface in the axial direction, substantially conforming to the surface of a cylinder. Adistal side 95 of thethread 92 is inclined radially outwardly in a proximal direction. Aproximal side 97 of thethread 92 also inclines radially outwardly in a proximal direction thereby defining a proximally facing undercut along the length of the thread. - Referring to
FIGS. 6B and 6C , the illustratedtip 90 includes an atraumatic, tapereddistal advance segment 100 extending between an atraumatic distal tip at 102 and a transition to thedistal end 96 of thethread 92.Helical thread 92 extends proximally from the transition to aproximal end 94 of thehelical thread 92. In some instances, a trailingsegment 104 may extend between theproximal end 94 of the thread and theproximal end 106 of the tip. - The axial length of the
distal advance segment 100 may be at least about 5 mm or at least about 8 mm or 9 mm and generally less than about 15 mm, and in some implementations is within the range of from about 8 mm to about 12 mm. - The outside diameter of the
flexible shaft 82 is generally less than about 0.02 inches, or less than about 0.015 inches and, in one implementation, is about 0.008 inches. In some instances, theflexible shaft 82 may comprise a distal tapered section. The distal tapered section may advantageously increase tip flexibility and/or maximize aspiration. The outside diameter at the distal end of the distal tapered section of theflexible shaft 82 is generally less than about 0.01 inches, or less than about 0.008 inches and, in one implementation, is no more than about 0.006 inches. - The outside diameter of the
advance segment 100 atdistal tip 102 is generally less than about 0.024 inches, or less than about 0.020 inches and, in one implementation, is about 0.018 inches. The maximum outside diameter of theadvance segment 100 andhelical thread 92 may be within the range from about 0.020 to about 0.045 inches, and, in one implementation, is less than about 0.040 inches, such as about 0.035 inches. The advance segment, helical thread and trailing segment of thetip 90 may be molded as a single piece over theflexible shaft 82 using any of a variety of polymers known in the catheter arts. - Referring to
FIG. 6C , a firstradiopaque marker 110 may be carried on theflexible shaft 82 beneath theadvance segment 100. A secondradiopaque marker 112 may be carried on theflexible shaft 82 within the trailingsegment 104. Each radiopaque marker may comprise a radiopaque tube or a coil of radiopaque wire such as a platinum iridium alloy wire having a diameter about 0.002 inches and positioned or wrapped around theflexible shaft 82 and soldered to theflexible shaft 82 to produce an RO sleeve or coil having an outside diameter of less than about 0.020 inches, such as about 0.012 inches. The radiopaque markers may also provide an axial interference fit between theflexible shaft 82 and theadvance segment 100 and trailingsegment 104 to resist core wire axial pull out from the tip 90 (tip detachment). - In certain implementations, the maximum OD of the
thread 92 exceeds the maximum OD of theadvance segment 100 by at least about 15% or 25% or 30% or more of the OD of theadvance segment 100, to facilitate crossing the clot with theadvance segment 100 and engaging the clot with thethread 92. - Depending upon the clinical application, it may be desirable to control the extent to which, if any, the
distal tip 102 can extend beyond the distal end of thecatheter 12. In certain implementations, thedistal tip 102 may be permitted to extend at least about 2 cm or 3 cm and preferably as much as 4 to 8 cm beyond the catheter (such as to permit manual removal of engaged thrombus), but generally will be limited to extend no more than a preset distance such as 12 cm or 8 cm or 5 cm beyond the catheter (e.g., within the range of from about 5 cm to about 10 cm) depending upon desired performance. - Distal advance of the
tip 102 may be limited by providing mechanical interference at the desired distal limit of travel. In one implementation, adistal stop surface 114 which may be on the handle 88 (seeFIG. 6A ) provides an interference engagement with a complementary proximal surface (e.g.proximal surface 33 onconnector module 30 or on the catheter hub) carried by the aspiration catheter through which thethrombus engagement tool 80 is advanced. Alternatively, a distal engagement surface can be carried anywhere along the length of thethrombus engagement tool 80, for sliding rotational engagement with a complementary proximally facing stop surface carried by the catheter. Additional details of distal limit configurations may be found in U.S. patent application Ser. No. 17/036,258 filed Sep. 29, 2020 and entitled Embolic Retrieval Catheter, which is hereby expressly incorporated in its entirety herein by reference. - The limit on distal advance of the helical tip may enable a first configuration in which the distal tip may be advanced through the catheter and placed at a first position approximately aligned with the distal end of the
catheter 12. The physician may then advance the tip to a second position extending beyond the distal end of the catheter such as for inspection and cleaning purposes. - A
position indicator 85 may be carried by theflexible shaft 82 spaced apart from thedistal surface 114 by a distance corresponding to the maximum length of the thrombus engagement tool intended to extend beyond the distal end of the catheter. When theposition indicator 85 is located at a corresponding reference point relative to the catheter hub, thedistal tip 102 may be positioned approximately at the distal end of the catheter. This way the physician will know that any further distal advance of the thrombus engagement tool will be extending beyond the distal end of the catheter. The maximum extension will be reached when thedistal surface 114 contacts the catheter hub. - The
position indicator 85 may comprise any of a variety of visual or tactile features, such as a color change or a colored band surrounding theflexible shaft 82. In a visual indicium implementation (color change or circumferential line) thedistal tip 102 may be positioned approximately at the distal end of the catheter when the indicator is visible just outside of the hub. In another implementation, theposition indicator 85 comprises the transition between the distal end of thehypo tube 87 and the underlyingflexible shaft 82. This provides haptic feedback as the indicator (step in outside diameter) encounters and passes through the valve of the RHV. Thehypo tube 87 additionally functions as a strain relief or anti buckling feature and may have an axial length within the range of from about 3 cm to about 15 cm and in some implementations within the range of from about 5 cm to about 9 cm. - Referring to
FIG. 7A , there is illustrated one example of an outer jacket segment stacking pattern for a progressive flexibility catheter of the type discussed in connection withFIG. 1 . Adistal segment 120 may have a length within the range of about 1-3 cm and a durometer of less than about 35 D or 30 D. An adjacentproximal segment 122 may have a length within the range of about 4-6 cm, and a durometer of less than about 35 D or 30 D. An adjacentproximal segment 124 may have a length within the range of about 4-6 cm, and a durometer of about 35 D or less. An adjacentproximal segment 126 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35 D to about 45 D (e.g., 40 D). An adjacentproximal segment 128 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 50 D to about 60 D (e.g., about 55 D). An adjacentproximal segment 130 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35 D to about 50 D to about 60 D (e.g., about 55 D). An adjacentproximal segment 132 may have a length within the range of about 1-3 cm, and a durometer of at least about 60 D and typically less than about 75 D. More proximal segments may have a durometer of at least about 65 D or 70 D. - The distal most two or three segments may comprise a material such as Tecothane and/or PEBAX, and more proximal segments may comprise PEBAX or other catheter jacket materials known in the art. At least three or five or seven or nine or more discrete segments may be utilized, having a change in durometer between highest and lowest along the length of the catheter shaft of at least about 10 D, preferably at least about 20 D and in some implementations at least about 30 D or 40 D or more.
-
FIGS. 7A-7E illustrate various embodiments of catheters, at least some of which incorporate a plurality of catheter outer jacket segments with varying lengths and/or hardness for varying flexibility along the length of the catheter body. It will be understood that any of the features shown or described in connection with any of the catheters ofFIGS. 7A-7E can be used with any of the embodiments described and/or contemplated herein. It will also be understood that any of the features described and/or contemplated in connection with any of the embodiments disclosed herein can be utilized with any of the catheters described in connection withFIGS. 7A-7E . As with all embodiments in this specification, any feature, structure, material, method, or step that is described and/or illustrated in the embodiments ofFIGS. 7A-7E can be used with or instead of any feature, structure, material, method, or step that is described and/or illustrated in any other embodiment of this specification. -
FIGS. 7B-7E illustrates embodiments ofvarious catheters catheters catheters other catheters FIG. 7E , each ofcatheters catheters other catheters catheters - For instance,
catheter 500 may be configured to pass through and extend beyondcatheter 400. By way of further example,catheter 600 may be configured to pass through and extend beyond at least one ofcatheter 500 orcatheter 400 in a telescoping manner. WhileFIG. 7E illustrates an example telescoping catheter stack including each ofcatheters catheters catheter 400 andcatheter 500, the use ofcatheter 400 andcatheter 600, or the use ofcatheter 500 andcatheter 600. -
Catheter 400 may comprise an 8 F catheter. In some instances,catheter 400 comprises a diameter larger than the diameter of any of the remaining catheters in a system. Additionally, or alternatively,catheter 400 may comprise an overall length shorter than the length of any of the remaining catheters in a system. In this manner,catheter 400 may comprise the outermost catheter in a telescoping system and may permit any of the remainingcatheters catheter 400. Thecatheter 400 may comprise a length between about 35 cm and about 105 cm or, a length between about 45 cm and about 95 cm. Thecatheter 400 may comprise a length of from about 50 cm to about 90 cm. Thecatheter 400 may comprise a length at least shorter than any catheter with a diameter smaller than catheter 400 (e.g., such ascatheter 500, 600). -
Catheter 500 may comprise a 6 F catheter. In some instances,catheter 500 comprises a diameter in between the diameters of the remaining catheters in a system. Additionally, or alternatively,catheter 500 may comprise a length in between the lengths of the remaining catheters in the system. In this manner,catheter 500 may comprise a middle catheter in a telescoping system and may be configured to pass through and extend beyond one or more catheters while also permitting another catheter to extend distally beyond a distal end ofcatheter 500. Thecatheter 500 may comprise a length between about 120 cm and about 155 cm or between about 130 cm and about 145 cm. Thecatheter 500 may comprise a length of about from 135 cm to about 137 cm. Thecatheter 500 may comprise a length at least longer than any catheter with a diameter larger than catheter 500 (e.g., such as catheter 400). Thecatheter 500 may comprise a length at least shorter than any catheter with a diameter smaller than catheter 500 (e.g., such as catheter 600). -
Catheter 600 may comprise a 5 F catheter. In some instances,catheter 600 comprises a diameter smaller than the diameters of the remaining catheters in a system. Additionally, or alternatively,catheter 600 may comprise a length longer than the lengths of any of the remaining catheters in the system. In this manner,catheter 600 may comprise an innermost catheter in a telescoping system and may be configured to pass through and extend beyond one or more of the other catheters. Thecatheter 600 may comprise a length between about 145 cm and about 175 cm or between about 155 cm and about 165 cm. Thecatheter 600 may comprise a length of about 160 cm. Thecatheter 600 may comprise a length at least longer than any catheter with a diameter larger than catheter 600 (e.g., such ascatheter 400, 500). - One or more of the
catheters catheter catheter catheter catheter catheter -
Catheter 600 may comprise one or more discrete sections with braid properties varying between one or more of the sections. In some instances,catheter 600 may comprise a first section, a second (e.g., intermediate) section, and a third distal section. However, it will be understood by one having skill in the art that thecatheter 600 may comprise a fewer number of sections (e.g., one section or two sections) or a greater number of sections (e.g., four sections or greater). A sidewall property, such as a length and/or a wire density the braid along a respective section, may vary between the sections. In some instances, a pics per inch (ppi) count of the braid in connection with the wire density of the braid may gradually transition between one or more of the catheter sections. For example, the ppi count of the braid, in some instances, may remain generally consistent through a length of the first section and a length of the third section but gradually transition along the length of the second, intermediate section. - The first section of
catheter 600 may have a length of at least about 20 cm. For example, the length of the first section may be from about 25 cm to about 35 cm or, in one example, about 30 cm. The braid through the first section may have a wire density of at least about 100 ppi. For example, the braid through the first section may have wire density of at least about 120 ppi or, more specifically, about 130 ppi. - The third section of
catheter 600 may have a length of at least about 100 cm. For example, the length of the third section may be from about 120 cm to about 140 cm or, more specifically, about 130 cm. The braid through the third section may have a wire density of no greater than about 85 ppi. For example, the braid through the third section may have wire density from about 70 ppi to about 80 ppi. - The second section of
catheter 600 may be an intermediate section between the first section and the third section. The second section may have a length of at least about 3 cm. In some instances, the second section may have a length no greater than about 20 cm or, more specifically, no greater than about 10 cm. For example, the length of the second section may be about 5 cm. The braid through the second section may have a wire density of no greater than the wire density of the first section and no less than the wire density of the third section. -
Catheter 500 may comprise one or more discrete sections with braid properties varying between one or more of the sections. In some instances,catheter 500 may comprise a first section, a second (e.g., intermediate) section, and a third section. However, it will be understood by one having skill in the art that the catheter may comprise a fewer number of sections (e.g., one section or two sections) or a greater number of sections (e.g., four sections or greater). A sidewall property, such as a length and/or a wire density the braid along a respective section, may vary between the sections. In some instances, a ppi count of the braid in connection with the wire density of the braid may gradually transition between one or more of the catheter sections. For example, the ppi count of the braid, in some instances, may remain generally consistent through a length of the first section and a length of the third section but gradually transition along the length of the second, intermediate section. - The first section of
catheter 500 may have a length of at least about 20 cm. For example, the length of the first section may be from about 25 cm to about 35 cm or, in one example, about 30 cm. The braid through the first section may have a wire density of at least about 100 ppi. For example, the braid through the first section may have wire density of at least about 120 ppi or, in one example, about 130 ppi. - The third section of
catheter 500 may have a length of at least about 80 cm. For example, the length of the third section may be from about 100 cm to about 120 cm or, in one example, about 105 cm. The braid through the third section may have a wire density of no greater than about 100 ppi. For example, the braid through the third section may have wire density from about 80 ppi to about 90 ppi. - The second section of
catheter 600 may be an intermediate section between the first section and the third section. The second section may have a length of at least about 3 cm. In some instances, the second section may have a length no greater than about 20 cm or, more specifically, no greater than about 10 cm. For example, the length of the second section may be about 5 cm. The braid through the second section may have a wire density of no greater than the wire density of the first section and no less than the wire density of the third section. -
Catheter 400 may comprise one or more discrete sections with braid properties varying between one or more of the sections. In some instances,catheter 400 may comprise one section. However, it will be understood by one having skill in the art that thecatheter 400 may comprise a greater number of sections (e.g., two sections, three sections, four sections, or greater). For example,catheter 400 may comprise three sections as described in connection with either one orcatheter 500 orcatheter 600. A sidewall property, such as a length and/or a wire density the braid, may vary alongcatheter 400. In some instances, a ppi count of the braid in connection with the wire density of the braid may gradually transition to increasing flexibility in a distal direction alongcatheter 400. The section ofcatheter 400 may have a length of at least about 40 cm. For example, the length of the section may be from about 50 cm to about 60 cm or, in one example, about 55 cm. The braid through the section may have a wire density of at least about 80 ppi. For example, the braid through the section may have wire density of at least about 90 ppi. - The braid, in some instances, may extend along an entire length of the catheter sidewall. In some instance, a junction between the braid and a coil is not present in the catheter and/or the catheter sidewall does not incorporate a coil. It will be understood that this braid configuration may be applied to any catheter disclosed herein, including, but not limited to,
catheters - One or more of the
catheters catheter catheter catheter -
Catheter 600 may comprise a plurality of discrete segments of the outer jacket with varying flexibility between one or more of the segments. In some instances,catheter 600 may comprise a plurality of segments. A sidewall property, such as Shore D hardness and/or flexibility, may vary between the segments. In some instances, a Shore D hardness of the outer jacket segments may gradually transition from higher at proximal end segment of the outer jacket to lower at a distal end segment of the outer jacket. - The proximal end segment of the outer jacket of the
catheter 600 may have a Shore D hardness of at least about 60. For example, the Shore D hardness of the proximal end segment may be from about 70 to about 80 or, more specifically, at least about 75. - The distal end segment of the outer jacket of the
catheter 600 may have a Shore D hardness of at most about 40. For example, the Shore D hardness of the distal end segment may be from about 30 to about 20 or, more specifically, no more than about 27. - A plurality of the intermediate segments between the distal end segment and the proximal end segment may each comprise a variety of Shore D hardness. In some instances, each segment decreases in a Shore D hardness in a distal direction and may have a smaller Shore D hardness than a proximally adjacent segment. For example, the Shore D hardness of a first segment may be from about 30 to about 50 or, more specifically, about 40. The first segment, in some instances, may be between positioned about 120 cm to about 160 cm or, more specifically, about 140 cm away from a distal end face of the
catheter 600. By way of another example, the Shore D hardness of the second segment may be from about 50 to about 70 or, more specifically, about 65. The second segment, in some instances, may be between positioned about 220 cm to about 260 cm or, more specifically, about 240 cm away from a distal end face of thecatheter 600. -
Catheter 500 may comprise a plurality of discrete segments of the outer jacket with varying flexibility between one or more of the segments. In some instances, catheter may comprise a plurality of segments. A sidewall property, such as Shore D hardness and/or flexibility, may vary between the segments. In some instances, a Shore D hardness of the outer jacket segments may gradually transition from higher at a proximal end segment of the outer jacket to lower at a distal end segment of the outer jacket. - The proximal end segment of the outer jacket of the
catheter 500 may have a Shore D hardness of at least about 60. For example, the Shore D hardness of the proximal end segment may be from about 70 to about 80 or, more specifically, at least about 75. - The distal end segment of the outer jacket of the
catheter 500 may have a Shore D hardness of at most about 40. For example, the Shore D hardness of the distal end segment may be from about 30 to about 20 or, more specifically, no more than about 27. - a plurality of the intermediate segments between the distal end segment and the proximal end segment may each comprise a variety of Shore D hardness. In some instances, each segment decreases in a Shore D hardness in a distal direction and may have a smaller Shore D hardness than a proximally adjacent segment. For example, the Shore D hardness of a first segment may be from about 30 to about 50 or, more specifically, about 40. The first segment, in some instances, may be between positioned about 70 cm to about 110 cm or, more specifically, about 90 cm away from a distal end face of the
catheter 500. By way of another example, the Shore D hardness of a second segment may be from about 50 to about 70 or, more specifically, about 65. The second segment, in some instances, may be between positioned about 160 cm to about 200 cm or, more specifically, about 180 cm away from a distal end face of thecatheter 500. -
Catheter 400 may comprise a plurality of discrete segments of the outer jacket with varying flexibility between one or more of the segments. In some instances,catheter 400 may comprise a plurality of segments. A sidewall property, such as Shore D hardness and/or flexibility, may vary between the segments. In some instances, a Shore D hardness of the outer jacket segments may gradually transition from a proximal end segment of the outer jacket to a distal end segment of the outer jacket. - The proximal end segment of the outer jacket of the
catheter 400 may have a Shore D hardness of at least about 60. For example, the Shore D hardness of the proximal end segment may be from about 70 to about 80 or, more specifically, about 75. - The distal end segment of the outer jacket of the
catheter 400 may have a Shore D hardness of at most about 40. For example, the Shore D hardness of the distal end segment may be from about 30 to about 20 or, more specifically, no more than about 27. - A plurality of the intermediate segments between the distal end segment and the proximal end segment may each comprise a variety of Shore D hardness. In some instances, each segment decreases in a Shore D hardness in a distal direction and may have a smaller Shore D hardness than a proximally adjacent segment. For example, the Shore D hardness of a first segment may be from about 30 to about 50 or, more specifically, about 40. A first segment, in some instances, may be between positioned about 65 cm to about 105 cm or, more specifically, about 85 cm away from a distal end face of the
catheter 400. By way of another example, the Shore D hardness of a second segment may be from about 40 to about 65 or, more specifically, about 55. The second segment, in some instances, may be between positioned about 105 cm to about 145 cm or, more specifically, about 125 cm away from a distal end face of thecatheter 400. By way of further example, the Shore D hardness of a third segment may be from about 60 to about 80 or, more specifically, about 70. The third segment, in some instances, may be between positioned about 140 cm to about 180 cm or, more specifically, about 160 cm away from a distal end face of thecatheter 400. -
Catheter 400 may comprise a tubular body length of about 90+/−5 cm. In some instances,catheter 400 may comprise a tubular body length of about 50+/−5 cm. A number of the plurality of discrete segments of the outer jacket ofcatheter 400 may vary with respect to the tubular body length ofcatheter 400. A length of the respective segments of the plurality of discrete segments of the outer jacket ofcatheter 400 may vary with respect to the tubular body length ofcatheter 400. - A coating, in some instances, may be located along an outer diameter of a distal portion of the catheter sidewall. The coating can be configured to decrease frictional resistance of the distal portion of the catheter sidewall with any adjacent structure (e.g., a vessel wall). In some instances, the coating increases the lubriciousness of the catheter distal portion outer sidewall. The coating may advantageously reduce friction on the distal end of the catheter going through tortuous vasculature. This may facilitate advancement and rotation of the catheter distal end, particularly in situations where the catheter contains an increased flexibility along a distal end portion of the catheter. The coating may extend in a proximal direction from, or proximate to, a catheter distal end face. The coating may extend at least about 20 cm in a proximal direction. In some instances, the coating extends no farther than about 50 cm from the catheter distal end face. For example, the coating may extend for a length of about 25 cm to about 35 cm or, more specifically, about 30 cm from a catheter distal end face. It will be understood that the coating may be applied to any catheter disclosed herein, including, but not limited to,
catheters -
FIG. 8 illustrates a cross section through the sidewall of a distal portion of a single lumen catheter. An internal support layer may comprise either a coil or braid. In a coil implementation, adjacent loops or filars of thecoil 140 may have a constant pitch throughout the length of the coil or may be closely tightly wound in a proximal zone with a distal section having looser spacing between adjacent loops. In an embodiment having acoil section 140 with an axial length of at least between about 20% and about 30% of the overall catheter length, (e.g., 28 cm coil length in a 110 cm catheter shaft 16), at least the distal about 1 cm or about 2 cm or about 3 cm or about 4 cm of the coil will have a spacing that is at least about 130%, and in some implementations at least about 150% or more than the spacing in the proximal coil section. In a 110 cm catheter shaft 3000 having a Nitinol coil, the spacing in the proximal coil may be about 0.004 inches and in the distal section may be at least about 0.006 inches or about 0.007 inches or more. - The distal end of the coil or braid 140 can be spaced proximally from the distal end of the
inner liner 142, for example, to provide room for an annularradiopaque marker 144. The coil orbraid 140 may be set back proximally from the distal end, in some embodiments, by approximately no more than about 1 cm, about 2 cm, or about 3 cm. In one embodiment, the distal end of thecatheter 12 is provided with a beveled (inclined)distal surface 146 residing on a plane having an angle of at least about 10 degrees or about 20 degrees and in one embodiment about 30 degrees with respect to a longitudinal axis of thecatheter 10. At least a distally facing edge of the annularradiopaque marker 144 may be an ellipse, residing on a plane which is inclined with respect to the longitudinal axis to complement the bevel angle of thedistal surface 146. Additional details are described in connection withFIG. 9 below. - After applying a braid or braid and coil over
tie layer 152 and/or over a liner, the distal braid or coil and theRO marker 144 are provided with anouter jacket 156 such as a polymer tube formed from a plurality of axially adjacent cylindrical segments to enclose thecatheter body 16. Theouter sleeve 156 may comprise any of a variety of materials, such as polyethylene, polyurethane, polyether block amide (e.g., PEBAX™), nylon or others known in the art. Sufficient heat is applied to cause the polymer to flow into and embed the proximal braid and distal coil. - In one implementation, the
outer jacket 156 is formed by sequentially advancing a plurality of shorttubular segments catheter 12 and provide a smooth continuous outer tubular body. The foregoing segmented construction may extend along at least the most distal about 10 cm, and preferably at least about the most distal about 20 cm, about 25 cm, about 30 cm, about 35 cm, about 40 cm, or more than about 40 cm of thecatheter body 10. The entire length of theouter jacket 156 may be formed from tubular segments and the length of the distal tubular segments may be shorter than the one or more tubular segments forming the proximal portion of theouter jacket 156 proximal to the junction between thebraid 150 andcoil 140 in order to provide proximal backup support and steeper transitions in flexibility toward the distal end of thecatheter 12. - The durometer of the outer wall segments may decrease in a distal direction. For example, proximal segments such as 133 and 132, may have a durometer of at least about 60 D or about 70 D, with gradual decrease in durometer of successive segments in a distal direction to a durometer of no more than about 35 D or about 25 D or lower. A 25 cm section may have at least about 3 or about 5 or about 7 or more segments and the
catheter 12 overall may have at least about 6 or about 8 or about 10 or more distinct flexibility zones. The distal 1 or 2 or 4 ormore segments finished catheter body 16. The length of alower OD section 160 may be within the range of from about 3 cm to about 15 cm and, in some embodiments, is within the range of from about 5 cm to about 10 cm such as about 7 cm or about 8 cm and may be accomplished by providing thedistal segments - In another embodiment, the most distal portion of the
catheter 12 may comprise a durometer of less than approximately 35 D (e.g., 25 D) to form a highly flexible distal portion of the catheter and have a length between approximately 25 cm and approximately 35 cm. The distal portion may comprise one or more tubular segments of the same durometer (e.g., segment 120). A series of proximally adjacent tubular segments may form a transition region between a proximal stiffer portion of thecatheter 12 and the distal highly flexible portion of the catheter. The series of tubular segments forming the transition region may have the same or substantially similar lengths, such as approximately 1 cm. - The relatively short length of each of the series of tubular segments may provide a steep drop in durometer over the transition region. For example, the transition region may have a proximal tubular segment 122 (proximally adjacent the distal portion) having a durometer of approximately 35 D. An adjacent
proximal segment 124 may have a durometer of approximately 55 D. An adjacentproximal segment 126 may have a durometer of approximately 63 D. An adjacentproximal segment 128 may have a durometer of approximately 72 D. - More proximal segments may comprise a durometer or durometers greater than approximately 72 D and may extend to the proximal end of the catheter. For instance, a catheter segment may comprise a proximal portion greater than approximately 72 D between about 1 cm and about 3 cm. In some embodiments, the proximal portion may be about 2 cm long. In some embodiments, the most distal segments (e.g., 120, 122) may comprise PEBAX™ and more proximal segments may comprise a generally stiffer material, such as Vestamid®.
- The inner diameter of the
catheter 10 may be between approximately 0.06 and 0.08 inches, between approximately 0.065 and 0.075 inches, or between approximately 0.068 and 0.073 inches. In some embodiments, the inner diameter is approximately 0.071 inches. - In some embodiments, the distal most portion may step or taper to a decreased inner diameter such as under
segments catheter 12. In some embodiments, the inner diameter may remain constant, at least over the catheter extension segment. - In some hybrid coil/braid embodiments, the
coil 140 may extend proximally from a distal end of thecatheter 12 along the highly flexible distal portion ending at or overlapping with the distal end of thebraid 150. In other embodiments, thecoil 140 may extend the entire length of thecatheter 12. Thebraid 150, when present, may extend from about thetransition 163 the proximal end of thecoil 140 to the proximal end of thecatheter 12. - Any of the catheters disclosed herein may be provided with an angled distal tip. Referring to
FIG. 9 ,distal catheter tip 18 comprises atubular body 14 which includes anadvance segment 200, and amarker band 144. An innertubular liner 142 may extend throughout the length of the distal catheter tip and may comprise dip coated PTFE. - A reinforcing
element 140 such as a braid and/or spring coil is embedded in an outer jacket which may extend the entire length of the catheter proximally of the radiopaque marker. - The
advance segment 200 terminates distally in anangled face 146, to provide a leadingside wall portion 202 having a length measured between thedistal end 204 of themarker band 144 and adistal tip 206. A trailingside wall portion 208 of theadvance segment 200, has an axial length in the illustrated embodiment of approximately equal to the axial length of the leadingside wall portion 202 as measured at approximately 180 degrees around the catheter from the leadingside wall portion 202. The leadingside wall portion 202 may have an axial length within the range of from about 0.1 mm to about 5 mm and generally within the range of from about 1 to 3 mm. The trailingside wall portion 208 may be at least about 0.1 or 0.5 or 1 mm or 2 mm or more shorter than the axial length of the leadingside wall portion 202, depending upon the desired performance. - The
angled face 146 inclines at an angle A within the range of from about 45 degrees to about 80 degrees from the longitudinal axis of the catheter. For certain implementations, the angle is within the range of from about 50 degrees to about 70 degrees or within the range of from about 55 degrees to about 65 degrees from the longitudinal axis of the catheter. In one implementation, the angle A is about 60 degrees. One consequence of an angle A of less than 90 degrees is an elongation of a major axis of the area of the distal port which increases the surface area of the port and may enhance clot aspiration or clot retention. Compared to the surface area of the circular, transverse port (angle A is 90 degrees), the area of the angled port is generally at least about 105%, and no more than about 130%, in some implementations within the range of from about 110% and about 125% and in one example is about 115%. - In the illustrated embodiment, the axial length of the advance segment is substantially constant around the circumference of the catheter, so that the
angled face 146 is approximately parallel to thedistal surface 210 of themarker band 144. Themarker band 144 has a proximal surface approximately transverse to the longitudinal axis of the catheter, producing amarker band 144 having a right trapezoid configuration in a side elevational view. Ashort sidewall 212 is rotationally aligned with the trailingside wall portion 208, and has an axial length within the range of from about 0.2 mm to about 4 mm, and typically from about 0.5 mm to about 2 mm. An opposinglong sidewall 214 is rotationally aligned with the leadingside wall portion 202.Long sidewall 214 of themarker band 144 is generally at least about 10% or 20% longer thanshort sidewall 212 and may be at least about 50% or 70% or 90% or more longer thanshort sidewall 212, depending upon desired performance. Generally, thelong sidewall 214 will have a length of at least about 0.5 mm or 1 mm and less than about 5 mm or about 4 mm. - Any of the marker bands described herein may be a continuous annular structure, or may optionally have at least one and optionally two or three or more axially extending slits throughout its length. The slit may be located on the
short sidewall 212 or thelong sidewall 214 or in between, depending upon desired bending characteristics. Any of the marker bands described herein may comprise any of a variety of radiopaque materials, such as a platinum/iridium alloy, with a wall thickness preferably no more than about 0.003 inches and in one implementation is about 0.001 inches. - The
advance segment 200 may comprise a distal extension of the outer polymer jacket and optionally the inner liner, without other internal supporting structures distally of themarker band 144. The outer jacket may comprise extruded Tecothane and/or PEBAX. Theadvance segment 200 may have a bending stiffness and radial crush stiffness that is no more than about 50%, and in some implementations no more than about 25% or 15% or 5% or less than the corresponding value for the adjacent proximal catheter body. - The proximal end of the
catheter 12 is preferably provided with a hemostasis valve, to facilitate introduction of a thrombus engagement tool or a secondary catheter there through. The hemostasis valve may be carried by theconnector module 30, or directly by theproximal catheter connector 22. Any of a variety of hemostasis valve configurations may be used. - Referring to
FIGS. 10A-10C , there is illustrated a valve inserter in accordance with another embodiment. The inserter enables opening a valve (e.g., the hemostasis valve and/or an introducer sheath valve having an elastomeric membrane valve with a passive slit) and supporting it in an open configuration while providing an access lumen therethrough to enable a delicate secondary device such as a thrombus engagement tool or a catheter to advance therethrough without encountering any resistance or damage from the valve. - The
inserter 300 comprises an elongatetubular body 302 having aproximal end 304, adistal end 306, and acentral lumen 308 extending therethrough. Thetubular body 302 has an inside diameter sufficient to accommodate the secondary device, and an OD capable of passing through a compatible hemostasis valve. In general, tubular body will have an outside diameter within the range of from about 0.04″ to about 0.1, and a length within the range of from about 1″ to about 4″.Tubular body 302 can be formed as an extrusion from any of a variety of common catheter polymers such as Nylon, PEEK, polyethylene, polyimide or others known in the art having sufficient crush resistance and column strength to enter and to maintain patency under the closing pressure of a hemostasis valve. - The
proximal end 304 of thetubular body 302 may be provided with a funnel shapedlanding zone 322 leading to the central lumen, to facilitate introducing the distal tip of the secondary device into the inserter. In the illustrated embodiment, the proximal end of the tubular body is provided with aninclined face 314. A distal, leadingedge 316 of theinclined face 314 is axially distally spaced apart from the trailingproximal edge 318 of theface 314 by a distance D. The distance D [between 316 and 318] may be at least about 0.1″ and typically no more than about 0.5″. - The inclined face cooperates with the curved sidewall of the tube to create a side opening for funneling the distal tip of the secondary device into the proximal end of the lumen. For this purpose, the side wall at the trailing
edge 318 may be provided with a curvature having a greater radius than the radius of curvature at theleading edge 316 with a progressively changing radius in between, creating a funnel shape for thelanding zone 322. - The
tubular body 302 is provided with anaxially extending slit 310 extending between thedistal end 306 and theleading edge 316 of theinclined face 314, to enable the inserter to be peeled away laterally from the secondary device extending therethrough once the inserter has enabled passage of the secondary device through the hemostasis valve. - A
pull tab 312 may be provided on the proximal end of thetubular body 302 to enable theinserter 300 to be grasped and pulled away from the secondary device extending therethrough. Thepull tab 312 may be integrally formed with the tubular body 302 (e.g., as a portion of the sidewall of the tube stock as illustrated) or attached thereto such as by adhesive bonding or mechanical compression or interference engagement. In the illustrated embodiment, thepull tab 312 inclines laterally away from the longitudinal axis of the tubular body, to allow coaxial approach and introduction of the catheter into theinserter 300. - In one implementation of the inserter, the tubular body has a substantially constant diameter throughout most (e.g., at least about 80% or 90%) of its length overall. However, at least the outside diameter in a
distal nose segment 324 may be necked down to a smaller outside diameter at the distal end. This enables the inserter to better enter the hemostasis valve under distal compression. In one example, the tubular body has an 8 French ID along most of its length but necks down to 6 French in thedistal nose segment 324. This inserter will facilitate the introduction of either a 6 French or an 8 French catheter through the hemostasis valve, since the 8 French catheter can simply forcibly dilate the necked distal end due to theaxial slit 310. - In one implementation, the concave entrance funnel surface of the
landing zone 322 may be provided with a visual indicium such as a different color than the outside surface of thetubular body 302, to facilitate visualization of the funnel opening and assist in loading the secondary catheter into the funnel. This may be accomplished by providing a colored coating on either the inside or outside surface of the tube stock, or by forming at least a portion of the tube stock as a coextrusion of dissimilar colored materials. - A clot capture module for use in a thrombectomy system, the clot capture module comprising one or more of the following:
- a housing;
- a clot capture chamber in the housing;
- a window in the housing to permit visual inspection of the clot capture chamber;
- a filter in the clot capture chamber, the filter being visible through the window, the filter having an upstream surface and a downstream surface;
- an incoming flow path configured to direct incoming blood from an aspiration catheter against the upstream surface of the filter;
- a normally closed aspiration control valve in the incoming flow path, the aspiration control valve configured to block flow of incoming aspirated blood until actuated to permit inflow of aspirated blood; and
- an outgoing flow path configured to direct blood from a downstream side of the filter to a remote vacuum canister.
- A clot capture module as described in any embodiment herein, further comprising a normally closed vent being openable to permit air to be drawn into the clot capture chamber.
- A clot capture module as described in any embodiment herein, wherein the upstream surface of the filter is visible through the window.
- A clot capture module as described in any embodiment herein, wherein the upstream surface of the filter is substantially planar.
- A clot capture module as described in any embodiment herein, wherein the upstream surface of the filter is convex.
- A clot capture module as described in any embodiment herein, wherein the filter comprises a blood permeable membrane, and wherein the upstream surface of the filter is on a radially outwardly facing surface of the blood permeable membrane.
- A clot capture module as described in any embodiment herein, wherein the blood permeable membrane at least partially encloses a filtered blood chamber which is in fluid communication with the outgoing flow path.
- A clot capture module as described in any embodiment herein, wherein the window comprises a transparent tubular portion of the housing.
- A clot capture module as described in any embodiment herein, further comprising an aspiration actuator, configured to control the aspiration control valve.
- A clot capture module as described in any embodiment herein, wherein the aspiration actuator comprises a rocker switch.
- A clot capture module as described in any embodiment herein in combination with a vacuum line leading to an aspiration pump and canister, wherein the clot capture module is configured to reside within a sterile field while the aspiration pump and canister reside outside of the sterile field.
- A clot capture module as described in any embodiment herein, wherein the vacuum line is at least about 30 inches in length.
- A clot capture module as described in any embodiment herein, wherein the aspiration control valve comprises collapsible tubing.
- A clot capture module as described in any embodiment herein, further comprising a selector valve in the vacuum line.
- A clot capture module as described in any embodiment herein, wherein the aspiration pump comprises a syringe.
- A clot capture module as described in any embodiment herein, comprising a proximal housing, and a distal housing separated by a transparent tubular side wall.
- A clot capture module as described in any embodiment herein, wherein at least one of the proximal housing and distal housing is releasably connected to the transparent tubular side wall.
- A clot capture module as described in any embodiment herein, further comprising a coating to inhibit blood accumulation on an interior surface of the window.
- A thrombus engagement tool configured to be advanced through a catheter and to engage thrombus, the thrombus engagement tool comprising one or more of the following:
- a rotatable core having a proximal end and a distal end; and
- a thrombus engagement tip on the distal end of the rotatable core, the thrombus engagement tip comprising:
- a helical thread;
- an advance segment on a distal side of the helical thread; and
- a trailing segment on a proximal side of the helical thread.
- A thrombus engagement tool as described in any embodiment herein, further comprising a projection carried by the rotatable core, the projection being underneath at least one of the advance segment and the trailing segment to form an interference fit with the thrombus engagement tip.
- A thrombus engagement tool as described in any embodiment herein, wherein the projection comprises an annular ring.
- A thrombus engagement tool as described in any embodiment herein, wherein the projection comprises a radiopaque marker.
- A thrombus engagement tool as described in any embodiment herein, comprising a first radiopaque marker under the advance segment and a second radiopaque marker under the trailing segment.
- A thrombus engagement tool as described in any embodiment herein, wherein an outer periphery of the helical thread substantially conforms to a surface of a cylinder.
- A thrombus engagement tool as described in any embodiment herein, wherein the helical thread comprises a proximal surface which inclines radially outwardly in a proximal direction to define a proximally opening undercut.
- A thrombus engagement tool as described in any embodiment herein, further comprising a handle on the proximal end of the rotatable core.
- A thrombus engagement tool as described in any embodiment herein, comprising a limit bearing surface on the handle, the limit bearing surface being configured to limit projection of the thrombus engagement tip in a distal direction relative to a distal end of the aspiration catheter.
- A thrombus engagement tool as described in any embodiment herein, wherein the advance segment, the helical thread, and the trailing segment are all molded onto the rotatable core.
- A thrombus engagement tool as described in any embodiment herein, wherein the rotatable core is cannulated.
- A thrombus engagement tool as described in any embodiment herein, wherein the rotatable core is a solid wire.
- A thrombus engagement tool as described in any embodiment herein, wherein the advance segment comprises an atraumatic tip.
- A thrombus engagement tool as described in any embodiment herein, wherein the atraumatic tip comprises a soft polymer.
- A thrombus engagement tool as described in any embodiment herein, wherein the handle further comprises an indicium of rotational direction.
- A thrombus engagement tool as described in any embodiment herein, wherein the thrombus engagement tip has an axial length within the range of from about 15 mm to about 30 mm.
- A thrombus engagement tool as described in any embodiment herein in combination with a catheter having an inside diameter, wherein an outside diameter of the helical thread is no more than about 60% of the inside diameter of the catheter.
- A thrombus engagement tool as described in any embodiment herein, wherein the outside diameter of the helical thread is no more than about 40% of the inside diameter of the catheter.
- A thrombus engagement tool as described in any embodiment herein, further comprising a position indicator carried by the rotatable core.
- A thrombus engagement tool as described in any embodiment herein, wherein the position indicator comprises a distal end of a tube surrounding the rotatable core.
- A method of removing embolic material from a vessel with mechanical and aspiration assistance, the method comprising one or more of the following:
- providing an aspiration catheter having a central lumen and a distal end;
- advancing the distal end to obstructive material in a vessel;
- applying vacuum to the central lumen to draw clot into the central lumen;
- introducing a thrombus engagement tool into the central lumen, the thrombus engagement tool having a tip comprising a helical thread having a major diameter that is at least about 0.015 inches smaller than an inside diameter of the central lumen, the helical thread being configured to provide an aspiration flow path around the tip; and
- manually manipulating the tip to engage clot between the tip and an inside wall of the central lumen.
- A method of removing embolic material as described in any embodiment herein, wherein the tip is carried by a rotatable core having a proximal handle.
- A method of removing embolic material as described in any embodiment herein, wherein the rotatable core is cannulated.
- A method of removing embolic material as described in any embodiment herein, wherein the rotatable core is a microcatheter.
- A method of removing embolic material as described in any embodiment herein, wherein the rotatable core is a wire.
- A method of removing embolic material as described in any embodiment herein, wherein the axial length of the threaded portion of the tip is within the range of from about 5 mm to about 15 mm.
- A method of removing embolic material as described in any embodiment herein, further comprising the step of introducing the catheter via a femoral artery prior to the advancing step.
- A method of removing embolic material as described in any embodiment herein, comprising the step of advancing the catheter to a pulmonary embolism.
- A method of removing embolic material as described in any embodiment herein, comprising the step of advancing the catheter to a deep venous thrombosis.
- A method of removing embolic material as described in any embodiment herein, comprising the step of introducing a thrombus engagement tool having a tip with a major diameter that is no more than about 60% of the inside diameter of the central lumen.
- A method of removing embolic material as described in any embodiment herein, comprising introducing a thrombus engagement tool having a tip with a major diameter that is no more than about 40% of the inside diameter of the central lumen.
- A method of removing embolic material as described in any embodiment herein, wherein the tip is laterally displaced within the central lumen in response to the ingestion of clot.
- A method of removing embolic material as described in any embodiment herein, wherein an outer profile of the threaded tip in an end view is substantially circular.
- A method of removing embolic material as described in any embodiment herein, wherein the thread has a proximal face and a distal face, and the proximal face inclines radially outwardly in a proximal direction.
- A method of removing embolic material as described in any embodiment herein further comprising axially reciprocating the thrombus engagement tool within the catheter.
- A method of removing embolic material as described in any embodiment herein, further comprising axially extending the tip beyond the distal end of the catheter.
- A method of removing embolic material as described in any embodiment herein, comprising extending the distal tip at least about 2 cm beyond the distal end of the catheter.
- A method of removing embolic material as described in any embodiment herein, comprising axially aligning the distal tip with the distal end of the catheter using a position indicator on the rotatable core.
- A method of removing embolic material as described in any embodiment herein, further comprising advancing the thrombus engagement tool through a rotating hemostasis valve before introducing the thrombus engagement tool into the central lumen.
- A method of removing embolic material as described in any embodiment herein, wherein the position indicator provides haptic feedback as the position indicator passes through the hemostasis valve.
- An inserter for guiding a device through a valve, the inserter comprising one or more of the following:
- an elongate tubular body having a proximal end, a distal end, and a sidewall at least partially defining a central lumen;
- a laterally facing concave landing zone on the proximal end, the concave landing zone having a radius of curvature that increases in a proximal direction; and
- an axially extending slit in the sidewall, the axially extending slit extending from the distal end to the concave landing zone.
- An inserter as described in any embodiment herein, further comprising a tapered distal tip.
- An inserter as described in any embodiment herein, further comprising a pull tab.
- An inserter as described in any embodiment herein, wherein a surface of the concave landing zone comprises a different color than an outside surface of the elongate tubular body.
- A method of passing a device through a valve, the method comprising one or more of the following:
- providing an inserter having a tubular body with a split sidewall;
- advancing the tubular body through a valve;
- advancing a device through the tubular body and beyond the valve; and
- proximally retracting the tubular body so that the device escapes laterally from the tubular body through the split sidewall, leaving the device in place across the valve.
- A method of passing a device through a valve as described in any embodiment herein, wherein advancing the tubular body through the valve comprises advancing a tapered distal tip on the tubular body through the valve.
- A method of passing a device through a valve as described in any embodiment herein, wherein advancing the tubular body through the valve is accomplished with the device pre loaded inside the tubular body.
- A method of passing a device through a valve as described in any embodiment herein, wherein a distal nose segment of the tubular body expands in diameter in response to advancing the device therethrough.
- A method of passing a device through a valve as described in any embodiment herein, wherein the device is a thrombus engagement tool.
- A method of passing a device through a valve as described in any embodiment herein, wherein the device is a secondary catheter.
- A method of passing a device through a valve as described in any embodiment herein, wherein the device is an aspiration catheter.
Claims (11)
1. An inserter for guiding a device through a valve, the inserter comprising:
an elongate tubular body having a proximal end, a distal end, and a sidewall at least partially defining a central lumen;
a laterally facing concave landing zone on the proximal end, the concave landing zone having a radius of curvature that increases in a proximal direction; and
an axially extending slit in the sidewall, the axially extending slit extending from the distal end to the concave landing zone.
2. An inserter as in claim 1 , further comprising a tapered distal tip.
3. An inserter as in claim 1 , further comprising a pull tab.
4. An inserter as in claim 1 , wherein a surface of the concave landing zone comprises a different color than an outside surface of the elongate tubular body.
5. A method of passing a device through a valve, the method comprising:
providing an inserter having a tubular body with a split sidewall;
advancing the tubular body through a valve;
advancing a device through the tubular body and beyond the valve; and
proximally retracting the tubular body so that the device escapes laterally from the tubular body through the split sidewall, leaving the device in place across the valve.
6. A method as in claim 5 , wherein advancing the tubular body through the valve comprises advancing a tapered distal tip on the tubular body through the valve.
7. A method as in claim 5 , wherein advancing the tubular body through the valve is accomplished with the device pre loaded inside the tubular body.
8. A method as in claim 5 , wherein a distal nose segment of the tubular body expands in diameter in response to advancing the device therethrough.
9. A method as in claim 5 , wherein the device is a thrombus engagement tool.
10. A method as in claim 5 , wherein the device is a secondary catheter.
11. A method as in claim 5 , wherein the device is an aspiration catheter.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/810,743 US20230015259A1 (en) | 2019-12-18 | 2022-07-05 | Inserter for guiding a device through a hemostasis valve and method thereof |
PCT/US2023/066924 WO2023220707A2 (en) | 2022-05-13 | 2023-05-12 | Transvascular thrombectomy system |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962950058P | 2019-12-18 | 2019-12-18 | |
US202063044511P | 2020-06-26 | 2020-06-26 | |
US202063064273P | 2020-08-11 | 2020-08-11 | |
US17/125,723 US11065018B2 (en) | 2019-12-18 | 2020-12-17 | Methods and systems for advancing a catheter to a target site |
US17/357,490 US11457936B2 (en) | 2019-12-18 | 2021-06-24 | Catheter system for treating thromboembolic disease |
US202263341926P | 2022-05-13 | 2022-05-13 | |
US17/810,743 US20230015259A1 (en) | 2019-12-18 | 2022-07-05 | Inserter for guiding a device through a hemostasis valve and method thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/357,490 Continuation-In-Part US11457936B2 (en) | 2019-12-18 | 2021-06-24 | Catheter system for treating thromboembolic disease |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230015259A1 true US20230015259A1 (en) | 2023-01-19 |
Family
ID=76437155
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/125,723 Active US11065018B2 (en) | 2019-12-18 | 2020-12-17 | Methods and systems for advancing a catheter to a target site |
US17/125,743 Active US11253277B2 (en) | 2019-12-18 | 2020-12-17 | Systems for accessing a central pulmonary artery |
US17/125,742 Pending US20210186537A1 (en) | 2019-12-18 | 2020-12-17 | Methods and systems for accessing and retrieving thrombo-emboli |
US17/125,217 Active 2041-10-25 US11819228B2 (en) | 2019-12-18 | 2020-12-17 | Methods and systems for treating a pulmonary embolism |
US17/810,743 Pending US20230015259A1 (en) | 2019-12-18 | 2022-07-05 | Inserter for guiding a device through a hemostasis valve and method thereof |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/125,723 Active US11065018B2 (en) | 2019-12-18 | 2020-12-17 | Methods and systems for advancing a catheter to a target site |
US17/125,743 Active US11253277B2 (en) | 2019-12-18 | 2020-12-17 | Systems for accessing a central pulmonary artery |
US17/125,742 Pending US20210186537A1 (en) | 2019-12-18 | 2020-12-17 | Methods and systems for accessing and retrieving thrombo-emboli |
US17/125,217 Active 2041-10-25 US11819228B2 (en) | 2019-12-18 | 2020-12-17 | Methods and systems for treating a pulmonary embolism |
Country Status (6)
Country | Link |
---|---|
US (5) | US11065018B2 (en) |
EP (1) | EP4076611A4 (en) |
JP (1) | JP2023507553A (en) |
CN (1) | CN113365687A (en) |
CA (1) | CA3162704A1 (en) |
WO (1) | WO2021127004A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
US11819228B2 (en) | 2019-12-18 | 2023-11-21 | Imperative Care, Inc. | Methods and systems for treating a pulmonary embolism |
US11850349B2 (en) | 2018-07-06 | 2023-12-26 | Incept, Llc | Vacuum transfer tool for extendable catheter |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110381855B (en) | 2017-01-06 | 2023-07-04 | 因赛普特有限责任公司 | Antithrombotic coating for aneurysm treatment devices |
CA3095844A1 (en) | 2018-05-01 | 2019-11-07 | Incept, Llc | Devices and methods for removing obstructive material from an intravascular site |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
US11517335B2 (en) | 2018-07-06 | 2022-12-06 | Incept, Llc | Sealed neurovascular extendable catheter |
JP2022551988A (en) | 2019-10-15 | 2022-12-14 | インパラティブ、ケア、インク. | Systems and methods for multivariate stroke detection |
US20210315598A1 (en) | 2019-12-18 | 2021-10-14 | Imperative Care, Inc. | Methods of placing large bore aspiration catheters |
US11638637B2 (en) | 2019-12-18 | 2023-05-02 | Imperative Care, Inc. | Method of removing embolic material with thrombus engagement tool |
CA3171899A1 (en) | 2020-03-10 | 2021-09-16 | Imperative Care, Inc. | Enhanced flexibility neurovascular catheter |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
EP4329643A1 (en) | 2021-04-27 | 2024-03-06 | Contego Medical, Inc. | Thrombus aspiration system and methods for controlling blood loss |
WO2023278495A2 (en) | 2021-06-28 | 2023-01-05 | Inquis Medical, Inc. | Apparatuses and methods for controlling removal of obstructive material |
US20230064188A1 (en) * | 2021-08-31 | 2023-03-02 | Imperative Care, Inc. | Neurovascular access catheter with microcatheter segment |
CN116407696B (en) * | 2023-04-14 | 2024-01-26 | 保定泰鑫德医疗器械制造有限公司 | Atraumatic sputum aspirator |
Family Cites Families (672)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3605750A (en) | 1969-04-07 | 1971-09-20 | David S Sheridan | X-ray tip catheter |
US3884242A (en) | 1971-03-29 | 1975-05-20 | Mpc Kurgisil | Catheter assembly |
US3890976A (en) | 1972-10-26 | 1975-06-24 | Medical Products Corp | Catheter tip assembly |
US3965901A (en) | 1974-10-03 | 1976-06-29 | American Hospital Supply Corporation | Suction catheter |
US4030503A (en) * | 1975-11-05 | 1977-06-21 | Clark Iii William T | Embolectomy catheter |
US4319580A (en) | 1979-08-28 | 1982-03-16 | The Board Of Regents Of The University Of Washington | Method for detecting air emboli in the blood in an intracorporeal blood vessel |
US4628168A (en) | 1980-05-14 | 1986-12-09 | Shiley, Inc. | Dielectric heating device for heating cannula members |
DE3020041A1 (en) | 1980-05-24 | 1981-12-03 | Sartorius GmbH, 3400 Göttingen | FILTRATION DEVICE FOR CONCENTRATING LIQUID MEDIA |
US4611594A (en) | 1984-04-11 | 1986-09-16 | Northwestern University | Medical instrument for containment and removal of calculi |
US4617019A (en) | 1984-09-28 | 1986-10-14 | Sherwood Medical Company | Catheter |
DE3442736A1 (en) | 1984-11-23 | 1986-06-05 | Tassilo Dr.med. 7800 Freiburg Bonzel | DILATATION CATHETER |
US4619274A (en) | 1985-04-18 | 1986-10-28 | Advanced Cardiovascular Systems, Inc. | Torsional guide wire with attenuated diameter |
US4810582A (en) | 1985-11-12 | 1989-03-07 | Tyndale Plains-Hunter Ltd. | Hydrophilic polyurethane composition |
US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
US4739768B2 (en) | 1986-06-02 | 1995-10-24 | Target Therapeutics Inc | Catheter for guide-wire tracking |
US4767399A (en) | 1986-12-05 | 1988-08-30 | Fisher Scientific Group Inc. Dba Imed Corporation | Volumetric fluid withdrawal system |
US4762130A (en) | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
US4923462A (en) | 1987-03-17 | 1990-05-08 | Cordis Corporation | Catheter system having a small diameter rotatable drive member |
US4898575A (en) | 1987-08-31 | 1990-02-06 | Medinnovations, Inc. | Guide wire following tunneling catheter system and method for transluminal arterial atherectomy |
US5217705A (en) | 1987-09-25 | 1993-06-08 | Neorx Corporation | Method of diagnosing blood clots using fibrin-binding proteins |
US4844064A (en) | 1987-09-30 | 1989-07-04 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument with end and side openings |
ES2047586T3 (en) | 1988-03-04 | 1994-03-01 | Angiomed Ag | PROCEDURE AND DEVICE TO REMOVE DEPOSITS OF MATERIAL IN VESSELS AND LIVING BODIES. |
US5843156A (en) | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
DE8900059U1 (en) | 1989-01-04 | 1989-05-24 | Schneider (Europe) Ag, Zuerich, Ch | |
US5226909A (en) | 1989-09-12 | 1993-07-13 | Devices For Vascular Intervention, Inc. | Atherectomy device having helical blade and blade guide |
US5120323A (en) | 1990-01-12 | 1992-06-09 | Schneider (Usa) Inc. | Telescoping guide catheter system |
US5279596A (en) | 1990-07-27 | 1994-01-18 | Cordis Corporation | Intravascular catheter with kink resistant tip |
US5527292A (en) | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
US5103827A (en) | 1990-12-14 | 1992-04-14 | Medasonics, Inc. | Apparatus for and a method of distinguishing ultrasound signals returned from bubbles and particles moving in a fluid from signals due to ultrasound transducer motion |
US5916192A (en) | 1991-01-11 | 1999-06-29 | Advanced Cardiovascular Systems, Inc. | Ultrasonic angioplasty-atherectomy catheter and method of use |
US5290247A (en) | 1991-05-21 | 1994-03-01 | C. R. Bard, Inc. | Intracoronary exchange apparatus and method |
US5234416A (en) | 1991-06-06 | 1993-08-10 | Advanced Cardiovascular Systems, Inc. | Intravascular catheter with a nontraumatic distal tip |
US5423846A (en) | 1991-10-21 | 1995-06-13 | Cathco, Inc. | Dottering auger catheter system |
US5308327A (en) | 1991-11-25 | 1994-05-03 | Advanced Surgical Inc. | Self-deployed inflatable retractor |
US5261916A (en) | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
US5407432A (en) | 1992-03-30 | 1995-04-18 | Pameda N.V. | Method of positioning a stent |
WO1993019679A1 (en) | 1992-04-07 | 1993-10-14 | The Johns Hopkins University | A percutaneous mechanical fragmentation catheter system |
US5713848A (en) | 1993-05-19 | 1998-02-03 | Dubrul; Will R. | Vibrating catheter |
US6936025B1 (en) | 1992-05-19 | 2005-08-30 | Bacchus Vascular, Inc. | Thrombolysis device |
US5328472A (en) | 1992-07-27 | 1994-07-12 | Medtronic, Inc. | Catheter with flexible side port entry |
FR2696924B1 (en) | 1992-08-06 | 1995-01-06 | Domilens Laboratoires | Surgical instrument for the in situ fragmentation of a living material, in particular a phaco-fragmentation or phaco-emulsification instrument. |
WO1994003230A1 (en) | 1992-08-07 | 1994-02-17 | Boston Scientific Corporation | Support catheter assembly |
US5243997A (en) | 1992-09-14 | 1993-09-14 | Interventional Technologies, Inc. | Vibrating device for a guide wire |
US5474563A (en) | 1993-03-25 | 1995-12-12 | Myler; Richard | Cardiovascular stent and retrieval apparatus |
US5429136A (en) * | 1993-04-21 | 1995-07-04 | Devices For Vascular Intervention, Inc. | Imaging atherectomy apparatus |
US5417697A (en) | 1993-07-07 | 1995-05-23 | Wilk; Peter J. | Polyp retrieval assembly with cauterization loop and suction web |
US6858024B1 (en) | 1994-02-14 | 2005-02-22 | Scimed Life Systems, Inc. | Guide catheter having selected flexural modulus segments |
AU690237B2 (en) | 1994-03-03 | 1998-04-23 | Target Therapeutics, Inc. | Method for detecting separation of a vasoocclusion device |
US5466222A (en) | 1994-03-30 | 1995-11-14 | Scimed Life Systems, Inc. | Longitudinally collapsible and exchangeable catheter |
US5454795A (en) | 1994-06-27 | 1995-10-03 | Target Therapeutics, Inc. | Kink-free spiral-wound catheter |
WO1996001079A1 (en) | 1994-07-01 | 1996-01-18 | Scimed Life Systems, Inc. | Intravascular device utilizing fluid to extract occlusive material |
US5549119A (en) | 1994-09-13 | 1996-08-27 | Cordis Corporation | Vibrating tip catheter |
DE69504104T2 (en) | 1995-01-04 | 1999-05-06 | Medtronic Inc | IMPROVED METHOD FOR PRODUCING A SOFT TIP |
US5441051A (en) | 1995-02-09 | 1995-08-15 | Hileman; Ronald E. | Method and apparatus for the non-invasive detection and classification of emboli |
DE19504261A1 (en) | 1995-02-09 | 1996-09-12 | Krieg Gunther | Angioplasty catheter for dilating and / or opening blood vessels |
BR9607836A (en) | 1995-03-28 | 1998-06-16 | Straub Federnfabrik | Catheter to remove abnormal deposits of blood vessels in humans |
WO1996029942A1 (en) | 1995-03-28 | 1996-10-03 | Straub Federnfabrik Ag | Catheter for detaching abnormal deposits in human blood vessels |
US5662622A (en) | 1995-04-04 | 1997-09-02 | Cordis Corporation | Intravascular catheter |
US6824553B1 (en) | 1995-04-28 | 2004-11-30 | Target Therapeutics, Inc. | High performance braided catheter |
US5702373A (en) | 1995-08-31 | 1997-12-30 | Target Therapeutics, Inc. | Composite super-elastic alloy braid reinforced catheter |
US5658263A (en) | 1995-05-18 | 1997-08-19 | Cordis Corporation | Multisegmented guiding catheter for use in medical catheter systems |
US5938645A (en) | 1995-05-24 | 1999-08-17 | Boston Scientific Corporation Northwest Technology Center Inc. | Percutaneous aspiration catheter system |
US5591187A (en) | 1995-07-14 | 1997-01-07 | Dekel; Moshe | Laparoscopic tissue retrieval device and method |
US5776141A (en) | 1995-08-28 | 1998-07-07 | Localmed, Inc. | Method and apparatus for intraluminal prosthesis delivery |
US5569178A (en) | 1995-10-20 | 1996-10-29 | Henley; Julian L. | Power assisted suction lipectomy device |
US5885209A (en) | 1996-02-02 | 1999-03-23 | Green; Anthony D. | Endoscopic working channel and method of making same |
US5895398A (en) | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US6776766B2 (en) * | 1996-04-03 | 2004-08-17 | Rush-Presbyterian-St. Luke's Medical Center | Method and apparatus for characterizing gastrointestinal sounds |
US6022336A (en) | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
US6152909A (en) | 1996-05-20 | 2000-11-28 | Percusurge, Inc. | Aspiration system and method |
SE9601974L (en) | 1996-05-23 | 1997-10-13 | Elekta Ab | Device for injecting a substance into a body, especially human or animal |
US5782811A (en) | 1996-05-30 | 1998-07-21 | Target Therapeutics, Inc. | Kink-resistant braided catheter with distal side holes |
US5899892A (en) | 1996-05-31 | 1999-05-04 | Scimed Life Systems, Inc. | Catheter having distal fiber braid |
US5827242A (en) | 1996-06-21 | 1998-10-27 | Medtronic, Inc. | Reinforced catheter body and method for its fabrication |
US5735816A (en) | 1996-07-23 | 1998-04-07 | Medtronic, Inc. | Spiral sheath retainer for autoperfusion dilatation catheter balloon |
US6221038B1 (en) | 1996-11-27 | 2001-04-24 | Pharmasonics, Inc. | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers |
US5690613A (en) | 1996-12-06 | 1997-11-25 | Medtronic, Inc. | Rapid exchange high pressure transition for high pressure catheter with non-compliant balloon |
US6582440B1 (en) | 1996-12-26 | 2003-06-24 | Misonix Incorporated | Non-clogging catheter for lithotrity |
US6355016B1 (en) | 1997-03-06 | 2002-03-12 | Medtronic Percusurge, Inc. | Catheter core wire |
CA2322876A1 (en) | 1997-03-06 | 1998-09-11 | Percusurge, Inc. | Intravascular aspiration system |
US5843103A (en) | 1997-03-06 | 1998-12-01 | Scimed Life Systems, Inc. | Shaped wire rotational atherectomy device |
US20020026145A1 (en) | 1997-03-06 | 2002-02-28 | Bagaoisan Celso J. | Method and apparatus for emboli containment |
US6059745A (en) | 1997-05-20 | 2000-05-09 | Gelbfish; Gary A. | Thrombectomy device and associated method |
US6228046B1 (en) | 1997-06-02 | 2001-05-08 | Pharmasonics, Inc. | Catheters comprising a plurality of oscillators and methods for their use |
US5951539A (en) | 1997-06-10 | 1999-09-14 | Target Therpeutics, Inc. | Optimized high performance multiple coil spiral-wound vascular catheter |
US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US7037316B2 (en) | 1997-07-24 | 2006-05-02 | Mcguckin Jr James F | Rotational thrombectomy device |
US6090118A (en) | 1998-07-23 | 2000-07-18 | Mcguckin, Jr.; James F. | Rotational thrombectomy apparatus and method with standing wave |
AU3532197A (en) | 1997-07-24 | 1999-02-16 | Australian National University, The | Method for detection of fibrin clots |
US5891114A (en) | 1997-09-30 | 1999-04-06 | Target Therapeutics, Inc. | Soft-tip high performance braided catheter |
US5935112A (en) | 1997-10-15 | 1999-08-10 | Stevens; Brian W. | Hemostasis valve with catheter/guidewire seals |
US5908435A (en) | 1997-10-23 | 1999-06-01 | Samuels; Shaun L. W. | Expandable lumen device and method of use |
US20100030256A1 (en) | 1997-11-12 | 2010-02-04 | Genesis Technologies Llc | Medical Devices and Methods |
US6183432B1 (en) | 1997-11-13 | 2001-02-06 | Lumend, Inc. | Guidewire and catheter with rotating and reciprocating symmetrical or asymmetrical distal tip |
EP1054634A4 (en) | 1998-02-10 | 2006-03-29 | Artemis Medical Inc | Entrapping apparatus and method for use |
US6824550B1 (en) | 2000-04-06 | 2004-11-30 | Norbon Medical, Inc. | Guidewire for crossing occlusions or stenosis |
US6796976B1 (en) | 1998-03-06 | 2004-09-28 | Scimed Life Systems, Inc. | Establishing access to the body |
IE980241A1 (en) | 1998-04-02 | 1999-10-20 | Salviac Ltd | Delivery catheter with split sheath |
US6666874B2 (en) | 1998-04-10 | 2003-12-23 | Endicor Medical, Inc. | Rotational atherectomy system with serrated cutting tip |
US6482217B1 (en) | 1998-04-10 | 2002-11-19 | Endicor Medical, Inc. | Neuro thrombectomy catheter |
US6511492B1 (en) | 1998-05-01 | 2003-01-28 | Microvention, Inc. | Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders |
US6740104B1 (en) | 1998-05-15 | 2004-05-25 | Advanced Cardiovascular Systems, Inc. | Enhanced catheter with alignment means |
US6368316B1 (en) | 1998-06-11 | 2002-04-09 | Target Therapeutics, Inc. | Catheter with composite stiffener |
WO2000000100A1 (en) | 1998-06-30 | 2000-01-06 | Ethicon, Inc. | Endometrial balloon ablation catheter having heater |
US6285903B1 (en) | 1998-06-30 | 2001-09-04 | Eclipse Surgical Technologies, Inc. | Intracorporeal device with radiopaque marker |
US6322534B1 (en) | 1998-11-07 | 2001-11-27 | Cordis Corporation | Variable stiffness balloon catheter |
US6214036B1 (en) | 1998-11-09 | 2001-04-10 | Cordis Corporation | Stent which is easily recaptured and repositioned within the body |
US6196972B1 (en) | 1998-11-11 | 2001-03-06 | Spentech, Inc. | Doppler ultrasound method and apparatus for monitoring blood flow |
US6591472B1 (en) | 1998-12-08 | 2003-07-15 | Medtronic, Inc. | Multiple segment catheter and method of fabrication |
DE69902986D1 (en) | 1998-12-09 | 2002-10-24 | Jms Co Ltd | infusion filters |
US6165199A (en) | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
CA2358661A1 (en) | 1999-01-20 | 2000-07-27 | Boston Scientific Limited | Intravascular catheter with composite reinforcement |
US6171295B1 (en) | 1999-01-20 | 2001-01-09 | Scimed Life Systems, Inc. | Intravascular catheter with composite reinforcement |
DE60042316D1 (en) | 1999-01-28 | 2009-07-16 | Salviac Ltd | CATHETER WITH EXPANDABLE END CUT |
US6143009A (en) | 1999-02-02 | 2000-11-07 | Shiber; Samuel | Flexible-agitator system and method |
US6350271B1 (en) | 1999-05-17 | 2002-02-26 | Micrus Corporation | Clot retrieval device |
EP1992308B1 (en) | 1999-06-02 | 2015-10-28 | Microtransform, Inc. | Intracorporeal occlusive device |
US6355027B1 (en) | 1999-06-09 | 2002-03-12 | Possis Medical, Inc. | Flexible microcatheter |
US6458139B1 (en) | 1999-06-21 | 2002-10-01 | Endovascular Technologies, Inc. | Filter/emboli extractor for use in variable sized blood vessels |
US6179859B1 (en) | 1999-07-16 | 2001-01-30 | Baff Llc | Emboli filtration system and methods of use |
CA2378720A1 (en) | 1999-07-23 | 2001-02-01 | Tfx Medical Extrusion Products | Catheter device having multi-lumen reinforced shaft and method of manufacture for same |
US6251122B1 (en) | 1999-09-02 | 2001-06-26 | Scimed Life Systems, Inc. | Intravascular filter retrieval device and method |
AU1361901A (en) | 1999-11-03 | 2001-05-14 | Endocare, Inc. | Method of loading a stent on a delivery catheter |
US7037267B1 (en) | 1999-11-10 | 2006-05-02 | David Lipson | Medical diagnostic methods, systems, and related equipment |
DE19959230C1 (en) | 1999-12-08 | 2001-04-05 | Fresenius Medical Care De Gmbh | Two-sheet pouch, used as disposable haemodialysis container, comprises top and bottom closed by convex weld seams and is repeatedly folded parallel to its vertical axis |
US6206852B1 (en) | 1999-12-15 | 2001-03-27 | Advanced Cardiovascular Systems, Inc. | Balloon catheter having a small profile catheter |
US6579246B2 (en) | 1999-12-22 | 2003-06-17 | Sarcos, Lc | Coronary guidewire system |
US6520934B1 (en) | 1999-12-29 | 2003-02-18 | Advanced Cardiovascular Systems, Inc. | Catheter assemblies with flexible radiopaque marker |
WO2001049341A2 (en) | 1999-12-31 | 2001-07-12 | Bacchus Vascular Inc. | Method and system for re-infusing filtered bodily aspirates |
US6929633B2 (en) | 2000-01-25 | 2005-08-16 | Bacchus Vascular, Inc. | Apparatus and methods for clot dissolution |
US6663613B1 (en) | 2000-01-25 | 2003-12-16 | Bacchus Vascular, Inc. | System and methods for clot dissolution |
US6394976B1 (en) | 2000-01-31 | 2002-05-28 | Intraluminal Therapeutics, Inc. | Catheter for controlling the advancement of a guide wire |
JP3915862B2 (en) | 2000-02-09 | 2007-05-16 | テルモ株式会社 | catheter |
US6554820B1 (en) | 2000-03-08 | 2003-04-29 | Scimed Life Systems, Inc. | Composite flexible tube for medical applications |
US6719717B1 (en) | 2000-03-17 | 2004-04-13 | Advanced Research & Technology Institute, Inc. | Thrombectomy treatment system and method |
US7713227B2 (en) | 2000-03-20 | 2010-05-11 | Michael Wholey | Method and apparatus for medical device for aspiration of thromboemobolic debris |
US6514273B1 (en) | 2000-03-22 | 2003-02-04 | Endovascular Technologies, Inc. | Device for removal of thrombus through physiological adhesion |
US6468301B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Repositionable and recapturable vascular stent/graft |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
US6638268B2 (en) | 2000-04-07 | 2003-10-28 | Imran K. Niazi | Catheter to cannulate the coronary sinus |
US6468219B1 (en) | 2000-04-24 | 2002-10-22 | Philip Chidi Njemanze | Implantable telemetric transcranial doppler device |
IL136213A0 (en) | 2000-05-17 | 2001-05-20 | Xtent Medical Inc | Selectively expandable and releasable stent |
US6890315B1 (en) | 2000-05-23 | 2005-05-10 | Chf Solutions, Inc. | Method and apparatus for vein fluid removal in heart failure |
KR100387384B1 (en) | 2000-07-26 | 2003-06-12 | 규 호 이 | Embolic material detachment detection system and method and assembly for embolic treatments |
US6613017B1 (en) | 2000-08-08 | 2003-09-02 | Scimed Life Systems, Inc. | Controlled depth injection device and method |
US6776770B1 (en) | 2000-09-07 | 2004-08-17 | Advanced Research & Technology Institute | Thromboaspiration valve-filter device and methods |
US6524303B1 (en) | 2000-09-08 | 2003-02-25 | Stereotaxis, Inc. | Variable stiffness magnetic catheter |
CA2424306A1 (en) | 2000-10-18 | 2002-04-25 | Nmt Medical, Inc. | Medical implant delivery system |
US20060100530A1 (en) | 2000-11-28 | 2006-05-11 | Allez Physionix Limited | Systems and methods for non-invasive detection and monitoring of cardiac and blood parameters |
US6554827B2 (en) | 2000-12-11 | 2003-04-29 | Scimed Life Systems, Inc. | Radio frequency ablation system |
US6533751B2 (en) | 2001-01-09 | 2003-03-18 | Andrew Cragg | Micro catheter and guidewire system having improved pushability and control |
US6673023B2 (en) * | 2001-03-23 | 2004-01-06 | Stryker Puerto Rico Limited | Micro-invasive breast biopsy device |
US20020177800A1 (en) | 2001-04-16 | 2002-11-28 | Bagaoisan Celso J. | Aspiration catheters and method of use |
US20020156460A1 (en) | 2001-04-20 | 2002-10-24 | Scimed Life Systems, Inc | Microcatheter with improved distal tip and transitions |
US20020156459A1 (en) | 2001-04-20 | 2002-10-24 | Scimed Life Systems, Inc | Microcatheter with improved distal tip and transitions |
US7635342B2 (en) | 2001-05-06 | 2009-12-22 | Stereotaxis, Inc. | System and methods for medical device advancement and rotation |
US20020188314A1 (en) | 2001-06-07 | 2002-12-12 | Microvena Corporation | Radiopaque distal embolic protection device |
US6818013B2 (en) | 2001-06-14 | 2004-11-16 | Cordis Corporation | Intravascular stent device |
DE20110121U1 (en) | 2001-06-19 | 2002-12-05 | Braun Melsungen Ag | catheter |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
CA2461927C (en) | 2001-10-03 | 2012-07-10 | Greg J. Kampa | Medical device with polymer coated inner lumen |
US7172572B2 (en) | 2001-10-04 | 2007-02-06 | Boston Scientific Scimed, Inc. | Manifold system for a medical device |
US20030088266A1 (en) | 2001-11-02 | 2003-05-08 | Bowlin Gary L. | Method of fusing electroprocessed matrices to a substrate |
EP2248549A3 (en) * | 2001-12-26 | 2010-12-08 | Yale University | Vascular access device |
US7029482B1 (en) | 2002-01-22 | 2006-04-18 | Cardica, Inc. | Integrated anastomosis system |
US7335216B2 (en) | 2002-01-22 | 2008-02-26 | Cardica, Inc. | Tool for creating an opening in tissue |
US7223274B2 (en) | 2002-01-23 | 2007-05-29 | Cardica, Inc. | Method of performing anastomosis |
AU2003220474A1 (en) * | 2002-03-21 | 2003-10-08 | Radiant Medical, Inc. | Measuring blood flow rate or cardiac output |
US20030212384A1 (en) | 2002-05-10 | 2003-11-13 | Hayden Scott William | Expandable interventional system |
US7399307B2 (en) | 2002-05-14 | 2008-07-15 | Bacchus Vascular, Inc. | Apparatus and method for removing occlusive material within blood vessels |
US7029468B2 (en) | 2002-06-25 | 2006-04-18 | Enpath Medical, Inc. | Catheter assembly with side wall exit lumen and method therefor |
US7232452B2 (en) | 2002-07-12 | 2007-06-19 | Ev3 Inc. | Device to create proximal stasis |
US7309334B2 (en) | 2002-07-23 | 2007-12-18 | Von Hoffmann Gerard | Intracranial aspiration catheter |
US7608058B2 (en) | 2002-07-23 | 2009-10-27 | Micrus Corporation | Stretch resistant therapeutic device |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US20070225614A1 (en) | 2004-05-26 | 2007-09-27 | Endothelix, Inc. | Method and apparatus for determining vascular health conditions |
US20040045645A1 (en) | 2002-09-10 | 2004-03-11 | Scimed Life Systems, Inc. | Shaped reinforcing member for medical device and method for making the same |
US7060051B2 (en) | 2002-09-24 | 2006-06-13 | Scimed Life Systems, Inc. | Multi-balloon catheter with hydrogel coating |
US20070043333A1 (en) | 2002-10-03 | 2007-02-22 | Scimed Life Systems, Inc. | Method for forming a medical device with a polymer coated inner lumen |
DE60330478D1 (en) | 2002-10-10 | 2010-01-21 | Micro Therapeutics Inc | WIRE-STRENGTH MICRO-CATHETER |
US6814746B2 (en) | 2002-11-01 | 2004-11-09 | Ev3 Peripheral, Inc. | Implant delivery system with marker interlock |
US20040138693A1 (en) | 2003-01-14 | 2004-07-15 | Scimed Life Systems, Inc. | Snare retrievable embolic protection filter with guidewire stopper |
US8016752B2 (en) | 2003-01-17 | 2011-09-13 | Gore Enterprise Holdings, Inc. | Puncturable catheter |
JP4409179B2 (en) | 2003-01-22 | 2010-02-03 | ニプロ株式会社 | Thrombus aspiration catheter with improved suction and crossability |
JP2004275435A (en) | 2003-03-14 | 2004-10-07 | Terumo Corp | Catheter |
US7001369B2 (en) | 2003-03-27 | 2006-02-21 | Scimed Life Systems, Inc. | Medical device |
US20040199201A1 (en) | 2003-04-02 | 2004-10-07 | Scimed Life Systems, Inc. | Embolectomy devices |
WO2004087017A1 (en) | 2003-04-02 | 2004-10-14 | Boston Scientific Limited | Detachable and retrievable stent assembly |
US7413563B2 (en) | 2003-05-27 | 2008-08-19 | Cardia, Inc. | Flexible medical device |
US7625346B2 (en) | 2003-05-30 | 2009-12-01 | Boston Scientific Scimed, Inc. | Transbronchial needle aspiration device |
JP4653104B2 (en) | 2003-06-10 | 2011-03-16 | ルーメンド インコーポレイテッド | Catheter apparatus and method for opening a vascular occlusion |
US20050004553A1 (en) | 2003-07-02 | 2005-01-06 | Medtronic Ave, Inc. | Sheath catheter having variable over-the-wire length and methods of use |
JP4667376B2 (en) | 2003-07-02 | 2011-04-13 | クック インコーポレイテッド | Small gauge needle catheter insertion device |
JP2007503918A (en) | 2003-09-04 | 2007-03-01 | セカント メディカル エルエルシー | Intravascular snare for capturing and removing arterial emboli |
US8034003B2 (en) | 2003-09-11 | 2011-10-11 | Depuy Mitek, Inc. | Tissue extraction and collection device |
US7588555B2 (en) | 2003-09-24 | 2009-09-15 | Enpath Medical, Inc. | Bi-directional catheter assembly and method therefor |
US20050103332A1 (en) | 2003-11-17 | 2005-05-19 | Bruce Gingles | Airway exchange catheter |
WO2005051206A1 (en) | 2003-11-21 | 2005-06-09 | Vnus Medical Technologies, Inc. | Method and apparatus for treating a carotid artery |
US7740626B2 (en) | 2003-11-21 | 2010-06-22 | Terumo Kabushiki Kaisha | Laser induced liquid jet generating apparatus |
US8382739B2 (en) | 2003-12-02 | 2013-02-26 | Boston Scientific Scimed, Inc. | Composite medical device and method of forming |
US20050153309A1 (en) | 2003-12-22 | 2005-07-14 | David Hoon | Method and apparatus for in vivo surveillance of circulating biological components |
US7763011B2 (en) | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
SG183072A1 (en) | 2004-01-23 | 2012-08-30 | Iscience Surgical Corp | Composite ophthalmic microcannula |
US20050182386A1 (en) | 2004-02-17 | 2005-08-18 | Steen Aggerholm | Catheter with stiffening element |
EP1987787A1 (en) | 2004-02-19 | 2008-11-05 | Applied Medical Resources Corporation | Embolectomy capture sheath |
US8157792B2 (en) | 2004-02-26 | 2012-04-17 | Haemonetics Corporation | Wound drainage suction relief |
PL1722694T3 (en) | 2004-03-04 | 2010-01-29 | Straub Medical Ag | Catheter for sucking, fragmenting removing material extractable from blood vessels |
CN100577116C (en) | 2004-03-04 | 2010-01-06 | 施特劳勃医疗器械股份公司 | Catheter for sucking, fragmenting and removing extractable material from blood vessels |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US7686825B2 (en) | 2004-03-25 | 2010-03-30 | Hauser David L | Vascular filter device |
US8235968B2 (en) | 2004-04-13 | 2012-08-07 | Gyrus Acmi, Inc. | Atraumatic ureteral access sheath |
US8535293B2 (en) | 2004-04-13 | 2013-09-17 | Gyrus Acmi, Inc. | Atraumatic ureteral access sheath |
US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
EP1750619B1 (en) | 2004-05-25 | 2013-07-24 | Covidien LP | Flexible vascular occluding device |
US7815627B2 (en) | 2004-05-27 | 2010-10-19 | Abbott Laboratories | Catheter having plurality of stiffening members |
US20190269368A1 (en) | 2004-05-28 | 2019-09-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic Surgical System and Method for Automated Creation of Ablation Lesions |
US20060030835A1 (en) | 2004-06-29 | 2006-02-09 | Sherman Darren R | Catheter shaft tubes and methods of making |
ES2549371T3 (en) | 2004-08-25 | 2015-10-27 | Microvention, Inc. | Thermal separation system for implantable devices |
US7931659B2 (en) | 2004-09-10 | 2011-04-26 | Penumbra, Inc. | System and method for treating ischemic stroke |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20060064036A1 (en) | 2004-09-21 | 2006-03-23 | Cook Incorporated | Variable flexibility wire guide |
JP2006087643A (en) | 2004-09-24 | 2006-04-06 | Terumo Corp | Apparatus for sucking foreign substance from blood vessel |
US7306585B2 (en) | 2004-09-30 | 2007-12-11 | Engineering Resources Group, Inc. | Guide catheter |
JP2006102222A (en) | 2004-10-06 | 2006-04-20 | Sekisui Chem Co Ltd | Detachable balloon catheter |
US7621904B2 (en) | 2004-10-21 | 2009-11-24 | Boston Scientific Scimed, Inc. | Catheter with a pre-shaped distal tip |
EP1809363A4 (en) | 2004-11-01 | 2010-01-20 | Medical Components Inc | Universal catheter tunneler |
US20060217664A1 (en) | 2004-11-15 | 2006-09-28 | Hattler Brack G | Telescoping vascular dilator |
WO2006055826A2 (en) | 2004-11-18 | 2006-05-26 | Chang David W | Endoluminal delivery of anesthesia |
US20080086110A1 (en) | 2004-11-19 | 2008-04-10 | Galdonik Jason A | Extendable Device On An Aspiration Catheter |
US20060111649A1 (en) | 2004-11-19 | 2006-05-25 | Scimed Life Systems, Inc. | Catheter having improved torque response and curve retention |
US9775963B2 (en) | 2010-11-03 | 2017-10-03 | Biocardia, Inc. | Steerable endoluminal devices and methods |
US20060235348A1 (en) | 2005-02-14 | 2006-10-19 | Callicoat David N | Method of extracting and analyzing the composition of bodily fluids |
US8622997B2 (en) | 2005-03-23 | 2014-01-07 | Ronald D. Shippert | Tissue transfer method and apparatus |
JP4724827B2 (en) | 2005-03-24 | 2011-07-13 | 国立大学法人山口大学 | Agitation treatment device and catheter |
WO2006113866A2 (en) | 2005-04-20 | 2006-10-26 | Cook Incorporated | Internal joint for medical devices |
US7806871B2 (en) | 2005-05-09 | 2010-10-05 | Boston Scientific Scimed, Inc. | Method and device for tissue removal and for delivery of a therapeutic agent or bulking agent |
US9014786B2 (en) | 2005-05-11 | 2015-04-21 | Eyoca Medical Ltd. | Device and method for opening vascular obstructions |
US7771358B2 (en) | 2005-05-20 | 2010-08-10 | Spentech, Inc. | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
JP4549933B2 (en) | 2005-06-08 | 2010-09-22 | ジョンソン・エンド・ジョンソン株式会社 | Vascular catheter |
US20120330196A1 (en) | 2005-06-24 | 2012-12-27 | Penumbra Inc. | Methods and Apparatus for Removing Blood Clots and Tissue from the Patient's Head |
US20120078140A1 (en) | 2005-06-24 | 2012-03-29 | Penumbra, Inc. | Method and Apparatus for Removing Blood Clots and Tissue from the Patient's Head |
US8123769B2 (en) | 2005-08-12 | 2012-02-28 | Cook Medical Technologies Llc | Thrombus removal device |
US8021351B2 (en) | 2005-08-18 | 2011-09-20 | Medtronic Vascular, Inc. | Tracking aspiration catheter |
US7938820B2 (en) | 2005-08-18 | 2011-05-10 | Lumen Biomedical, Inc. | Thrombectomy catheter |
GR20050100452A (en) | 2005-09-02 | 2007-04-25 | Estelle Enterprises Limited | Fluid exchange catheter's system |
US20070060888A1 (en) | 2005-09-06 | 2007-03-15 | Kerberos Proximal Solutions, Inc. | Methods and apparatus for assisted aspiration |
US20080188928A1 (en) | 2005-09-16 | 2008-08-07 | Amr Salahieh | Medical device delivery sheath |
US7850623B2 (en) | 2005-10-27 | 2010-12-14 | Boston Scientific Scimed, Inc. | Elongate medical device with continuous reinforcement member |
US8206343B2 (en) | 2005-11-08 | 2012-06-26 | Custom Medical Applications, Inc. | Reinforced catheter with articulated distal tip |
EP1973680B1 (en) | 2005-11-17 | 2018-01-10 | Microvention, Inc. | Three-dimensional complex coil |
US20080262350A1 (en) | 2005-11-18 | 2008-10-23 | Imarx Therapeutics, Inc. | Ultrasound Apparatus and Method to Treat an Ischemic Stroke |
US20070185521A1 (en) * | 2005-12-05 | 2007-08-09 | Cook Incorporated | Rapid exchange assembly |
WO2007067952A2 (en) * | 2005-12-07 | 2007-06-14 | The Board Of Trustees Of The University Of Illinois | Optical microprobe for blood clot detection |
DE102005059670A1 (en) | 2005-12-12 | 2007-06-14 | Phenox Gmbh | Device for removing thrombi from blood vessels |
WO2007079415A2 (en) | 2005-12-30 | 2007-07-12 | C.R. Bard Inc. | Embolus blood clot filter removal system and method |
US20070208302A1 (en) | 2006-01-26 | 2007-09-06 | Webster Mark W | Deflection control catheters, support catheters and methods of use |
CA2638012A1 (en) | 2006-02-02 | 2007-08-09 | Releaf Medical Ltd. | Shock-wave generating device, such as for the treatment of calcific aortic stenosis |
US7608063B2 (en) | 2006-02-23 | 2009-10-27 | Medrad, Inc. | Dual lumen aspiration catheter system |
US9615832B2 (en) | 2006-04-07 | 2017-04-11 | Penumbra, Inc. | Aneurysm occlusion system and method |
US20120150147A1 (en) | 2010-12-08 | 2012-06-14 | Penumbra, Inc. | System and method for treating ischemic stroke |
US8048032B2 (en) | 2006-05-03 | 2011-11-01 | Vascular Solutions, Inc. | Coaxial guide catheter for interventional cardiology procedures |
US7905877B1 (en) | 2006-05-12 | 2011-03-15 | Micrus Design Technology, Inc. | Double helix reinforced catheter |
US7558622B2 (en) | 2006-05-24 | 2009-07-07 | Bao Tran | Mesh network stroke monitoring appliance |
US7803136B2 (en) | 2006-06-05 | 2010-09-28 | Schatz Richard A | Myocardial injector |
US20080097251A1 (en) | 2006-06-15 | 2008-04-24 | Eilaz Babaev | Method and apparatus for treating vascular obstructions |
CA2655026C (en) | 2006-06-15 | 2016-08-02 | Microvention, Inc. | Embolization device constructed from expansible polymer |
WO2008091584A2 (en) | 2007-01-22 | 2008-07-31 | Cv Devices, Llc | Devices, systems and methods for an epicardial cardiac monitoring system |
KR20090037906A (en) | 2006-06-30 | 2009-04-16 | 아테로메드, 아이엔씨. | Atherectomy devices and methods |
JP5085648B2 (en) | 2006-07-05 | 2012-11-28 | クック メディカル テクノロジーズ エルエルシー | Suction clip |
JP5336369B2 (en) | 2006-08-11 | 2013-11-06 | コーニンクレッカ フィリップス エヌ ヴェ | Ultrasound system for cerebral blood flow imaging and microbubble improvement thrombus resolution |
US20080086051A1 (en) | 2006-09-20 | 2008-04-10 | Ethicon Endo-Surgery, Inc. | System, storage medium for a computer program, and method for displaying medical images |
US8394078B2 (en) | 2006-10-04 | 2013-03-12 | Medrad, Inc. | Interventional catheters incorporating an active aspiration system |
WO2008057554A1 (en) | 2006-11-08 | 2008-05-15 | Cook Incorporated | Thrombus removal device |
JP5221032B2 (en) | 2006-12-11 | 2013-06-26 | 株式会社グツドマン | Insertion aid, catheter assembly and catheter set |
WO2008089282A2 (en) | 2007-01-16 | 2008-07-24 | Silver James H | Sensors for detecting subtances indicative of stroke, ischemia, infection or inflammation |
WO2008097993A2 (en) | 2007-02-05 | 2008-08-14 | Boston Scientific Limited | Thrombectomy apparatus and method |
WO2008095492A2 (en) | 2007-02-05 | 2008-08-14 | Aarhus Universitet | A method for diagnosing atherosclerotic plaques by measurement of cd36 |
WO2008101206A2 (en) | 2007-02-15 | 2008-08-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter and method of manufacture |
EP2138200B1 (en) | 2007-04-03 | 2013-02-27 | Nipro Corporation | Thrombus-aspiration catheter |
WO2008124618A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Implant recovery device |
US20080262471A1 (en) | 2007-04-17 | 2008-10-23 | Medtronic Vascular, Inc. | Catheter with braided and coiled reinforcing layer |
US7927309B2 (en) | 2007-05-29 | 2011-04-19 | Cordis Corporation | Expandable sheath introducer |
US20080312639A1 (en) | 2007-06-13 | 2008-12-18 | Jan Weber | Hardened polymeric lumen surfaces |
JP5758626B2 (en) | 2007-06-26 | 2015-08-05 | ロックスウッド・メディカル・インコーポレイテッド | Catheter apparatus for treating vasculature |
US8157760B2 (en) | 2007-07-18 | 2012-04-17 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US9669191B2 (en) | 2008-02-05 | 2017-06-06 | Silk Road Medical, Inc. | Interventional catheter system and methods |
US20090030400A1 (en) | 2007-07-25 | 2009-01-29 | Arani Bose | System and method for intracranial access |
WO2010014075A1 (en) | 2007-07-27 | 2010-02-04 | Microvention, Inc. | Detachable coil incorporating stretch resistance |
US20090043330A1 (en) | 2007-08-09 | 2009-02-12 | Specialized Vascular Technologies, Inc. | Embolic protection devices and methods |
US8211136B2 (en) * | 2007-08-31 | 2012-07-03 | Kimberly-Clark Worldwide, Inc. | Stoma dilator |
US8357152B2 (en) | 2007-10-08 | 2013-01-22 | Biosense Webster (Israel), Ltd. | Catheter with pressure sensing |
EP2211732B1 (en) | 2007-10-22 | 2018-05-16 | Atheromed, Inc. | Atherectomy devices |
CA2643261A1 (en) | 2007-11-06 | 2009-05-06 | Queen's University At Kingston | Method and system for identifying and quantifing particles in flow systems |
US9451884B2 (en) | 2007-12-13 | 2016-09-27 | Board Of Trustees Of The University Of Arkansas | Device and method for in vivo detection of clots within circulatory vessels |
US9144383B2 (en) | 2007-12-13 | 2015-09-29 | The Board Of Trustees Of The University Of Arkansas | Device and method for in vivo noninvasive magnetic manipulation of circulating objects in bioflows |
US8734374B2 (en) | 2007-12-20 | 2014-05-27 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system during a surgical procedure |
JP5366974B2 (en) | 2007-12-21 | 2013-12-11 | マイクロベンション インコーポレイテッド | System and method for determining the position of a separation zone of a separable implant |
CA2709379C (en) | 2007-12-21 | 2016-08-16 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
WO2009091990A1 (en) | 2008-01-18 | 2009-07-23 | Ev3 Inc . | Angled tip catheter |
US20090234321A1 (en) | 2008-03-12 | 2009-09-17 | James Edward Shapland | Visualization of coronary vein procedure |
US8876854B2 (en) | 2008-04-03 | 2014-11-04 | Cook Medical Technologies Llc | Implant release mechanism |
JP4362536B2 (en) | 2008-04-11 | 2009-11-11 | 日本ライフライン株式会社 | catheter |
US8062316B2 (en) | 2008-04-23 | 2011-11-22 | Avinger, Inc. | Catheter system and method for boring through blocked vascular passages |
US20100125253A1 (en) * | 2008-11-17 | 2010-05-20 | Avinger | Dual-tip Catheter System for Boring through Blocked Vascular Passages |
US7947012B2 (en) | 2008-04-24 | 2011-05-24 | Medtronic Vascular, Inc. | Aspiration catheter having selectively deformable tip |
JP2011519632A (en) | 2008-05-02 | 2011-07-14 | シークエント メディカル, インコーポレイテッド | Filament devices for the treatment of vascular disorders |
US8974411B2 (en) | 2008-05-21 | 2015-03-10 | Becton, Dickinson And Company | Conical diffuser tip |
CA2726851C (en) | 2008-06-08 | 2018-11-27 | Hotspur Technologies, Inc. | Apparatus and methods for removing obstructive material from body lumens |
US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US20100023033A1 (en) | 2008-07-25 | 2010-01-28 | Medtronic Vescular, Inc. | Hydrodynamic Thrombectomy Catheter |
US8574245B2 (en) | 2008-08-13 | 2013-11-05 | Silk Road Medical, Inc. | Suture delivery device |
US9731094B2 (en) | 2008-08-20 | 2017-08-15 | Cook Medical Technologies Llc | Introducer sheath having dual reinforcing elements |
US20100063413A1 (en) * | 2008-08-25 | 2010-03-11 | Ekos Corporation | Lysis Indication |
US8343136B2 (en) | 2008-08-26 | 2013-01-01 | Cook Medical Technologies Llc | Introducer sheath with encapsulated reinforcing member |
US8758364B2 (en) | 2008-08-29 | 2014-06-24 | Rapid Medical Ltd. | Device and method for clot engagement and capture |
US8864792B2 (en) | 2008-08-29 | 2014-10-21 | Rapid Medical, Ltd. | Device and method for clot engagement |
US8298591B2 (en) | 2008-09-10 | 2012-10-30 | Micro-Dose Life Sciences Llc | Anti-fever botanical composition and uses thereof |
US8485969B2 (en) | 2008-09-18 | 2013-07-16 | Jeffrey Grayzel | Medical guide element with diameter transition |
US10631745B2 (en) | 2008-09-22 | 2020-04-28 | Cheetah Medical, Inc. | System and method for determining blood flow |
US9510854B2 (en) | 2008-10-13 | 2016-12-06 | Boston Scientific Scimed, Inc. | Thrombectomy catheter with control box having pressure/vacuum valve for synchronous aspiration and fluid irrigation |
AU2009313402C1 (en) | 2008-11-07 | 2015-10-15 | Johnson & Johnson Surgical Vision, Inc. | Automatically switching different aspiration levels and/or pumps to an ocular probe |
CH699981A2 (en) | 2008-11-27 | 2010-05-31 | Straub Medical Ag | Catheter for aspirating, fragmenting and out transport of removable material from blood vessels. |
US8725249B2 (en) | 2008-12-09 | 2014-05-13 | Nephera Ltd. | Stimulation of the urinary system |
WO2010068793A1 (en) | 2008-12-10 | 2010-06-17 | Microvention, Inc. | Microcatheter |
WO2010070685A1 (en) | 2008-12-18 | 2010-06-24 | Invatec S.P.A. | Guide catheter |
JP2012513292A (en) | 2008-12-23 | 2012-06-14 | シルク・ロード・メディカル・インコーポレイテッド | Method and system for treating acute ischemic stroke |
US8998946B2 (en) | 2008-12-30 | 2015-04-07 | Invatec S.P.A. | Blood clot removal device |
WO2010093836A2 (en) | 2009-02-11 | 2010-08-19 | Mark Mallaby | Neurovascular microcatheter device, system and methods for use thereof |
US8361095B2 (en) | 2009-02-17 | 2013-01-29 | Cook Medical Technologies Llc | Loop thrombectomy device |
US20110295217A1 (en) | 2009-03-09 | 2011-12-01 | Sumitomo Bakelite Co., Ltd. | Catheter and method of manufacturing catheter |
EP2408509B1 (en) | 2009-03-18 | 2023-08-09 | Corindus, Inc. | Remote catheter system with steerable catheter |
US20100241155A1 (en) | 2009-03-20 | 2010-09-23 | Acclarent, Inc. | Guide system with suction |
KR101719831B1 (en) | 2009-04-15 | 2017-03-24 | 마이크로벤션, 인코포레이티드 | Implant delivery system |
CN102405069B (en) | 2009-04-23 | 2015-09-16 | 费森尼斯医疗德国公司 | Grumeleuse cuts resistance device, external functional device, blood circuit and treatment facility |
WO2010126786A1 (en) | 2009-05-01 | 2010-11-04 | Cook Incorporated | Aspiration catheter with thrombus removing device |
US8517955B2 (en) | 2009-05-08 | 2013-08-27 | Broncus Medical Inc. | Tissue sampling devices, systems and methods |
US20110082373A1 (en) | 2009-06-04 | 2011-04-07 | Gurley John C | Methods and apparatus for the detection of cardiopulmonary defects |
US9510855B2 (en) | 2009-06-15 | 2016-12-06 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US8409269B2 (en) | 2009-12-21 | 2013-04-02 | Covidien Lp | Procedures for vascular occlusion |
CN102481433B (en) | 2009-06-24 | 2014-12-31 | 施菲姆德控股有限责任公司 | Steerable medical delivery devices and methods of use |
US8795317B2 (en) | 2009-07-08 | 2014-08-05 | Concentric Medical, Inc. | Embolic obstruction retrieval devices and methods |
WO2011011493A1 (en) | 2009-07-23 | 2011-01-27 | Neurointerventional Therapeutics, Inc. | System and method for removing a blood clot |
US8057497B1 (en) | 2009-07-28 | 2011-11-15 | Seshadri Raju | Thrombectomy removal device kit |
US20130006225A1 (en) | 2009-08-05 | 2013-01-03 | Rocin Laboratories, Inc. | Twin-type cannula assemblies for hand-held power-assisted tissue aspiration instruments |
CH701695A1 (en) | 2009-08-27 | 2011-02-28 | Straub Medical Ag | Catheter with protection system for aspirating, fragmenting and out pumping of removable material from hollow bodies or vessels, in particular of the human or animal body. |
US20110054504A1 (en) | 2009-08-31 | 2011-03-03 | Boston Scientific Scimed, Inc. | Recanalization device with expandable cage |
EP2475417B1 (en) | 2009-09-11 | 2018-10-10 | Onset Medical Corporation | Expandable cerebrovascular sheath |
BR112012005835A2 (en) | 2009-09-16 | 2019-09-24 | Univ Texas | change of temperature in a mammalian body |
US8911487B2 (en) | 2009-09-22 | 2014-12-16 | Penumbra, Inc. | Manual actuation system for deployment of implant |
US20110077620A1 (en) | 2009-09-30 | 2011-03-31 | Debeer Nicholas C | Guide Catheters |
US9375223B2 (en) | 2009-10-06 | 2016-06-28 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US11039845B2 (en) | 2009-10-06 | 2021-06-22 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110106200A1 (en) | 2009-10-29 | 2011-05-05 | Medtronic, Inc. | Stroke risk monitoring system including implantable medical device |
CN102686180B (en) * | 2009-11-04 | 2015-09-30 | 艾姆西森有限公司 | Intracavity remodeling device and method |
US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
WO2011084342A1 (en) | 2009-12-17 | 2011-07-14 | Cook Medical Technologies Llc | Delivery system with retractable proximal end |
WO2011083460A2 (en) | 2010-01-11 | 2011-07-14 | Assis Medical Ltd. | Device system and method for reshaping tissue openings |
US10342570B2 (en) | 2014-02-03 | 2019-07-09 | Medinol Ltd. | Device for traversing vessel occlusions and method of use |
WO2011098926A1 (en) | 2010-02-09 | 2011-08-18 | Koninklijke Philips Electronics N.V. | Apparatus, system and method for imaging and treatment using optical position sensing |
CN201596219U (en) | 2010-02-09 | 2010-10-06 | 北京泰杰伟业科技有限公司 | Micro-catheter for vascular interventional therapy |
US8545552B2 (en) | 2010-02-26 | 2013-10-01 | Silk Road Medical, Inc. | Systems and methods for transcatheter aortic valve treatment |
US20110238041A1 (en) | 2010-03-24 | 2011-09-29 | Chestnut Medical Technologies, Inc. | Variable flexibility catheter |
EP4039203A1 (en) | 2010-04-13 | 2022-08-10 | Mivi Neuroscience, Inc. | Embolectomy devices for treatment of acute ischemic stroke condition |
JP5899200B2 (en) | 2010-04-14 | 2016-04-06 | マイクロベンション インコーポレイテッド | Implant delivery device |
US20120041411A1 (en) | 2010-04-19 | 2012-02-16 | Micrus Endovascular Llc | Low profile guiding catheter for neurovascular applications |
US10238362B2 (en) | 2010-04-26 | 2019-03-26 | Gary And Mary West Health Institute | Integrated wearable device for detection of fetal heart rate and material uterine contractions with wireless communication capability |
US8663259B2 (en) | 2010-05-13 | 2014-03-04 | Rex Medical L.P. | Rotational thrombectomy wire |
US8764779B2 (en) | 2010-05-13 | 2014-07-01 | Rex Medical, L.P. | Rotational thrombectomy wire |
US9023070B2 (en) | 2010-05-13 | 2015-05-05 | Rex Medical, L.P. | Rotational thrombectomy wire coupler |
US9387077B2 (en) | 2010-05-27 | 2016-07-12 | Medtronic Vascular Galway | Catheter assembly with prosthesis crimping and prosthesis retaining accessories |
AU2011267862B2 (en) | 2010-06-14 | 2013-11-07 | Covidien Lp | Material removal device |
US10238833B2 (en) | 2010-08-12 | 2019-03-26 | C. R. Bard, Inc. | Access port and catheter assembly including catheter distal portion stability features |
KR101910207B1 (en) | 2010-08-12 | 2018-10-19 | 씨. 알. 바드, 인크. | Trimmable catheter including distal portion stability features |
WO2012021406A2 (en) | 2010-08-12 | 2012-02-16 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US20120040858A1 (en) | 2010-08-13 | 2012-02-16 | Morehouse School Of Medicine | Biomarkers for stroke |
EP2611370A2 (en) | 2010-09-03 | 2013-07-10 | University of Washington | Neurosurgical devices and associated systems and methods |
MX2013003290A (en) * | 2010-09-22 | 2013-05-30 | Acclarent Inc | Apparatus for treating disorders of the sinuses. |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
CN106110469B (en) | 2010-10-04 | 2019-07-30 | 科维蒂恩有限合伙公司 | Conduit device |
US10238456B2 (en) | 2010-10-14 | 2019-03-26 | Corindus, Inc. | Occlusion traversal robotic catheter system |
WO2012050630A1 (en) | 2010-10-14 | 2012-04-19 | Medtronic, Inc. | Cannular device and method of manufacture |
EP2450067A1 (en) | 2010-10-18 | 2012-05-09 | MaRVis Technologies GmbH | Medical device |
US9107691B2 (en) | 2010-10-19 | 2015-08-18 | Distal Access, Llc | Apparatus for rotating medical devices, systems including the apparatus, and associated methods |
JP5126910B2 (en) | 2010-10-29 | 2013-01-23 | 朝日インテック株式会社 | Auxiliary dilator and catheter assembly using the same |
EP2640287B1 (en) | 2010-11-21 | 2023-01-18 | Merit Medical Systems, Inc. | Tissue removal device |
DE102010053111B4 (en) | 2010-12-01 | 2012-10-25 | Acandis Gmbh & Co. Kg | Arrangement with a device for supplying a medical functional element |
WO2012078678A1 (en) | 2010-12-06 | 2012-06-14 | Tyco Healthcare Group Lp | Vascular remodeling device |
US9867725B2 (en) | 2010-12-13 | 2018-01-16 | Microvention, Inc. | Stent |
WO2012109198A1 (en) | 2011-02-07 | 2012-08-16 | Brigham And Women's Hospital, Inc. | Medical aspiration apparatus |
EP3871617A1 (en) | 2011-03-09 | 2021-09-01 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
US9737646B2 (en) | 2011-03-23 | 2017-08-22 | Abbott Cardiovascular Systems Inc. | Small vessel stent and methods of use |
US10722683B2 (en) | 2011-04-05 | 2020-07-28 | Thermopeutix, Inc. | Microcatheter with distal tip portion and proximal solution lumen |
US9724491B2 (en) | 2011-04-05 | 2017-08-08 | Thermopeutix, Inc. | Microcatheter with distal tip portion and proximal solution lumen |
WO2012145826A1 (en) | 2011-04-29 | 2012-11-01 | Evysio Medical Devices Ulc | Endovascular prosthesis and delivery device |
AU2012253583B2 (en) | 2011-05-11 | 2014-09-25 | Covidien Lp | Vascular remodeling device |
WO2012155954A1 (en) | 2011-05-16 | 2012-11-22 | Brainlab Ag | Medical catheter with reduced backflow |
EP2524653A1 (en) | 2011-05-17 | 2012-11-21 | Carag AG | Occluder |
WO2013003757A2 (en) | 2011-06-30 | 2013-01-03 | The Spectranetics Corporation | Reentry catheter and method thereof |
CN102847220A (en) | 2011-06-30 | 2013-01-02 | 南通伊诺精密塑胶导管有限公司 | Thin-wall fracture-resistant high pressure catheter |
US10130789B2 (en) | 2011-06-30 | 2018-11-20 | Covidien Lp | Distal access aspiration guide catheter |
US11097081B2 (en) | 2011-07-06 | 2021-08-24 | Boston Scientific Scimed, Inc. | Dual durometer soft/flexible enhanced bond strength guiding tip |
US9039715B2 (en) | 2011-07-11 | 2015-05-26 | Great Aspirations Ltd. | Apparatus for entrapping and extracting objects from body cavities |
US8676301B2 (en) * | 2011-07-14 | 2014-03-18 | Med Works Limited | Guide wire incorporating a handle |
US9486605B2 (en) | 2011-07-15 | 2016-11-08 | Cook Medical Technologies Llc | Introducer sheath with braided filament securement mechanism |
US11026708B2 (en) | 2011-07-26 | 2021-06-08 | Thrombx Medical, Inc. | Intravascular thromboembolectomy device and method using the same |
CN102319097A (en) | 2011-08-04 | 2012-01-18 | 东莞永胜医疗制品有限公司 | Thrombus aspiration catheter and using method thereof |
WO2013022796A2 (en) | 2011-08-05 | 2013-02-14 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US8787944B2 (en) | 2011-08-18 | 2014-07-22 | Rivada Research, Llc | Method and system for providing enhanced location based information for wireless handsets |
DE102011111534A1 (en) | 2011-08-31 | 2013-02-28 | QUALIMED Innovative Medizinprodukte Gesellschaft mit beschränkter Haftung | aspiration |
WO2013050880A2 (en) | 2011-10-04 | 2013-04-11 | AVNERI, Ben-Ami | Devices and methods for percutaneous endarterectomy |
EP3738527A1 (en) | 2011-10-05 | 2020-11-18 | Pulsar Vascular, Inc. | Devices for enclosing an anatomical opening |
US9345511B2 (en) | 2011-10-13 | 2016-05-24 | Atheromed, Inc. | Atherectomy apparatus, systems and methods |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US8771341B2 (en) | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
WO2013070758A2 (en) | 2011-11-09 | 2013-05-16 | Boston Scientific Scimed, Inc. | Guide extension catheter |
DE102011120004B3 (en) | 2011-11-30 | 2013-03-14 | Universitätsklinikum Freiburg | Device for detaching wall-shaped thrombi from a body vessel |
US20130144328A1 (en) | 2011-12-06 | 2013-06-06 | Boston Scientific Scimed, Inc. | Expanding distal sheath with combined embolic protection |
GB2498175B (en) | 2011-12-19 | 2014-04-09 | Cook Medical Technologies Llc | Thrombus removal apparatus and method |
KR102044570B1 (en) | 2012-01-04 | 2019-12-05 | 라피드 메디칼 리미티드 | Braided devices for assisting medical treatments |
US20160081825A1 (en) | 2012-01-04 | 2016-03-24 | Rapid Medical Ltd. | Heat-treated braided intravascular devices and methods |
EP2808051B1 (en) | 2012-01-23 | 2020-03-11 | Terumo Kabushiki Kaisha | Medical tube, catheter, and method for producing medical tube |
CN104185490B (en) | 2012-01-31 | 2017-10-20 | 波士顿科学西美德公司 | Guiding extension conduit |
US10028854B2 (en) | 2012-02-02 | 2018-07-24 | Covidien Lp | Stent retaining systems |
WO2013119332A2 (en) | 2012-02-09 | 2013-08-15 | Stout Medical Group, L.P. | Embolic device and methods of use |
JP6149855B2 (en) | 2012-02-28 | 2017-06-21 | 住友ベークライト株式会社 | Medical equipment |
KR101871144B1 (en) | 2012-03-16 | 2018-06-27 | 마이크로벤션, 인코포레이티드 | Stent and stent delivery device |
US9011884B2 (en) | 2012-04-18 | 2015-04-21 | Microvention, Inc. | Embolic devices |
CN102698328B (en) | 2012-06-08 | 2014-12-03 | 李广成 | Double-container balanced lavaging device for hematoma remover |
JP6480327B2 (en) | 2012-06-14 | 2019-03-06 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Polymer therapeutic composition |
US8948832B2 (en) | 2012-06-22 | 2015-02-03 | Fitbit, Inc. | Wearable heart rate monitor |
US9211132B2 (en) | 2012-06-27 | 2015-12-15 | MicoVention, Inc. | Obstruction removal system |
US9445828B2 (en) | 2012-07-05 | 2016-09-20 | Cognition Medical Corp. | Methods, devices, and systems for postconditioning with clot removal |
US8684963B2 (en) | 2012-07-05 | 2014-04-01 | Abbott Cardiovascular Systems Inc. | Catheter with a dual lumen monolithic shaft |
JP5676054B2 (en) | 2012-07-10 | 2015-02-25 | パナソニックIpマネジメント株式会社 | CONTROL DEVICE AND OPERATION METHOD FOR INSERTION DEVICE, INSERTION DEVICE HAVING CONTROL DEVICE, CONTROL PROGRAM FOR INSERTION DEVICE, AND INTEGRATED ELECTRONIC CIRCUIT FOR CONTROLLING INSERTION DEVICE |
US20140025043A1 (en) | 2012-07-17 | 2014-01-23 | Boston Scientific Scimed, Inc. | Guide extension catheter |
JP6050045B2 (en) | 2012-07-20 | 2016-12-21 | テルモ株式会社 | Coronary catheter |
WO2014022310A1 (en) | 2012-08-01 | 2014-02-06 | Boston Scientific Scimed, Inc. | Guide extension catheters and methods for manufacturing the same |
US9332999B2 (en) | 2012-08-13 | 2016-05-10 | Covidien Lp | Apparatus and methods for clot disruption and evacuation |
US9332998B2 (en) | 2012-08-13 | 2016-05-10 | Covidien Lp | Apparatus and methods for clot disruption and evacuation |
US9770251B2 (en) | 2012-08-13 | 2017-09-26 | Microvention, Inc. | Shaped removal device |
US9597171B2 (en) | 2012-09-11 | 2017-03-21 | Covidien Lp | Retrieval catheter with expandable tip |
US9504476B2 (en) | 2012-10-01 | 2016-11-29 | Microvention, Inc. | Catheter markers |
WO2014062696A1 (en) | 2012-10-15 | 2014-04-24 | Microvention, Inc. | Polymeric treatment compositions |
US9044575B2 (en) | 2012-10-22 | 2015-06-02 | Medtronic Adrian Luxembourg S.a.r.l. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US20150257659A1 (en) | 2012-10-23 | 2015-09-17 | Koninklijke Philips N.V. | Device and method for obtaining vital sign information of a living being |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
WO2014076748A1 (en) | 2012-11-13 | 2014-05-22 | テルモ株式会社 | Catheter |
US8784434B2 (en) | 2012-11-20 | 2014-07-22 | Inceptus Medical, Inc. | Methods and apparatus for treating embolism |
EP2922590B1 (en) | 2012-11-21 | 2020-02-05 | Amgen Inc. | Drug delivery device |
US9539022B2 (en) | 2012-11-28 | 2017-01-10 | Microvention, Inc. | Matter conveyance system |
JP6054543B2 (en) | 2012-12-04 | 2016-12-27 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Device and method for obtaining vital sign information of a living body |
US20140163367A1 (en) | 2012-12-07 | 2014-06-12 | Covidien Lp | Microcatheter |
JP6391910B2 (en) | 2012-12-14 | 2018-09-19 | 株式会社グッドマン | Aspiration catheter |
DE102012112732B4 (en) | 2012-12-20 | 2019-06-19 | Acandis Gmbh | Medical device, system with such a device and manufacturing method |
US9358021B2 (en) | 2013-01-09 | 2016-06-07 | Covidien Lp | Connection of an endovascular intervention device to a manipulation member |
US20160256255A9 (en) | 2013-02-22 | 2016-09-08 | Jianlu Ma | Design and methods for a device with blood flow restriction feature for embolus removal in human vasculature |
CN105163789A (en) | 2013-03-01 | 2015-12-16 | 波士顿科学国际有限公司 | Guide extension catheter with a retractable wire |
US9370639B2 (en) | 2013-03-12 | 2016-06-21 | Cook Medical Technologies, LLC | Variable stiffness catheter |
US11154313B2 (en) | 2013-03-12 | 2021-10-26 | The Volcano Corporation | Vibrating guidewire torquer and methods of use |
US10531971B2 (en) | 2013-03-12 | 2020-01-14 | Abbott Cardiovascular System Inc. | Balloon catheter having hydraulic actuator |
JP6087020B2 (en) | 2013-03-12 | 2017-03-01 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Atherectomy device |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
WO2014140978A1 (en) | 2013-03-14 | 2014-09-18 | Koninklijke Philips N.V. | Device and method for obtaining vital sign information of a subject |
US9737328B2 (en) | 2013-03-14 | 2017-08-22 | Boston Scientific Limited | Hydrodynamic eccentrically pivoting catheter |
US9549783B2 (en) | 2013-03-15 | 2017-01-24 | Corindus, Inc. | Catheter system with magnetic coupling |
US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
ES2774327T3 (en) | 2013-03-15 | 2020-07-20 | Qxmedical Llc | Reinforcement catheter |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
AU2014228240A1 (en) | 2013-03-15 | 2015-11-05 | Zansors Llc | Health monitoring, surveillance and anomaly detection |
US10813663B2 (en) | 2013-03-15 | 2020-10-27 | National University Of Ireland, Galway | Device suitable for removing matter from inside the lumen and the wall of a body lumen |
CN105377184B (en) | 2013-03-15 | 2017-06-30 | 微仙美国有限公司 | Embolization protective device |
US20140271718A1 (en) | 2013-03-15 | 2014-09-18 | University Of Florida Research Foundation Incorporated | Novel type 1 diabetes vaccines, and methods of use |
WO2014151209A1 (en) | 2013-03-18 | 2014-09-25 | Virginia Commonwealth Univerisity | Dynamic aspiration methods and systems |
US9693789B2 (en) | 2013-03-29 | 2017-07-04 | Silk Road Medical, Inc. | Systems and methods for aspirating from a body lumen |
CN203263993U (en) | 2013-04-02 | 2013-11-06 | 业聚医疗器械(深圳)有限公司 | Fast switching guide catheter |
ITMI20130516A1 (en) | 2013-04-05 | 2014-10-06 | Sofar Spa | SURGICAL SYSTEM WITH STERILE TOWELS |
US20140330286A1 (en) | 2013-04-25 | 2014-11-06 | Michael P. Wallace | Methods and Devices for Removing Obstructing Material From the Human Body |
US20150005704A1 (en) | 2013-05-07 | 2015-01-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Steerable Medical Device Having Multiple Curve Profiles |
US9629978B2 (en) | 2013-05-20 | 2017-04-25 | Clph, Llc | Catheters with intermediate layers and methods for making them |
US10322260B2 (en) * | 2013-05-30 | 2019-06-18 | Terumo Kabushiki Kaisha | Treatment method for treating lower limbs using multi-member catheter assembly |
US20150335288A1 (en) | 2013-06-06 | 2015-11-26 | Tricord Holdings, Llc | Modular physiologic monitoring systems, kits, and methods |
WO2014203336A1 (en) | 2013-06-18 | 2014-12-24 | 住友ベークライト株式会社 | Medical device and method for manufacturing medical device |
US20160151010A1 (en) | 2013-07-17 | 2016-06-02 | Glucocheck Ltd. | Blood sampling device and methods |
KR102129536B1 (en) | 2013-08-06 | 2020-07-03 | 삼성전자주식회사 | Mobile terminal and method for controlling the mobile terminal |
US9827126B2 (en) | 2013-08-27 | 2017-11-28 | Covidien Lp | Delivery of medical devices |
AU2014321278B2 (en) | 2013-09-19 | 2016-11-10 | Microvention, Inc. | Polymer films |
CA2923753C (en) | 2013-09-19 | 2021-10-12 | Terumo Corporation | Polymer particles |
JP6554475B2 (en) | 2013-10-16 | 2019-07-31 | メッドワークス,エルエルシーMedwerks, Llc | Non-invasive medical device |
US9913961B2 (en) | 2013-10-24 | 2018-03-13 | St. Jude Medical, Cardiology Division, Inc. | Flexible catheter shaft and method of manufacture |
US10695025B2 (en) | 2013-11-07 | 2020-06-30 | The Board Of Trustees Of The Leland Stanford Junior University | Wearable ultrasonic device for circulating tumor cell detection |
AU2014346486B2 (en) | 2013-11-08 | 2016-12-08 | Terumo Corporation | Polymer particles |
US10639061B2 (en) | 2013-11-11 | 2020-05-05 | Cook Medical Technologies Llc | Devices and methods for modifying veins and other bodily vessels |
US10278592B2 (en) | 2013-12-09 | 2019-05-07 | Samsung Electronics Co., Ltd. | Modular sensor platform |
US10219814B2 (en) | 2013-12-13 | 2019-03-05 | Rex Medical, L.P. | Aspiration system for thrombectomy procedures |
EP3082930B1 (en) | 2013-12-20 | 2019-07-17 | Boston Scientific Scimed, Inc. | Integrated catheter system |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
EP3348214A1 (en) | 2014-02-03 | 2018-07-18 | Medinol Ltd. | Improved device for traversing vessel occlusions |
US9789283B2 (en) | 2014-02-03 | 2017-10-17 | Medinol Ltd. | Catheter tip assembled with a spring |
US9999355B2 (en) | 2014-02-12 | 2018-06-19 | Koninklijke Philips N.V. | Device, system and method for determining vital signs of a subject based on reflected and transmitted light |
US20160066921A1 (en) | 2014-02-21 | 2016-03-10 | Neuravi Limited | DEVICE AND METHOD FOR ENDOVASCULAR TREATMENT OF ANEURYSMS USING EMBOLIC ePTFE |
CN105120776A (en) | 2014-03-20 | 2015-12-02 | 波士顿科学有限公司 | Thrombectomy catheter |
US20150269825A1 (en) | 2014-03-20 | 2015-09-24 | Bao Tran | Patient monitoring appliance |
US9241699B1 (en) * | 2014-09-04 | 2016-01-26 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US9820761B2 (en) | 2014-03-21 | 2017-11-21 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
US9433427B2 (en) | 2014-04-08 | 2016-09-06 | Incuvate, Llc | Systems and methods for management of thrombosis |
JP5954748B2 (en) | 2014-04-25 | 2016-07-20 | 朝日インテック株式会社 | catheter |
US9883877B2 (en) | 2014-05-19 | 2018-02-06 | Walk Vascular, Llc | Systems and methods for removal of blood and thrombotic material |
JP6344762B2 (en) | 2014-05-21 | 2018-06-20 | 朝日インテック株式会社 | catheter |
US10792056B2 (en) | 2014-06-13 | 2020-10-06 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
WO2015189354A1 (en) | 2014-06-13 | 2015-12-17 | Neuravi Limited | Devices for removal of acute blockages from blood vessels |
US10478127B2 (en) | 2014-06-23 | 2019-11-19 | Sherlock Solutions, LLC | Apparatuses, methods, processes, and systems related to significant detrimental changes in health parameters and activating lifesaving measures |
US10265086B2 (en) | 2014-06-30 | 2019-04-23 | Neuravi Limited | System for removing a clot from a blood vessel |
EP3164086B1 (en) | 2014-07-01 | 2020-04-08 | Boston Scientific Scimed, Inc. | Overlapped braid termination |
CN204158457U (en) | 2014-07-14 | 2015-02-18 | 业聚医疗器械(深圳)有限公司 | The conduit of band cutting atherosclerotic plaque and pumping function |
US10456552B2 (en) | 2014-07-28 | 2019-10-29 | Mayank Goyal | System and methods for intracranial vessel access |
EP3174591B1 (en) | 2014-07-28 | 2023-11-15 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US20160030079A1 (en) * | 2014-08-01 | 2016-02-04 | Patrick Cohen | Cannula assembly |
US10792043B2 (en) | 2014-08-07 | 2020-10-06 | Perflow Medical Ltd. | Aneurysm treatment device and method |
CN107206208B (en) | 2014-08-22 | 2020-12-15 | 杰万特·P·帕马 | Advanced electromagnetic motion and tracking peripherally inserted central catheter system with extended intravascular applications |
US9801643B2 (en) | 2014-09-02 | 2017-10-31 | Cook Medical Technologies Llc | Clot retrieval catheter |
US20160136398A1 (en) | 2014-10-31 | 2016-05-19 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
WO2016073498A1 (en) | 2014-11-07 | 2016-05-12 | Boston Scientific Scimed, Inc. | Medical device having an atraumatic distal tip |
US20160135829A1 (en) | 2014-11-13 | 2016-05-19 | Angiodynamics, Inc. | Systems and methods for en bloc removal of undesirable material from passageways |
WO2016081950A1 (en) | 2014-11-21 | 2016-05-26 | Microvention, Inc. | Improved reinforced balloon catheter |
US9943321B2 (en) | 2014-12-16 | 2018-04-17 | Penumbra, Inc. | Methods and devices for removal of thromboembolic material |
US20160166265A1 (en) | 2014-12-16 | 2016-06-16 | Penumbra Inc. | Methods and Devices for Removal of Thromboembolic Material |
US10518066B2 (en) | 2015-01-09 | 2019-12-31 | Mivi Neuroscience, Inc. | Medical guidewires for tortuous vessels |
CN107427377B (en) | 2015-01-12 | 2019-09-03 | 微仙美国有限公司 | Bracket |
ES2577288B8 (en) | 2015-01-13 | 2019-01-10 | Anaconda Biomed S L | Device for thrombectomy |
CN107205663A (en) | 2015-01-19 | 2017-09-26 | 皇家飞利浦有限公司 | Equipment, system and method for skin detection |
US20160213396A1 (en) | 2015-01-22 | 2016-07-28 | Cook Medical Technologies Llc | Catheter with an auger and method of use thereof |
US10426497B2 (en) | 2015-07-24 | 2019-10-01 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
EP4137070A1 (en) * | 2015-02-04 | 2023-02-22 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system |
KR20170115574A (en) | 2015-02-06 | 2017-10-17 | 라피드 메디칼 리미티드 | Systems and methods for removing vascular occlusion |
US9987028B2 (en) | 2015-02-12 | 2018-06-05 | Cook Medical Technologies Llc | Partially covered braided funnel aspiration catheter |
US20160242764A1 (en) | 2015-02-24 | 2016-08-25 | Silk Road Medical, Inc. | Suture Delivery Device |
US20160242893A1 (en) | 2015-02-25 | 2016-08-25 | Microvention, Inc. | Stent And Filter |
WO2016138443A2 (en) | 2015-02-26 | 2016-09-01 | Stryker Corporation | Surgical instrument with articulation region |
CN204909516U (en) * | 2015-02-28 | 2015-12-30 | 卡迪欧凯尼迪克斯公司 | System of vascular system through patient of marcing and carry out external member of surgery operation to patient's chambers of heart |
EP3265064A4 (en) | 2015-03-04 | 2018-11-07 | Microvention, Inc. | Drug delivery device |
JP6694870B2 (en) | 2015-03-11 | 2020-05-20 | テルモ株式会社 | Foreign matter removal device |
CN104622538A (en) | 2015-03-12 | 2015-05-20 | 湖南瑞康通科技发展有限公司 | Thrombus excision system |
WO2016154592A1 (en) | 2015-03-26 | 2016-09-29 | Microvention, Inc. | Embiolic particles |
EP3280354B1 (en) | 2015-04-10 | 2019-09-04 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
CN107708610A (en) | 2015-04-30 | 2018-02-16 | 丝绸之路医药公司 | System and method for being treated through conduit aorta petal |
CN107278160B (en) * | 2015-05-26 | 2019-02-15 | 泰利福创新有限责任公司 | Seal wire ligamentopexis |
US10398874B2 (en) | 2015-05-29 | 2019-09-03 | Covidien Lp | Catheter distal tip configuration |
EP4233738A3 (en) | 2015-05-29 | 2023-10-18 | Microvention, Inc. | Catheter circuit |
WO2016201250A1 (en) | 2015-06-11 | 2016-12-15 | Microvention, Inc. | Expansile device for implantation |
US10631893B2 (en) | 2015-07-10 | 2020-04-28 | Warsaw Orthopedic, Inc. | Nerve and soft tissue removal device |
US10888280B2 (en) | 2016-09-24 | 2021-01-12 | Sanmina Corporation | System and method for obtaining health data using a neural network |
US20170028170A1 (en) | 2015-07-28 | 2017-02-02 | Andrew Ho, M.D., Inc. | Guide catheter extension device and methods of use for cardiology procedures |
US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
WO2017025775A1 (en) | 2015-08-11 | 2017-02-16 | Latvijas Universitate | Device for adaptive photoplethysmography imaging |
CN107847243B (en) | 2015-08-11 | 2021-06-01 | 泰尔茂株式会社 | Systems and methods for implant delivery |
WO2017040484A1 (en) | 2015-08-31 | 2017-03-09 | Gentuity, Llc | Imaging system includes imaging probe and delivery devices |
US10463386B2 (en) | 2015-09-01 | 2019-11-05 | Mivi Neuroscience, Inc. | Thrombectomy devices and treatment of acute ischemic stroke with thrombus engagement |
US20170072163A1 (en) | 2015-09-11 | 2017-03-16 | Cathera, Inc. | Catheter shaft and associated devices, systems, and methods |
US20170072165A1 (en) | 2015-09-11 | 2017-03-16 | Cathera, Inc. | Catheter shaft and associated devices, systems, and methods |
US11253292B2 (en) | 2015-09-13 | 2022-02-22 | Rex Medical, L.P. | Atherectomy device |
EP3349669B1 (en) | 2015-09-18 | 2020-10-21 | Terumo Corporation | Vessel prosthesis |
WO2017049312A1 (en) | 2015-09-18 | 2017-03-23 | Microvention, Inc. | Releasable delivery system |
JP6938471B2 (en) | 2015-09-18 | 2021-09-22 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Implant retention, separation and pressing system |
JP6854282B2 (en) | 2015-09-18 | 2021-04-07 | テルモ株式会社 | Pressable implant delivery system |
US10639456B2 (en) | 2015-09-28 | 2020-05-05 | Microvention, Inc. | Guidewire with torque transmission element |
EP3406208B1 (en) | 2015-09-28 | 2020-01-22 | Stryker Corporation | Mechanical thrombectomy apparatuses |
US20170100142A1 (en) | 2015-10-09 | 2017-04-13 | Incuvate, Llc | Systems and methods for management of thrombosis |
EP3361944A4 (en) | 2015-10-12 | 2019-05-29 | Northwestern University | Ambulatory blood pressure and vital sign monitoring apparatus, system and method |
JP6941098B2 (en) | 2015-10-28 | 2021-09-29 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Equipment and methods for determining SUVs in radiation tomography |
EP3368137B1 (en) | 2015-10-30 | 2021-03-03 | CereVasc, Inc. | Systems for treating hydrocephalus |
BR112018008678B1 (en) | 2015-10-31 | 2022-11-29 | NeuroVasc Technologies, Inc | BLOOD FLOW RESTRICTED PISTRO REMOVAL DEVICE AND RELATED METHODS |
US10413226B2 (en) | 2015-11-09 | 2019-09-17 | Arizona Board Of Regents On Behalf Of Arizona State University | Noncontact monitoring of blood oxygen saturation using camera |
WO2017087816A1 (en) | 2015-11-19 | 2017-05-26 | Penumbra, Inc. | Systems and methods for treatment of stroke |
WO2017087923A1 (en) | 2015-11-21 | 2017-05-26 | Boston Scientific Scimed Inc. | Force sensing catheter with a slotted tube element |
US10716915B2 (en) | 2015-11-23 | 2020-07-21 | Mivi Neuroscience, Inc. | Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems |
US10617509B2 (en) * | 2015-12-29 | 2020-04-14 | Emboline, Inc. | Multi-access intraprocedural embolic protection device |
US20170189033A1 (en) | 2016-01-06 | 2017-07-06 | Microvention, Inc. | Occlusive Embolic Coil |
AU2017217879B9 (en) | 2016-02-10 | 2021-08-19 | Microvention, Inc. | Intravascular treatment site access |
US10729447B2 (en) | 2016-02-10 | 2020-08-04 | Microvention, Inc. | Devices for vascular occlusion |
CN113350655B (en) | 2016-02-24 | 2024-03-19 | 禾木(中国)生物工程有限公司 | Nerve vascular catheter with enhanced flexibility |
US10828061B2 (en) | 2016-03-03 | 2020-11-10 | Boston Scientific Scimed, Inc. | Accessory devices for use with catheters |
US10583270B2 (en) | 2016-03-14 | 2020-03-10 | Covidien Lp | Compound curve navigation catheter |
WO2017201316A1 (en) | 2016-05-18 | 2017-11-23 | Microvention, Inc. | Embolic containment |
WO2017201288A1 (en) | 2016-05-19 | 2017-11-23 | Acist Medical Systems, Inc. | Position sensing in intravascular processes |
US10653873B2 (en) | 2016-05-26 | 2020-05-19 | Merit Medical Systems, Inc. | Expandable introducer assembly |
CN109890452B (en) | 2016-06-01 | 2021-08-17 | 微仙美国有限公司 | Balloon catheter with improved reinforcement |
CN111904522B (en) | 2016-06-10 | 2023-06-16 | 泰尔茂株式会社 | Vascular occlusion device |
EP3474740A1 (en) | 2016-06-24 | 2019-05-01 | Koninklijke Philips N.V. | System and method for vital signs detection |
US10980555B2 (en) | 2016-07-12 | 2021-04-20 | Cardioprolific Inc. | Methods and devices for clots and tissue removal |
BR112019001481A2 (en) | 2016-07-26 | 2019-04-30 | Neuravi Limited | clot removal system to remove occlusive clots from a blood vessel |
WO2018029033A1 (en) | 2016-08-09 | 2018-02-15 | Koninklijke Philips N.V. | Device, system and method for monitoring of peripheral arterial perfusion of a subject |
JP7061996B6 (en) | 2016-08-09 | 2022-06-06 | コーニンクレッカ フィリップス エヌ ヴェ | Device for use in blood oxygen saturation measurement |
US20180042623A1 (en) | 2016-08-11 | 2018-02-15 | Stanley Batiste | Blood Clot Aspiration Catheter |
US11350825B2 (en) | 2016-08-25 | 2022-06-07 | Vivonics, Inc. | Contactless system and method for measuring and continuously monitoring arterial blood pressure |
US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
US10610668B2 (en) | 2016-10-05 | 2020-04-07 | Becton, Dickinson And Company | Catheter with an asymmetric tip |
CA3041271A1 (en) | 2016-10-19 | 2018-04-26 | Medtec Medical, Inc. | Electronic vacuum regulator device |
US9775730B1 (en) | 2016-11-02 | 2017-10-03 | Walzman Innovations, Llc | Flow-diverting covered stent |
TW201825137A (en) | 2016-11-25 | 2018-07-16 | 日商住友電木股份有限公司 | Catheter and process for producing catheter |
CN108245292B (en) | 2016-12-29 | 2019-11-08 | 先健科技(深圳)有限公司 | Conveying device and transportation system |
CN110381855B (en) | 2017-01-06 | 2023-07-04 | 因赛普特有限责任公司 | Antithrombotic coating for aneurysm treatment devices |
US10905853B2 (en) | 2017-01-17 | 2021-02-02 | DePuy Synthes Products, Inc. | System and method for delivering a catheter |
WO2018136745A1 (en) | 2017-01-20 | 2018-07-26 | Route 92 Medical, Inc. | Single operator intracranial medical device delivery systems and methods of use |
US10912919B2 (en) | 2017-01-23 | 2021-02-09 | Edwards Lifesciences Corporation | Expandable sheath |
US20180228502A1 (en) | 2017-02-13 | 2018-08-16 | Penumbra, Inc. | Dual lumen hypotube catheter |
EP3554391A4 (en) | 2017-02-24 | 2020-09-16 | Inceptus Medical LLC | Vascular occlusion devices and methods |
US11123098B2 (en) | 2017-02-28 | 2021-09-21 | Angiosafe, Inc. | Device and method for centering and crossing a vascular occlusion |
WO2018169032A1 (en) | 2017-03-16 | 2018-09-20 | テルモ株式会社 | Catheter assembly |
EP3603726B1 (en) | 2017-03-29 | 2024-02-21 | Terumo Kabushiki Kaisha | Catheter assembly |
WO2018193601A1 (en) | 2017-04-20 | 2018-10-25 | 朝日インテック株式会社 | Catheter |
US10537710B2 (en) | 2017-04-20 | 2020-01-21 | Covidien Lp | Catheter including an inner liner with a flexible distal section |
CN110650695B (en) | 2017-05-23 | 2023-05-12 | 朝日英达科株式会社 | Assisted jet aspiration thrombectomy catheter and method of use |
US10478535B2 (en) | 2017-05-24 | 2019-11-19 | Mivi Neuroscience, Inc. | Suction catheter systems for applying effective aspiration in remote vessels, especially cerebral arteries |
US11234723B2 (en) | 2017-12-20 | 2022-02-01 | Mivi Neuroscience, Inc. | Suction catheter systems for applying effective aspiration in remote vessels, especially cerebral arteries |
EP3632494A4 (en) | 2017-05-26 | 2021-03-17 | Sumitomo Bakelite Co., Ltd. | Catheter |
US11432835B2 (en) | 2017-06-07 | 2022-09-06 | Penumbra, Inc. | Apparatus and methods for clot aspiration |
EP4085853A1 (en) | 2017-07-31 | 2022-11-09 | Boston Scientific Scimed, Inc. | Introducer system with expandable capabilities |
JP7006020B2 (en) | 2017-08-25 | 2022-01-24 | 住友ベークライト株式会社 | Catheter and catheter kit |
US20190070387A1 (en) | 2017-09-02 | 2019-03-07 | Mayank Goyal | System and methods for accessing and treating cerebral venous sinus thrombosis |
US10105154B1 (en) | 2017-11-09 | 2018-10-23 | Pebble Hill Partners, Llc | Basket for a catheter device |
CN108013918B (en) | 2017-12-26 | 2018-06-29 | 微创心脉医疗科技(上海)有限公司 | One kind takes bolt conduit |
EP3742991A4 (en) | 2018-01-25 | 2021-09-22 | Ischemicure Ltd. | Devices, systems and methods to remove blood clots |
WO2019147414A1 (en) | 2018-01-26 | 2019-08-01 | Smith & Nephew, Inc. | Tissue collection and delivery device and methods of use thereof |
US11154314B2 (en) | 2018-01-26 | 2021-10-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
JP2021517850A (en) | 2018-03-12 | 2021-07-29 | エクストラクト メディカル,インコーポレイティド | Devices and methods for removing substances from patients |
EP3539486A1 (en) | 2018-03-13 | 2019-09-18 | The University of Toledo | Minimally invasive thrombectomy |
CA3095844A1 (en) | 2018-05-01 | 2019-11-07 | Incept, Llc | Devices and methods for removing obstructive material from an intravascular site |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
JP2021523793A (en) | 2018-05-17 | 2021-09-09 | ルート92メディカル・インコーポレイテッドRoute 92 Medical, Inc. | Suction catheter system and how to use |
US20200289136A1 (en) | 2018-05-17 | 2020-09-17 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US10716880B2 (en) | 2018-06-15 | 2020-07-21 | Incuvate, Llc | Systems and methods for aspiration and monitoring |
WO2019246583A1 (en) | 2018-06-21 | 2019-12-26 | Nasser Rafiee | Guidewires and related methods and systems |
US11517335B2 (en) | 2018-07-06 | 2022-12-06 | Incept, Llc | Sealed neurovascular extendable catheter |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
DE102018212091A1 (en) | 2018-07-19 | 2020-01-23 | Siemens Healthcare Gmbh | Determination of a load-optimized MR sequence |
US10531883B1 (en) | 2018-07-20 | 2020-01-14 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
CN112533550A (en) | 2018-07-24 | 2021-03-19 | 半影公司 | Device and method for controlled clot aspiration |
AU2019321256B2 (en) | 2018-08-13 | 2023-06-22 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US20210001141A1 (en) | 2018-10-22 | 2021-01-07 | Joovv, Inc. | Photobiomodulation therapy systems and devices |
US11020014B2 (en) | 2018-11-30 | 2021-06-01 | Microsoft Technology Licensing, Llc | Photoplethysmogram device with skin temperature regulator |
TR201900192A2 (en) | 2019-01-08 | 2019-02-21 | Canakkale Onsekiz Mart Ueniversitesi Rektoerluegue | INTERNAL MOVING ASPIRATION CATHETER |
US20200297972A1 (en) | 2019-02-27 | 2020-09-24 | Imperative Care, Inc. | Catheter with seamless flexibility transitions |
US20200345979A1 (en) | 2019-03-22 | 2020-11-05 | Yince Loh | Transradial Access Systems Particularly Useful for Cerebral Access |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
CN114502086A (en) | 2019-07-19 | 2022-05-13 | 万能医药公司 | Device and method for aspirating thrombi |
US20210093336A1 (en) | 2019-10-01 | 2021-04-01 | Incept, Llc | Embolic retrieval catheter |
JP7339355B2 (en) | 2019-10-03 | 2023-09-05 | 朝日インテック株式会社 | medical tubular body |
JP2022551988A (en) | 2019-10-15 | 2022-12-14 | インパラティブ、ケア、インク. | Systems and methods for multivariate stroke detection |
CN114555168A (en) | 2019-11-08 | 2022-05-27 | 朝日英达科株式会社 | Catheter tube |
GB201917184D0 (en) | 2019-11-26 | 2020-01-08 | Univ Sheffield | Guiding device for a vascular catheter |
US11426076B2 (en) | 2019-11-27 | 2022-08-30 | Vivonics, Inc. | Contactless system and method for assessing and/or determining hemodynamic parameters and/or vital signs |
CN110916768A (en) | 2019-11-29 | 2020-03-27 | 昆山金泰医疗科技有限公司 | High-efficient spiral shell rotary-cut bolt device |
JP2023507553A (en) | 2019-12-18 | 2023-02-24 | インパラティブ、ケア、インク. | Methods and systems for treating venous thromboembolism |
US20210315598A1 (en) | 2019-12-18 | 2021-10-14 | Imperative Care, Inc. | Methods of placing large bore aspiration catheters |
US11638637B2 (en) | 2019-12-18 | 2023-05-02 | Imperative Care, Inc. | Method of removing embolic material with thrombus engagement tool |
US20210353314A1 (en) | 2020-01-23 | 2021-11-18 | Stryker Corporation | Mechanically resonant pulse relief valve for assisted clearing of plugged aspiration |
US11617865B2 (en) | 2020-01-24 | 2023-04-04 | Mivi Neuroscience, Inc. | Suction catheter systems with designs allowing rapid clearing of clots |
EP4153286A1 (en) | 2020-05-22 | 2023-03-29 | Orbusneich Medical Pte. Ltd | Pre-shaped medical devices |
EP4157427A2 (en) | 2020-05-27 | 2023-04-05 | Embrace Medical Ltd. | Vascular access catheter |
US20220047849A1 (en) | 2020-08-11 | 2022-02-17 | Imperative Care, Inc. | Catheter with a preset curve |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
US11523841B2 (en) | 2020-09-03 | 2022-12-13 | Cardiovascular Systems, Inc. | Systems, methods and devices for removal of thrombus and/or soft plaque with asymmetric mass distribution within working region of impeller |
CN116456917A (en) | 2020-11-13 | 2023-07-18 | 微仙美国有限公司 | Distal aspiration catheter and method |
US20230064188A1 (en) | 2021-08-31 | 2023-03-02 | Imperative Care, Inc. | Neurovascular access catheter with microcatheter segment |
US20230061728A1 (en) | 2021-08-31 | 2023-03-02 | Imperative Care, Inc. | Neurovascular access catheter with microcatheter segment |
KR20230036992A (en) | 2021-09-08 | 2023-03-15 | 뉴라비 리미티드 | Neuro access guide wire |
-
2020
- 2020-12-16 JP JP2022530917A patent/JP2023507553A/en active Pending
- 2020-12-16 EP EP20904092.2A patent/EP4076611A4/en active Pending
- 2020-12-16 CA CA3162704A patent/CA3162704A1/en active Pending
- 2020-12-16 WO PCT/US2020/065349 patent/WO2021127004A1/en unknown
- 2020-12-16 CN CN202080009666.7A patent/CN113365687A/en active Pending
- 2020-12-17 US US17/125,723 patent/US11065018B2/en active Active
- 2020-12-17 US US17/125,743 patent/US11253277B2/en active Active
- 2020-12-17 US US17/125,742 patent/US20210186537A1/en active Pending
- 2020-12-17 US US17/125,217 patent/US11819228B2/en active Active
-
2022
- 2022-07-05 US US17/810,743 patent/US20230015259A1/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11850349B2 (en) | 2018-07-06 | 2023-12-26 | Incept, Llc | Vacuum transfer tool for extendable catheter |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
US11819228B2 (en) | 2019-12-18 | 2023-11-21 | Imperative Care, Inc. | Methods and systems for treating a pulmonary embolism |
Also Published As
Publication number | Publication date |
---|---|
US11253277B2 (en) | 2022-02-22 |
US20210186536A1 (en) | 2021-06-24 |
US20210187244A1 (en) | 2021-06-24 |
CN113365687A (en) | 2021-09-07 |
EP4076611A1 (en) | 2022-10-26 |
US20210186537A1 (en) | 2021-06-24 |
JP2023507553A (en) | 2023-02-24 |
WO2021127004A1 (en) | 2021-06-24 |
EP4076611A4 (en) | 2023-11-15 |
US20210186542A1 (en) | 2021-06-24 |
CA3162704A1 (en) | 2021-06-24 |
US11819228B2 (en) | 2023-11-21 |
US11065018B2 (en) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230015259A1 (en) | Inserter for guiding a device through a hemostasis valve and method thereof | |
US11457936B2 (en) | Catheter system for treating thromboembolic disease | |
US11633272B2 (en) | Manually rotatable thrombus engagement tool | |
US11147949B2 (en) | Method of making an enhanced flexibility neurovascular catheter | |
US20190381221A1 (en) | Suction catheter systems for applying effective aspiration in remote vessels, especially cerebral arteries | |
EP3753599B1 (en) | Systems for treatment of acute ischemic stroke | |
US20210386440A1 (en) | Hydraulic displacement and removal of thrombus clots, and catheters for performing hydraulic displacement | |
US8241315B2 (en) | Apparatus and method for treating occluded vasculature | |
US20230248502A1 (en) | Sterile field clot capture module for use in thrombectomy system | |
WO2023220707A2 (en) | Transvascular thrombectomy system | |
EP4171400A1 (en) | Aspiration system with accelerated response |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: IMPERATIVE CARE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BUCK, MICHAEL;FOX, JULIA;JACOBS, JAMES;REEL/FRAME:061547/0297 Effective date: 20221005 |